EurekaMag PDF full texts Chapter 53,470

Li, Y.; Wang, H.-J.; Lin, B.; Zhao, Z.; Zhou, Y. 2012: HPLC fingerprint chromatogram of Polygonum multiflorum from Guizhou. Zhong Yao Cai 35(12): 1928-1932

Ma, S.-Y.; Lin, S.; Guan, W.-W.; Liu, M.-S. 2014: HPLC fingerprint of Callicarpa nudiflora. Zhong Yao Cai 37(3): 404-408

Peng, R.; Ma, P.; Li, L.; Wei, Y. 2010: HPLC fingerprint of Codonopsis tangshen from different habitats. Zhongguo Zhong Yao Za Zhi 35(2): 183-186

Zhao, P.; Xu, H.; Xu, J.; Zhang, T.; Zhu, X. 2010: HPLC fingerprint of Euodiae Fructus. Zhongguo Zhong Yao Za Zhi 35(23): 3178-3183

Zhang, C.-F.; Chen, L.-X.; Zhang, M.; Wang, Z.-T. 2008: HPLC fingerprint of Herba Senecionis Scandentis and its ESI-MS analysis. Zhongguo Zhong Yao Za Zhi 33(18): 2093-2096

Gao, X.-B.; Sun, L.; Qiao, S.-Y.; Gao, S.; Che, Y.-Z.; Zhang, K.-R. 2012: HPLC fingerprint of Liuwei Dihuang condensed pills. Zhongguo Zhong Yao Za Zhi 37(22): 3411-3415

Yang, Y.; Jiang, L.; Zheng, G.-d.; Lin, L.-w.; Chen, J.-l.; Zhou, W. 2011: HPLC fingerprint of Pericarpium Citri Reticultae from Guangdong province. Zhong Yao Cai 34(2): 191-195

Gao, Y.-l.; Lin, R.-c.; Wang, G.-l.; Zhao, H.-r.; Gao, Y.; Bianba, C.-r. 2007: HPLC fingerprint of Phlomis younghusbandii. Zhong Yao Cai 30(8): 919-922

Wen, Y.; Zhang, M.; Liao, Z.-H.; Sun, M.; Chen, M. 2008: HPLC fingerprint of Pinellia ternata. Zhong Yao Cai 31(4): 503-506

Marrassini, C.; Anesini, C.; Ferraro, G. 2011: HPLC fingerprint of a flower extract of Tilia × viridis and correlation with antiproliferative and antioxidant activity. PhytoTherapy Research: Ptr 25(10): 1466-1471

Liu, Y.-f.; Yang, X.-w. 2009: HPLC fingerprint of chemical constituents of Flos Farfarae. Yao Xue Xue Bao 44(5): 510-514

Wang, L.-J.; Lin, L.; Wei, H.; She, D.; Huang, X.-L. 2012: HPLC fingerprint of citri grandis exocarpium from different cultivars. Zhongguo Zhong Yao Za Zhi 37(20): 3092-3096

Liang, J.-P.; Liu, Z.-Z.; Peng, W.; Su, W.-W. 2012: HPLC fingerprint of compound xueshuantong capsule. Zhong Yao Cai 35(11): 1854-1858

Zhou, M.; Chen, H.-G.; Xian, C.; Huang, Z.-J.; Zhou, X. 2013: HPLC fingerprint of ethyl acetate extraction of Saxifraga stolonifera. Zhongguo Zhong Yao Za Zhi 38(7): 1026-1029

Ou, H.-J.; Cheng, J.-L.; Li, X.-X.; Zhan, R.-T.; Liang, Y.-Z.; Xu, J.-Y.; Xu, H.; Yan, P. 2009: HPLC fingerprint of flavonoids and phenols of Dendrobium nobile. Zhong Yao Cai 32(6): 871-874

Ma, H.-Y.; Zhou, W.-S.; Chu, F.-J.; Wang, D.; Liang, S.-W.; Li, S. 2013: HPLC fingerprint of flavonoids in Sophora flavescens and determination of five components. Zhongguo Zhong Yao Za Zhi 38(16): 2690-2695

Liu, B.; Shi, R.-b.; Zhu, L.-j. 2007: HPLC fingerprint of flavonoids of Kushen Tang and its correlation to Scutellaria baicalensis and Sophora flavescens. Zhongguo Zhong Yao Za Zhi 32(16): 1631-1634

Sun, L.; Jin, Y.; Liu, X.-Q.; Qiao, S.-Y.; Gao, S.; Che, Y.-Z. 2014: HPLC fingerprint of glycyrrhizea radix et rhizoma praeparata cum melle. Zhongguo Zhong Yao Za Zhi 39(11): 2056-2059

Zhou, W.; Jiang, L.; Wang, X.-J.; Tao, H.; Zhen, X.-K.; Hu, J.-T. 2012: HPLC fingerprint of scrophulariae radix from southwest China. Zhong Yao Cai 35(8): 1230-1233

Duan, X.-Y.; Gong, Z.-F.; Chen, S.-H.; Fang, Y.; Liu, Y.-W. 2009: HPLC fingerprint of the antiarrhythmic fraction of Valeriana officinalis. Zhong Yao Cai 32(6): 866-870

Hao, X.-l.; Zhang, S.-q.; Wang, X.-j.; Li, Q.-s. 2008: HPLC fingerprint of total flavonoids of Folium Apocyni Veneti. Zhongguo Zhong Yao Za Zhi 33(16): 1968-1971

Zhou, Q.; Lv, J.; Li, G.; Shi, D.; Dai, Y.; Sun, L. 2010: HPLC fingerprint spectrum of honey-fried Radix Glycyrrhizae. Zhongguo Zhong Yao Za Zhi 35(12): 1547-1550

Tan, X.-F.; Li, X.-J.; Wang, Q.; Shi, M.-H.; Yang, J.; Cao, Y. 2011: HPLC fingerprint spectrum of xinjiang uyghur medicine Nigella glandulifera seed. Zhong Yao Cai 34(12): 1857-1860

Chen, X.-D.; Zhang, G.-D.; Lan, X.-Y.; Liu, F.-J.; Wei, M. 2013: HPLC fingerprint study for the quality evaluation of atractylodis macrocephalae rhizoma. Zhong Yao Cai 36(2): 208-212

Wang, G.-n.; Liao, H.-w.; Chen, Q.; Chen, Q.-l.; Lu, B. 2013: HPLC fingerprint study on Chaenomelis fructus and comparative study on different processed products. Zhong Yao Cai 36(11): 1758-1761

Cheng, X.-m.; Zhao, T.; Yang, T.; Wang, C.-h.; Bligh, S.W.A.; Wang, Z.-t. 2010: HPLC fingerprints combined with principal component analysis, hierarchical cluster analysis and linear discriminant analysis for the classification and differentiation of Peganum sp. indigenous to China. Phytochemical Analysis: Pca 21(3): 279-289

Liu, H.-T.; Cao, M.-P.; Zhang, X.-F.; Si, J.-P. 2013: HPLC fingerprints establishment of chemical constituents in genus Chimonanthus leaves. Zhongguo Zhong Yao Za Zhi 38(10): 1560-1563

Wang, Y.; Guo, M.-L.; Wang, X.-K.; Yin, J. 2008: HPLC fingerprints in seed of Celosia argentea. Zhongguo Zhong Yao Za Zhi 33(1): 51-53

Li, P.; Zhao, X.; Zhang, L.; Ding, A. 2009: HPLC fingerprints of Cortex Moutan Carbonisatum. Zhongguo Zhong Yao Za Zhi 34(19): 2463-2465

Zhang, C.; Li, L.; Xiao, Y.; Pang, Z.; Li, G. 2010: HPLC fingerprints of processed products from Sinapis alba. Zhongguo Zhong Yao Za Zhi 35(21): 2842-2845

Fei, Y.; Zhong, G.-Y.; Jiang, W. 2014: HPLC fingerprints of tibetan medicinal herb "songdi" (Saxifraga umbellulata var. pectinata). Zhongguo Zhong Yao Za Zhi 39(13): 2542-2546

Çakar, M.B.; Ulu, S.T. 2014: HPLC fluorescence method for the determination of nizatidine in human plasma and its application to pharmacokinetic study. Luminescence: the Journal of Biological and Chemical Luminescence 29(4): 357-361

Wu, C.-h.; Wang, X.; Zheng, L.-x. 2008: HPLC for determination of activity of serum CYP2E1. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26(8): 496-497

Dutov, A.A.; Nikitin, D.A.; Belen'kova, E.V.; Gatiiatov, I.F.; Titova, I.L. 2009: HPLC for the diagnosis and monitoring of phenylketonuria and ketoaciduria. Klinicheskaia Laboratornaia Diagnostika 5: 13-15

Singh, M.; Tamma, R.V.; Nigg, H.N. 1989: HPLC identification of allelopathic compounds from Lantana camara. Journal of Chemical Ecology 15(1): 81-89

De Paz, G.A.; Raggio, J.; Gómez-Serranillos, M.P.; Palomino, O.M.; González-Burgos, E.; Carretero, M.E.; Crespo, A. 2010: HPLC isolation of antioxidant constituents from Xanthoparmelia spp. Journal of Pharmaceutical and Biomedical Analysis 53(2): 165-171

Yang, Y.-Y.; Xu, L.; Hao, S.-Y.; Li, Y.; Zhang, Z.-Q. 2012: HPLC method determination of isoliquiritin apioside and isoliquiritin in rat plasma for application in pharmacokinetic study after an oral administration of zhigancao extract. Journal of Analytical Methods in Chemistry 2012: 364013

Mistiran, A.F.; Dzarr, A.A.; Gan, S.H. 2010: HPLC method development and validation for simultaneous detection of Arabinoside-C and doxorubicin. Toxicology Mechanisms and Methods 20(8): 472-481

Trivedi, P.; Kumar, J.K.; Negi, A.S.; Shanker, K. 2011: HPLC method development and validation of cytotoxic agent phenyl-heptatriyne in Bidens pilosa with ultrasonic-assisted cloud point extraction and preconcentration. Biomedical Chromatography: Bmc 25(6): 697-706

Sunarić, S.M.; Denić, M.S.; Bojanić, Z.Ž; Bojanić, V.V. 2013: HPLC method development for determination of doxycycline in human seminal fluid. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 939: 17-22

Liu, M.; Wang, J.; Wu, X.; Wang, E.; Baptista, D.; Scott, B.; Liu, P. 2014: HPLC method development, validation and impurity characterization for an antitumor Hsp90 inhibitor-PU-H71 (NSC 750424). Journal of Pharmaceutical and Biomedical Analysis 89: 34-41

Babu, S.V.S.; Shareef, M.M.; Shetty, A.P.K.; Shetty, K.T. 2002: HPLC method for amino acids profile in biological fluids and inborn metabolic disorders of aminoacidopathies. Indian Journal of Clinical Biochemistry: Ijcb 17(2): 7-26

Yilmaz, B.; Arslan, S.; Asci, A. 2012: HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey. Journal of Chromatographic Science 50(10): 914-919

Główka, F.K.; Romański, M.ł; Teżyk, A.; Zaba, C.ła.; Wróbel, T. 2012: HPLC method for determination of biologically active epoxy-transformers of treosulfan in human plasma: pharmacokinetic application. Journal of Pharmaceutical and Biomedical Analysis 62: 105-113

Yilmaz, B.; Asci, A.; Palabiyik, S.S. 2011: HPLC method for determination of diclofenac in human plasma and its application to a pharmacokinetic study in Turkey. Journal of Chromatographic Science 49(6): 422-427

Główka, F.K.; Kosicka, K.; Karaźniewicz-Łada, M. 2010: HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro- and allo-tetrahydro-metabolites in biological fluids. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 878(3-4): 283-289

Kar, M.; Choudhury, P.K. 2009: HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form. Indian Journal of Pharmaceutical Sciences 71(3): 318-320

Kulik, A.; Białecka, W.; Podolska, M.; Kwiatkowska-Puchniarz, B.; Mazurek, A. 2011: HPLC method for identification and quantification of benzimidazole derivatives in antiparasitic drugs. Acta Poloniae Pharmaceutica 68(6): 823-829

Podolska, M.; Kulik, A.; Białecka, W.; Kwiatkowska-Puchniarz, B.; Mazurek, A. 2014: HPLC method for identification and quantification of three active substances in a dermatological preparation--Viosept ointment. Acta Poloniae Pharmaceutica 71(5): 709-719

Kameda, K.; Ikawa, K.; Ikeda, K.; Morikawa, N.; Nakashima, A.; Ohge, H.; Sueda, T. 2010: HPLC method for measuring meropenem and biapenem concentrations in human peritoneal fluid and bile: application to comparative pharmacokinetic investigations. Journal of Chromatographic Science 48(5): 406-411

Yilmaz, B.; Asci, A.; Erdem, A.F. 2014: HPLC method for naproxen determination in human plasma and its application to a pharmacokinetic study in Turkey. Journal of Chromatographic Science 52(7): 584-589

Lazalde-Ramos, B.P.; Lares-Asseff, I.; Villanueva-Fierro, I.; Sosa-Macías, M.; Yahuaca-Mendoza, P.; Zamora-Perez, A. 2010: HPLC method for quantification of oxidative stress by salicilate hydroxylation in human plasma. Journal of Chromatographic Science 48(8): 675-679

Allen, S.J.; Ott, L.S. 2012: HPLC method for rapidly following biodiesel fuel transesterification reaction progress using a core-shell column. Analytical and Bioanalytical Chemistry 404(1): 267-272

Vijayakumar, E.K.S.; Dhore, D.M.; Kumar, M. 2009: HPLC method for simultaneous determination of impurities and degradation products in zonisamide. Indian Journal of Pharmaceutical Sciences 71(5): 521-526

Krcmová, L.; Urbánek, L.; Solichová, D.; Kasparová, M.ét.; Vlcková, H.; Melichar, B.; Sobotka, L.; Solich, P. 2009: HPLC method for simultaneous determination of retinoids and tocopherols in human serum for monitoring of anticancer therapy. Journal of Separation Science 32(15-16): 2804-2811

Wei, Z.; Bing-ren, X.; Ying, Z.; Liyan, Y.; Teng, W.; Cai-yun, W. 2008: HPLC method for the determination of bezafibrate in human plasma and application to a pharmacokinetic study of bezafibrate dispersible tablet. Journal of Chromatographic Science 46(10): 844-847

Hamarapurkar, P.D.; Parate, A.N. 2013: HPLC method for the determination of emtricitabine and related degradation substances. Journal of Chromatographic Science 51(5): 419-424

Pan, Y.; Gao, X.; Guo, N.; Li, J.; Guo, X. 2008: HPLC method for the determination of penciclovir in human plasma and application to a bioequivalence study. Journal of Chromatographic Science 46(9): 819-822

Cavazos-Rocha, N.; Carmona-Alvarado, I.; Vera-Cabrera, L.; Waksman-de-Torres, N.í; Salazar-Cavazos, M.ía.d.l.L. 2014: HPLC method for the simultaneous analysis of fluoroquinolones and oxazolidinones in plasma. Journal of Chromatographic Science 52(10): 1281-1287

Liu, X.; Yu, J.; Li, S.; Wang, H.; Liu, J. 2013: HPLC method to determine DEHP released into blood from a disposable extracorporeal circulation tube. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 30(4): 756-761

Kwon, H.-J.; Sim, H.-J.; Lee, S.-i.; Lee, Y.-M.; Park, Y.-D.; Hong, S.-P. 2011: HPLC method validation for Digitalis and its analogue by pulsed amperometric detection. Journal of Pharmaceutical and Biomedical Analysis 54(1): 217-221

Campas-Baypoli, O.N.; Sánchez-Machado, D.I.; Bueno-Solano, C.; Ramírez-Wong, B.; López-Cervantes, J. 2010: HPLC method validation for measurement of sulforaphane level in broccoli by-products. Biomedical Chromatography: Bmc 24(4): 387-392

Zhuang, L.; Gao, J.; Zeng, Y.; Yu, F.; Zhang, B.; Li, M.; Derendorf, H.; Liu, C. 2011: HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. European Journal of Drug Metabolism and Pharmacokinetics 36(2): 61-69

Van Arnum, S.D.; Niemczyk, H.J.; Chang, C. 2009: HPLC method validation studies on a specific assay for monomethoxypoly(ethylene glycol) succinimido carbonate (mPEG-SC). Journal of Pharmaceutical and Biomedical Analysis 50(2): 138-143

Zhang, X.Y.; Qiao, H.; Shi, Y.B. 2014: HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics. Pharmaceutical Biology 52(1): 21-30

Mukker, J.K.; Kotlyarova, V.; Singh, R.S.P.; Alcorn, J. 2010: HPLC method with fluorescence detection for the quantitative determination of flaxseed lignans. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 878(30): 3076-3082

Alanazi, A.M.; Abdelhameed, A.S.; Khalil, N.Y.; Khan, A.A.; Darwish, I.A. 2014: HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets. Acta Pharmaceutica 64(2): 187-198

López-Muñoz, F.J.; Vara Gama, N.; Soria-Arteche, O.; Hurtado y de la Peña, M.; Domínguez-Ramírez, A.M.; Medina López, J.é R.úl. 2014: HPLC method with solid-phase extraction for determination of (R)- and (S)-ketoprofen in plasma without caffeine interference: application to pharmacokinetic studies in rats. Journal of Chromatographic Science 52(10): 1204-1210

Woods, J.S.; Simmonds, P.L. 2001: HPLC methods for analysis of porphyrins in biological media. Current Protocols in Toxicology Chapter 8: Unit 8.9

Fisher, G.H.; Tsesarskaia, M. 2012: HPLC methods for determination of D-aspartate and N-methyl-D-aspartate. Methods in Molecular Biology 794: 253-264

Chen, J.; Chen, J.; Zhou, C. 2008: HPLC methods for determination of dihydroxyacetone and glycerol in fermentation broth and comparison with a visible spectrophotometric method to determine dihydroxyacetone. Journal of Chromatographic Science 46(10): 912-916

Stariat, J.án.; Kovaríková, P.; Klimes, J.í; Lovejoy, D.B.; Kalinowski, D.S.; Richardson, D.R. 2009: HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 877(3): 316-322

Manzi, A.E.; Hayes, B.K. 2001: HPLC methods for the fractionation and analysis of negatively charged oligosaccharides and gangliosides. Current Protocols in Molecular Biology Chapter 17: Unit 17.21a

Godziek, A.; Maciejowska, A.; Sajewicz, M.ła.; Kowalska, T. 2015: HPLC monitoring of spontaneous non-linear peptidization dynamics of selected amino acids in solution. Journal of Chromatographic Science 53(3): 401-410

Morgan, P.E.; Manwaring, V.; Flanagan, R.J. 2010: HPLC of basic drugs using non-aqueous ionic eluents: evaluation of a 3 mum strong cation-exchange material. Biomedical Chromatography: Bmc 24(3): 318-323

Krauze-Baranowska, M.ła.; Pobłocka-Olech, L.; Głód, D.; Wiwart, M.; Zieliński, J.; Migas, P. 2013: HPLC of flavanones and chalcones in different species and clones of Salix. Acta Poloniae Pharmaceutica 70(1): 27-34

Choi, H.J.; Cho, H.S.; Han, S.C.; Hyun, M.H. 2009: HPLC of fluoroquinolone antibacterials using chiral stationary phase based on enantiomeric (3,3'-diphenyl-1,1'-binaphthyl)-20-crown-6. Journal of Separation Science 32(4): 536-541

Boysen, R.I.; Hearn, M.T. 2001: HPLC of peptides and proteins. Current Protocols in Protein Science Chapter 8: Unit 8.7

Boysen, R.I.; Hearn, M.T. 2001: HPLC of peptides and proteins: preparation and system set-up. Current Protocols in Molecular Biology Chapter 10: Unit 10.12

Boysen, R.I.; Hearn, M.T. 2001: HPLC of peptides and proteins: standard operating conditions. Current Protocols in Molecular Biology Chapter 10: Unit 10.13

Anonymous 1983: HPLC of proteins, peptides and polynucleotide. Analytical Chemistry 55(13): 1298a-1306a

Roussel, C.; Vanthuyne, N.; Jobert, J-Laurent.; Loas, A.I.; Tanase, A.E.; Gherase, D. 2007: HPLC on chiral support with polarimetric detection: application to conglomerate discovery. Chirality 19(6): 497-502

Dowd, M.K.; Pelitire, S.M. 2008: HPLC preparation of the chiral forms of 6-methoxy-gossypol and 6,6'-dimethoxy-gossypol. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 867(1): 69-77

Li, C.G.; Sheng, S.J.; Pang, E.C.K.; May, B.; Xue, C.C.L. 2009: HPLC profiles and biomarker contents of Australian-grown Salvia miltiorrhiza f. alba roots. Chemistry and Biodiversity 6(7): 1077-1086

Bertrand, S.; Petit, C.; Marcourt, L.; Ho, R.; Gindro, K.; Monod, M.; Wolfender, J.-L. 2014: HPLC profiling with at-line microdilution assay for the early identification of anti-fungal compounds in plants from French Polynesia. Phytochemical Analysis: Pca 25(2): 106-112

Eglon, M.; McGrath, B.; O'Brien, T. 2010: HPLC purification of adenoviral vectors. Methods in Molecular Biology 594: 395-408

Ingalls, A.E.; Ellis, E.E.; Santos, G.M.; McDuffee, K.E.; Truxal, L.; Keil, R.G.; Druffel, E.R.M. 2010: HPLC purification of higher plant-dervied lignin phenols for compound specific radiocarbon analysis. Analytical Chemistry 82(21): 8931-8938

Weissman, D.; Pardi, N.; Muramatsu, H.; Karikó, K. 2013: HPLC purification of in vitro transcribed long RNA. Methods in Molecular Biology 969: 43-54

Almási, A.; Fischer, E.; Perjési, P.ál. 2011: HPLC quantification of 4-nitrophenol and its conjugated metabolites from bile. Scientia Pharmaceutica 79(4): 837-847

Paige, M.; Saprito, M.S.; Bunyan, D.A.; Shim, Y.M. 2009: HPLC quantification of 5-hydroxyeicosatetraenoic acid in human lung cancer tissues. Biomedical Chromatography: Bmc 23(8): 817-821

Maggi, F.; Barboni, L.; Caprioli, G.; Papa, F.; Ricciutelli, M.; Sagratini, G.; Vittori, S. 2011: HPLC quantification of coumarin in bastard balm (Melittis melissophyllum L., Lamiaceae). Fitoterapia 82(8): 1215-1221

Alhareth, K.; Vauthier, C.; Gueutin, C.; Ponchel, G.; Moussa, F. 2012: HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 887-888: 128-132

Tian, C.; Wang, M.; Liu, X.; Wang, H.; Zhao, C. 2014: HPLC quantification of nine chemical constituents from the five parts of Abutilon theophrasti Medic. Journal of Chromatographic Science 52(3): 258-263

Kongkiatpaiboon, S.; Gritsanapan, W. 2012: HPLC quantitative analysis of insecticidal didehydrostemofoline and stemofoline in Stemona collinsiae root extracts. Phytochemical Analysis: Pca 23(5): 554-558

Chewchinda, S.; Wuthi-udomlert, M.; Gritsanapan, W. 2013: HPLC quantitative analysis of rhein and antidermatophytic activity of Cassia fistula pod pulp extracts of various storage conditions. Biomed Research International 2013: 821295

Barak, J.A.; Kennedy, J.A. 2013: HPLC retention thermodynamics of grape and wine tannins. Journal of Agricultural and Food Chemistry 61(18): 4270-4277

Călinescu, O.; Badea, I.A.; Vlădescu, L.ţa.; Meltzer, V.; Pincu, E. 2012: HPLC separation of acetaminophen and its impurities using a mixed-mode reversed-phase/cation exchange stationary phase. Journal of Chromatographic Science 50(4): 335-342

Inoue, K.; Kitahara, K.-i.; Aikawa, Y.; Arai, S.; Masuda-Hanada, T. 2011: HPLC separation of all aldopentoses and aldohexoses on an anion-exchange stationary phase prepared from polystyrene-based copolymer and diamine: the effect of NaOH eluent concentration. Molecules 16(7): 5905-5915

Niessen, S.; McLeod, I.; Yates, J.R. 2006: HPLC separation of digested proteins and preparation for matrix-assisted laser desorption/ionization analysis. Csh Protocols 2006(7)

Jibuti, G.; Mskhiladze, A.; Takaishvili, N.; Karchkhadze, M.; Chankvetadze, L.; Farkas, T.; Chankvetadze, B. 2012: HPLC separation of dihydropyridine derivatives enantiomers with emphasis on elution order using polysaccharide-based chiral columns. Journal of Separation Science 35(19): 2529-2537

Matarashvili, I.; Chankvetadze, L.; Fanali, S.; Farkas, T.; Chankvetadze, B. 2013: HPLC separation of enantiomers of chiral arylpropionic acid derivatives using polysaccharide-based chiral columns and normal-phase eluents with emphasis on elution order. Journal of Separation Science 36(1): 140-147

Mericko, D.; Lehotay, J.; Cizmárik, J. 2007: HPLC separation of enantiomers using chiral stationary phases. Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 56(3): 107-113

Morales, R.; Bartholdi, C.S.; Cunningham, P.T. 1988: HPLC separation of heterocyclic beta-diketonates of actinide, lanthanide and transition metals. Talanta 35(6): 461-464

Turell, L.ía.; Botti, H.; Bonilla, L.ía.; Torres, M.ía.J.é; Schopfer, F.; Freeman, B.A.; Armas, L.; Ricciardi, A.; Alvarez, B.; Radi, R. 2014: HPLC separation of human serum albumin isoforms based on their isoelectric points. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 944: 144-151

Barker, C.J.; Illies, C.; Berggren, P.-O. 2010: HPLC separation of inositol polyphosphates. Methods in Molecular Biology 645: 21-46

Djordjevic, N.M.; Houdiere, F.; Fowler, P.; Natt, F. 1998: HPLC separation of oligonucleotides in isocratic and temperature-programming mode. Analytical Chemistry 70(9): 1921-1925

Yao, L.-F.; He, H.-B.; Feng, Y.-Q.; Da, S.-L. 2004: HPLC separation of positional isomers on a dodecylamine-N, N-dimethylenephosphonic acid modified zirconia stationary phase. Talanta 64(1): 244-251

Kuroda, I.; Nagai, T.; Mizobe, H.; Yoshimura, N.; Gotoh, N.; Wada, S. 2008: HPLC separation of triacylglycerol positional isomers on a polymeric ODS column. Analytical Sciences: the International Journal of the Japan Society for Analytical Chemistry 24(7): 865-869

Yan, M.-Q.; Chen, S.-H.; Lv, G.-Y.; Zhou, G.-F.; Liu, X. 2013: HPLC specific chromatogram of Dendrobium officinale. Zhongguo Zhong Yao Za Zhi 38(4): 516-519

Yu, L.-X.; Shan, M.-Q.; Ding, A.-W. 2014: HPLC specific chromatograms of drug pair of schizonepetae herba and saposhnikoviae radix. Zhongguo Zhong Yao Za Zhi 39(4): 679-683

Khaneghah, A.M.; Limbo, S.; Shoeibi, S.; Mazinani, S. 2014: HPLC study of migration of terephthalic acid and isophthalic acid from PET bottles into edible oils. Journal of the Science of Food and Agriculture 94(11): 2205-2209

Lauri, K.; Tanner, R.; Jerotskaja, J.; Luman, M.; Fridolin, I. 2010: HPLC study of uremic fluids related to optical dialysis adequacy monitoring. International Journal of Artificial Organs 33(2): 96-104

Pencheva, I.; Bogomilova, A.; Koseva, N.; Obreshkova, D.; Troev, K. 2008: HPLC study on the stability of bendamustine hydrochloride immobilized onto polyphosphoesters. Journal of Pharmaceutical and Biomedical Analysis 48(4): 1143-1150

Wang, L.; Song, M.; Hang, T.-j.; Zhang, Z.-x.; Chen, J. 2009: HPLC tandem-mass spectrometric analysis of the chemical components and decomposition products of allicin extract of garlic. Yao Xue Xue Bao 44(1): 74-79

Svobaite, R.ūt.; Solassol, I.; Pinguet, F.; Ivanauskas, L.; Brès, J.; Bressolle, F.ço.M.M. 2008: HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasma. Clinical Chemistry 54(9): 1463-1472

Morante-Zarcero, S.; del Hierro, I.; Fajardo, M.; Sierra, I. 2009: HPLC with polysaccharide chiral stationary phase in polar-organic phase mode: application to the asymmetric epoxidation of allylic alcohols. Journal of Separation Science 32(18): 3055-3063

Sim, H.-J.; Jeong, J.-S.; Kwon, H.-J.; Kang, T.H.; Park, H.M.; Lee, Y.-M.; Kim, S.Y.; Hong, S.-P. 2009: HPLC with pulsed amperometric detection for sorbitol as a biomarker for diabetic neuropathy. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 877(14-15): 1607-1611

Li, L.; Zhao, Y.; Liu, W.; Feng, F.; Xie, N. 2013: HPLC with quadrupole TOF-MS and chemometrics analysis for the characterization of Folium Turpiniae from different regions. Journal of Separation Science 36(15): 2552-2561

Cheomung, A.; Na-Bangchang, K. 2011: HPLC with ultraviolet detection for the determination of chloroquine and desethylchloroquine in whole blood and finger-prick capillary blood dried on filter paper. Journal of Pharmaceutical and Biomedical Analysis 55(5): 1031-1040

Abdel-Fattah, L.S.; El-Sherif, Z.A.; Kilani, K.M.; El-Haddad, D.A. 2010: HPLC, TLC, and first-derivative spectrophotometry stability-indicating methods for the determination of tropisetron in the presence of its acid degradates. Journal - Association of Official Analytical Chemists 93(4): 1180-1191

Saliu, F.; Modugno, F.; Orlandi, M.; Colombini, M.P. 2011: HPLC-APCI-MS analysis of triacylglycerols (TAGs) in historical pharmaceutical ointments from the eighteenth century. Analytical and Bioanalytical Chemistry 401(6): 1785-1800

Song, Q.; Wen, A.; Ding, L.; Dai, L.; Yang, L.; Qi, X. 2008: HPLC-APCI-MS for the determination of vitamin K(1) in human plasma: method and clinical application. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 875(2): 541-545

Tittel, G.; Habermeier, H.; Wagner, H. 1981: HPLC-Analyse von Herzglykosiden aus Pflanzenextrakten und Arzneifertigzubereitungen, 2. Mitteilung.. Planta Medica 42(6): 113

Uddin, R.; Saha, M.Rani.; Subhan, N.; Hossain, H.; Jahan, I.Ara.; Akter, R.; Alam, A. 2014: HPLC-Analysis of Polyphenolic Compounds in Gardenia jasminoides and Determination of Antioxidant Activity by Using Free Radical Scavenging Assays. Advanced Pharmaceutical Bulletin 4(3): 273-281

Bai, C.; Chai, X.; Gao, X.; Li, P.; Tu, P. 2009: HPLC-CAD in optimizating of saponins extraction from Radix et Rhizoma Notoginseng. Zhongguo Zhong Yao Za Zhi 34(6): 677-680

Hamzic, M.; Pietruszka, J.ör.; Sandkuhl, D. 2011: HPLC-CD selectivity assay for alcohol dehydrogenases. Chirality 23(Suppl 1): E110-E115

Callipo, L.; Foglia, P.; Gubbiotti, R.; Samperi, R.; Laganà, A. 2009: HPLC-CHIP coupled to a triple quadrupole mass spectrometer for carbonic anhydrase Ii quantification in human serum. Analytical and Bioanalytical Chemistry 394(3): 811-820

Vollmer, M.; van de Goor, T. 2009: HPLC-Chip/MS technology in proteomic profiling. Methods in Molecular Biology 544: 3-15

Da Silva, J.M.; Antinarelli, L.M.R.; Pinto, N.íc.d.C.C.; Coimbra, E.S.; de Souza-Fagundes, E.M.; Ribeiro, A.ôn.; Scio, E. 2014: HPLC-DAD analysis, antileishmanial, antiproliferative, and antibacterial activities of Lacistema pubescens: an Amazonian medicinal plant. Biomed Research International 2014: 545038

Shah, N.A.; Khan, M.R.; Sattar, S.; Ahmad, B.; Mirza, B. 2014: HPLC-DAD analysis, antioxidant potential and anti-urease activity of Asparagus gracilis collected from District Islamabad. Bmc Complementary and Alternative Medicine 14: 347

Karioti, A.; Chiarabini, L.; Alachkar, A.; Fawaz Chehna, M.; Vincieri, F.F.; Bilia, A.R. 2014: HPLC-DAD and HPLC-ESI-MS analyses of Tiliae flos and its preparations. Journal of Pharmaceutical and Biomedical Analysis 100: 205-214

Pellati, F.; Orlandini, G.; Pinetti, D.; Benvenuti, S. 2011: HPLC-DAD and HPLC-ESI-MS/MS methods for metabolite profiling of propolis extracts. Journal of Pharmaceutical and Biomedical Analysis 55(5): 934-948

Kovaríková, P.; Vávrová, K.; Tomalová, K.; Schöngut, M.; Hrusková, K.; Hasková, P.ín.; Klimes, J.í 2008: HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers. Journal of Pharmaceutical and Biomedical Analysis 48(2): 295-302

Branquinho, R.T.á; Mosqueira, V.C.F.; Kano, E.K.; de Souza, J.; Dorim, D.D.R.; Saúde-Guimarães, D.ên.A.; de Lana, M. 2014: HPLC-DAD and UV-spectrophotometry for the determination of lychnopholide in nanocapsule dosage form: validation and application to release kinetic study. Journal of Chromatographic Science 52(1): 19-26

Moreno, A.María.Jiménez.; Navas, Mía.José.; Asuero, Aín.G. 2014: HPLC-DAD determination of CNS-acting drugs in human blood, plasma, and serum. Critical Reviews in Analytical Chemistry 44(1): 68-106

Nieddu, M.; Boatto, G.; Serra, D.; Soro, A.; Lorenzoni, S.; Lubinu, F. 2007: HPLC-DAD determination of mepivacaine in cerebrospinal fluid from a fatal case. Journal of Forensic Sciences 52(5): 1223-1224

Hadad, G.M.; Abdel Salam, R.A.; Soliman, R.M.; Mesbah, M.K. 2014: HPLC-DAD determination of seven antioxidants and caffeine in different phytopharmaceuticals. Journal of Chromatographic Science 52(7): 617-623

Sajewicz, M.ła.; Gontarska, M.; Kowalska, T. 2014: HPLC-DAD evidence of the oscillatory chiral conversion of phenylglycine. Journal of Chromatographic Science 52(4): 329-333

Miron, D.; Lange, A.; Zimmer, A.R.; Mayorga, P.; Schapoval, E.E.S. 2014: HPLC-DAD for the determination of three different classes of antifungals: method characterization, statistical approach, and application to a permeation study. Biomedical Chromatography: Bmc 28(12): 1728-1737

Tang, H.-B.; Cai, H.-L.; Li, H.-D.; Zhang, L.-J.; Li, X.-L.; Tang, J.-H.; Chen, M.-L. 2013: HPLC-DAD method for comprehensive quality control of Semen Strychni. Pharmaceutical Biology 51(11): 1378-1383

Carlucci, G.; Di Federico, L.; Iuliani, P. 2010: HPLC-DAD method for the simultaneous determination of zofenopril and hydrochlorothiazide in oral pharmaceutical formulations. Journal of Separation Science 33(12): 1717-1722

Pereira, V.; Câmara, J.é S.; Cacho, J.; Marques, J.é C. 2010: HPLC-DAD methodology for the quantification of organic acids, furans and polyphenols by direct injection of wine samples. Journal of Separation Science 33(9): 1204-1215

Dziadosz, M.; Lessig, R.üd.; Bartels, H. 2012: HPLC-DAD protein kinase inhibitor analysis in human serum. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 893-894: 77-81

Shaalan, R.A.; Belal, T.S. 2010: HPLC-DAD stability indicating determination of nitrofurazone and lidocaine hydrochloride in their combined topical dosage form. Journal of Chromatographic Science 48(8): 647-653

Carrillo-López, A.; Yahia, E. 2013: HPLC-DAD-ESI-MS analysis of phenolic compounds during ripening in exocarp and mesocarp of tomato fruit. Journal of Food Science 78(12): C1839-C1844

Zhang, W.; Han, F.; He, J.; Duan, C. 2008: HPLC-DAD-ESI-MS/MS analysis and antioxidant activities of nonanthocyanin phenolics in mulberry (Morus alba L.). Journal of Food Science 73(6): C512-C518

Blanco-Vega, D.; López-Bellido, F.J.; Alía-Robledo, J.é M.ía.; Hermosín-Gutiérrez, I. 2011: HPLC-DAD-ESI-MS/MS characterization of pyranoanthocyanins pigments formed in model wine. Journal of Agricultural and Food Chemistry 59(17): 9523-9531

Abu-Reidah, I.M.; Ali-Shtayeh, M.S.; Jamous, R.M.; Arráez-Román, D.; Segura-Carretero, A. 2015: HPLC-DAD-ESI-MS/MS screening of bioactive components from Rhus coriaria L. (Sumac) fruits. Food Chemistry 166: 179-191

Peres, R.G.; Tonin, F.G.; Tavares, M.F.M.; Rodriguez-Amaya, D.B. 2013: HPLC-DAD-ESI/MS identification and quantification of phenolic compounds in Ilex paraguariensis beverages and on-line evaluation of individual antioxidant activity. Molecules 18(4): 3859-3871

Giovannetti, R.; Alibabaei, L.; Zannotti, M.; Ferraro, S.; Petetta, L. 2013: HPLC-DAD-ESI/MS identification of light harvesting and light screening pigments in the lake sediments at Edmonson Point. Thescientificworldjournal 2013: 741906

Ferreres, F.; Grosso, C.; Gil-Izquierdo, A.; Valentão, P.íc.; Azevedo, C.; Andrade, P.B. 2014: HPLC-DAD-ESI/MS(n) analysis of phenolic compounds for quality control of Grindelia robusta Nutt. and bioactivities. Journal of Pharmaceutical and Biomedical Analysis 94: 163-172

Mantzouris, D.; Karapanagiotis, I.; Valianou, L.; Panayiotou, C. 2011: HPLC-DAD-MS analysis of dyes identified in textiles from Mount Athos. Analytical and Bioanalytical Chemistry 399(9): 3065-3079

Guan, X.-Y.; Li, H.-F.; Yang, W.-Z.; Lin, C.-H.; Sun, C.; Wang, B.-R.; Guo, D.-A.; Ye, M. 2011: HPLC-DAD-MS(n) analysis and HPLC quantitation of chemical constituents in Xian-ling-gu-bao capsules. Journal of Pharmaceutical and Biomedical Analysis 55(5): 923-933

Arimboor, R.; Arumughan, C. 2012: HPLC-DAD-MS/MS profiling of antioxidant flavonoid glycosides in sea buckthorn (Hippophae rhamnoides L.) seeds. International Journal of Food Sciences and Nutrition 63(6): 730-738

Benzi, M.; Robotti, E.; Gianotti, V. 2011: HPLC-DAD-MSn to investigate the photodegradation pathway of nicosulfuron in aqueous solution. Analytical and Bioanalytical Chemistry 399(4): 1705-1714

Yan, Y.; Chai, C.-Z.; Wang, D.-W.; Yue, X.-Y.; Zhu, D.-N.; Yu, B.-Y. 2013: HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen Decoction. Journal of Pharmaceutical and Biomedical Analysis 80: 192-202

Yan, R.; Cao, Y.; Yang, B. 2014: HPLC-DPPH screening method for evaluation of antioxidant compounds extracted from Semen Oroxyli. Molecules 19(4): 4409-4417

Bartosova, Z.; Jirovsky, D.; Riman, D.; Halouzka, V.; Svidrnoch, M.; Hrbac, J. 2014: HPLC-ED of low-molecular weight brominated phenols and tetrabromobisphenol a using pretreated carbon fiber microelectrode. Talanta 122: 115-121

Zhou, J.; Zhang, L.; Wang, Y.; Yan, C. 2011: HPLC-ELSD analysis of spectinomycin dihydrochloride and its impurities. Journal of Separation Science 34(15): 1811-1819

Zhang, Y.; He, H.-M.; Zhang, J.; Liu, F.-J.; Li, C.; Wang, B.-W.; Qiao, R.-Z. 2015: HPLC-ELSD determination of kanamycin B in the presence of kanamycin a in fermentation broth. Biomedical Chromatography: Bmc 29(3): 396-401

Hu, Y.; Yuan, D.; He, Y.; Wang, H.; Sun, Z.; Zhang, C. 2010: HPLC-ELSD fingerprint and chemical constituents of Rhizoma Panacis Japonici. Zhongguo Zhong Yao Za Zhi 35(8): 1009-1013

Li, E.; Teng, Z.; Liu, S.; Qin, S.; Zhang, C. 2012: HPLC-ELSD fingerprint of Marsdenia tenacissima from different habitats. Zhongguo Zhong Yao Za Zhi 37(11): 1610-1613

Colorado-Ríos, J.; Muñoz, D.; Montoya, G.; Márquez, D.; Márquez, M.-E.; López, J.; Martínez, A. 2013: HPLC-ESI-IT-MS/MS analysis and biological activity of triterpene glycosides from the Colombian marine sponge Ectyoplasia ferox. Marine Drugs 11(12): 4815-4833

Inzitari, R.; Cabras, T.; Pisano, E.; Fanali, C.; Manconi, B.; Scarano, E.; Fiorita, A.; Paludetti, G.; Manni, A.; Nemolato, S.; Faa, G.; Castagnola, M.; Messana, I. 2009: HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). Journal of Separation Science 32(1): 57-63

Cabras, T.; Boi, R.; Pisano, E.; Iavarone, F.; Fanali, C.; Nemolato, S.; Faa, G.; Castagnola, M.; Messana, I. 2012: HPLC-ESI-MS and MS/MS structural characterization of multifucosylated N-glycoforms of the basic proline-rich protein IB-8a CON1+ in human saliva. Journal of Separation Science 35(9): 1079-1086

Wang, W.; Luo, J.; Kong, L. 2009: HPLC-ESI-MS(n) analysis of chemical constituents in Semen Ziziphi Spinosae. Zhongguo Zhong Yao Za Zhi 34(21): 2768-2773

Shi, R.-j.; Dai, Y.; Fang, M.-f.; Zhao, X.; Zheng, J.-b.; Zheng, X.-h. 2007: HPLC-ESI-MS(n) analysis of the water soluble extracts of Fructus Choerospondiatis. Zhong Yao Cai 30(3): 294-297

Haynes, C.A.; Guerra, S.L.; Fontana, J.C.; DeJesús, V.íc.R. 2013: HPLC-ESI-MS/MS analysis of hemoglobin peptides in tryptic digests of dried-blood spot extracts detects HbS, HbC, HbD, HbE, HbO-Arab, and HbG-Philadelphia mutations. Clinica Chimica Acta; International Journal of Clinical Chemistry 424: 191-200

Quirantes-Piné, R.; Lozano-Sánchez, J.ús.; Herrero, M.; Ibáñez, E.; Segura-Carretero, A.; Fernández-Gutiérrez, A. 2013: HPLC-ESI-QTOF-MS as a powerful analytical tool for characterising phenolic compounds in olive-leaf extracts. Phytochemical Analysis: Pca 24(3): 213-223

Do Amaral, F.P.; Napolitano, A.; Masullo, M.; dos Santos, L.C.; Festa, M.; Vilegas, W.; Pizza, C.; Piacente, S. 2012: HPLC-ESIMS(n) profiling, isolation, structural elucidation, and evaluation of the antioxidant potential of phenolics from Paepalanthus geniculatus. Journal of Natural Products 75(4): 547-556

Fernández, C.; Reviejo, A.J.; Polo, L.M.; Pingarrón, J.M. 1996: HPLC-Electrochemical detection with graphite-poly (tetrafluoroethylene) electrode Determination of the fungicides thiram and disulfiram. Talanta 43(8): 1341-1348

Li, Y.; Tang, A.-G.; Mu, S. 2011: HPLC-FLD determination of serum aromatic amino acids: application in chronic kidney disease patients. Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1032-1035

Buha, S.M.; Panchal, A.; Panchal, H.; Chambhare, R.; Kumar, S.; Jain, M.; Patel, P.R. 2011: HPLC-FLD for the simultaneous determination of primary and secondary amino acids from complex biological sample by pre-column derivatization. Journal of Chromatographic Science 49(2): 118-123

Oliveira, Líliam.Teixeira.; Garcia, G.Martins.; Kano, E.Kazue.; Tedesco, Aônio.Cláudio.; Mosqueira, V.Carla.Furtado. 2011: HPLC-FLD methods to quantify chloroaluminum phthalocyanine in nanoparticles, plasma and tissue: application in pharmacokinetic and biodistribution studies. Journal of Pharmaceutical and Biomedical Analysis 56(1): 70-77

Gao, W.; Xie, Q.; Jin, J.; Qiao, T.; Wang, H.; Chen, L.; Deng, H.; Lu, Z. 2010: HPLC-FLU detection of cortisol distribution in human hair. Clinical Biochemistry 43(7-8): 677-682

Alava, P.; Tack, F.; Laing, G.D.; de Wiele, T.V. 2012: HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota. Biomedical Chromatography: Bmc 26(4): 524-533

Sarmiento-González, A.; Ruiz Encinar, J.; Cantarero-Roldán, A.M.; Marchante-Gayón, J.M.; Sanz-Medel, A. 2008: HPLC-ICPMS and stable isotope-labeled approaches to assess quantitatively Ti(IV) uptake by transferrin in human blood serum. Analytical Chemistry 80(22): 8702-8711

Cai, T.; Ting, H.; Xin-Xiang, Z.; Jiang, Z.; Jin-Lan, Z. 2014: HPLC-MRM relative quantification analysis of fatty acids based on a novel derivatization strategy. Analyst 139(23): 6154-6159

Wang, Y.; Jiang, X.; Liu, J.; Zhao, M.; Kang, G.; Wu, J.; Peng, L.; Peng, S. 2011: HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NO. Molecular Biosystems 7(5): 1678-1683

Cheng, X.-Y.; Shi, Y.; Zhen, S.-L.; Sun, H.; Jin, W. 2010: HPLC-MS analysis of ethanol extract of Corydalis yanhusuo and simultaneous determination of eight protoberberine quaternary alkaloids by HPLC-DAD. Journal of Chromatographic Science 48(6): 441-444

Wang, Z.; Zhang, L.; He, P.; Li, M.; Yang, W. 2009: HPLC-MS analysis of iodotyrosines produced by sample hydrolysis: a simple method for monitoring iodinated casein in feed premixes. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 877(32): 4175-4179

Buendía, B.ña.; Gil, M.ía.I.; Tudela, J.A.; Gady, A.L.; Medina, J.J.; Soria, C.; López, J.M.; Tomás-Barberán, F.A. 2010: HPLC-MS analysis of proanthocyanidin oligomers and other phenolics in 15 strawberry cultivars. Journal of Agricultural and Food Chemistry 58(7): 3916-3926

An, D.; Wu, S.; Wei, J.; Yang, J. 2009: HPLC-MS analysis of quercetin and its metabolites in portal vein after intragastrical administration of quercetin in rats. Wei Sheng Yan Jiu 38(4): 417-419

Gardner, D.R.; Pfister, J.A. 2009: HPLC-MS analysis of toxic norditerpenoid alkaloids: refinement of toxicity assessment of low larkspurs (Delphinium spp.). Phytochemical Analysis: Pca 20(2): 104-113

Jiang, J.; Zhang, H.; Li, Z.; Zhang, X.; Su, X.; Li, Y.; Qiao, B.; Yuan, Y. 2013: HPLC-MS and GC-MS analyses combined with orthogonal partial least squares to identify cytotoxic constituents from turmeric (Curcuma longa L.). Natural Product Communications 8(8): 1129-1134

Baranov, P.A.; Appolonova, S.A.; Dikunets, M.A.; Rodchenkov, G.M.; Sariev, A.K.; Zherdev, V.P. 2009: HPLC-MS determination of 2-ethyl-6-methyl-3-oxypyridine. Eksperimental'naia i Klinicheskaia Farmakologiia 72(3): 22-28

Wang, W.-J.; Li, T.; Li, J.; Liu, Q.; Xie, Y.-C. 2012: HPLC-MS identification of degradation products of levofloxacin. Yao Xue Xue Bao 47(4): 498-501

D'Avolio, A.; Simiele, M.; Siccardi, M.; Baietto, L.; Sciandra, M.; Bonora, S.; Di Perri, G. 2010: HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. Journal of Pharmaceutical and Biomedical Analysis 52(5): 774-780

D'Avolio, A.; Simiele, M.; De Francia, S.; Ariaudo, A.; Baietto, L.; Cusato, J.; Fava, C.; Saglio, G.; Di Carlo, F.; Di Perri, G. 2012: HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). Journal of Pharmaceutical and Biomedical Analysis 59: 109-116

Thimm, N.; Handl, J.; Binder, M. 2001: HPLC-MS-Method for A-Trichothecenes. Mycotoxin Research 17(Suppl 2): 206-209

Bahaji, A.; Baroja-Fernández, E.; Sánchez-López, A.María.; Muñoz, F.José.; Li, J.; Almagro, G.; Montero, M.; Pujol, P.; Galarza, R.; Kaneko, K.; Oikawa, K.; Wada, K.; Mitsui, T.; Pozueta-Romero, J. 2014: HPLC-MS/MS analyses show that the near-Starchless aps1 and pgm leaves accumulate wild type levels of ADPglucose: further evidence for the occurrence of important ADPglucose biosynthetic pathway(s) alternative to the pPGI-pPGM-AGP pathway. PloS one 9(8): e104997

Shaw, L.-H.; Lin, L.-C.; Tsai, T.-H. 2012: HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats. Plos one 7(8): E43848

Rodila, R.; Kim, G.E.; Fan, L.; Chang, M.S.; Zhang, J.; Wu, H.; El-Shourbagy, T.A. 2008: HPLC-MS/MS determination of a hardly soluble drug in human urine through drug-albumin binding assisted dissolution. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 872(1-2): 128-132

Zhang, H.; Qian, M.; Wang, X.; Wang, X.; Xu, H.; Wang, Q.; Wang, M. 2012: HPLC-MS/MS enantioseparation of triazole fungicides using polysaccharide-based stationary phases. Journal of Separation Science 35(7): 773-781

Liu, H.; Yan, C.; Li, B. 2013: HPLC-MS/MS for determination of astragalin in rat plasma and its pharmacokinetics. Nan Fang Yi Ke da Xue Xue Bao 33(7): 1049-1052

Hsieh, Y. 2008: HPLC-MS/MS in drug metabolism and pharmacokinetic screening. Expert Opinion on Drug Metabolism and Toxicology 4(1): 93-101

Xu, X.-y.; Zhang, R.; Yuan, G.-y.; Wang, B.-j.; Liu, X.-y.; Guo, R.-c. 2008: HPLC-MS/MS method for determination of sodium cromoglycate concentration in human plasma and its pharmacokinetics. Yao Xue Xue Bao 43(9): 942-945

Zangarini, M.; Ceriani, L.; Bello, E.; Damia, G.; Cereda, R.; Camboni, M.G.; Zucchetti, M. 2014: HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies. Journal of Mass Spectrometry: Jms 49(1): 19-26

Hilhorst, M.J.; Hendriks, G.; van Hout, M.W.J.; Sillén, H.; van de Merbel, N.C. 2011: HPLC-MS/MS method for the determination of cytarabine in human plasma. Bioanalysis 3(14): 1603-1611

Meléndez, M.; Rosario, O.; Zayas, B.; Rodríguez, J.é F. 2009: HPLC-MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells. Journal of Pharmaceutical and Biomedical Analysis 49(5): 1233-1240

Radford, S.A.; Panuwet, P.; Hunter, R.E.; Barr, D.B.; Ryan, P.B. 2014: HPLC-MS/MS method for the measurement of insecticide degradates in baby food. Journal of Agricultural and Food Chemistry 62(29): 7085-7091

Karaźniewicz-Łada, M.; Danielak, D.; Teżyk, A.; Zaba, C.ła.; Tuffal, G.; Główka, F. 2012: HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 911: 105-112

Ding, Y.; Zhang, T.; Tao, J.-S.; Tan, B.; Guo, C.-R.; Yang, L. 2012: HPLC-MS/MS method to determine genipin in rat plasma after hydrolysis with sulfatase and its application to a pharmacokinetic study. Biomedical Chromatography: Bmc 26(7): 816-825

Geenen, S.; Guallar-Hoyas, C.; Michopoulos, F.; Kenna, J.G.; Kolaja, K.L.; Westerhoff, H.V.; Thomas, P.; Wilson, I.D. 2011: HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium. Journal of Pharmaceutical and Biomedical Analysis 56(3): 655-663

Geenen, S.; Michopoulos, F.; Kenna, J.G.; Kolaja, K.L.; Westerhoff, H.V.; Wilson, I. 2011: HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium. Journal of Pharmaceutical and Biomedical Analysis 54(5): 1128-1135

Gao, L.; Tao, D.; Shan, Y.; Liang, Z.; Zhang, L.; Huo, Y.; Zhang, Y. 2010: HPLC-MS/MS shotgun proteomic research of deer antlers with multiparallel protein extraction methods. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 878(32): 3370-3374

Liu, P.-f.; Xu, D.-r.; Kong, L.-y. 2007: HPLC-MS3 analysis of chemical constituents in Epimedium brevicornum. Zhongguo Zhong Yao Za Zhi 32(16): 1666-1668

Johansen, K.T.; Wubshet, S.G.; Nyberg, N.T. 2013: HPLC-NMR revisited: using time-slice high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance with database-assisted dereplication. Analytical Chemistry 85(6): 3183-3189

Ferreres, F.; Pereira, D.M.; Gil-Izquierdo, A.; Valentão, Pícia.; Botelho, Jão.; Mouga, T.; Andrade, P.B. 2010: HPLC-PAD-atmospheric pressure chemical ionization-MS metabolite profiling of cytotoxic carotenoids from the echinoderm Marthasterias glacialis (spiny sea-star). Journal of Separation Science 33(15): 2250-2257

Seo, C.-S.; Lim, H.-S.; Jeong, S.-J.; Ha, H.; Shin, H.-K. 2013: HPLC-PDA analysis and anti-inflammatory effects of Mori Cortex Radicis. Natural Product Communications 8(10): 1443-1446

Pavei, C.; Kaiser, S.; Verza, S.G.; Borre, G.L.; Ortega, G.G. 2012: HPLC-PDA method for quinovic acid glycosides assay in Cat's claw (Uncaria tomentosa) associated with UPLC/Q-TOF-MS analysis. Journal of Pharmaceutical and Biomedical Analysis 62: 250-257

Mencherini, T.; Campone, L.; Piccinelli, A.L.; Mesa, M.G.ía.; Sánchez, D.M.ía.; Aquino, R.P.; Rastrelli, L. 2013: HPLC-PDA-MS and NMR characterization of a hydroalcoholic extract of Citrus aurantium L. var. amara peel with antiedematogenic activity. Journal of Agricultural and Food Chemistry 61(8): 1686-1693

Borges, G.; Crozier, A. 2012: HPLC-PDA-MS fingerprinting to assess the authenticity of pomegranate beverages. Food Chemistry 135(3): 1863-1867

Rao, R.N.; Prasad, K.G.; Bindu Priya, P.; Bijarji, S. 2014: HPLC-PDA-ORD bioassay of S-(+) and R-(-) clopidogrel on rat dried blood spots. Chirality 26(2): 102-107

Fu, Z.; Ling, Y.; Li, Z.; Chen, M.; Sun, Z.; Huang, C. 2014: HPLC-Q-TOF-MS/MS for analysis of major chemical constituents of Yinchen-Zhizi herb pair extract. Biomedical Chromatography: Bmc 28(4): 475-485

Korepanova, A.; Matayoshi, E.D. 2012: HPLC-SEC characterization of membrane protein-detergent complexes. Current Protocols in Protein Science Chapter 29: Unit 29.5.1-12

Yan, L.; Wang, Y.; Yu, Q. 2011: HPLC-TOF-MS analysis of metabolites of Diffusa effective extracts in rats. Zhongguo Zhong Yao Za Zhi 36(10): 1301-1304

Mohamed, S.; Caporali, L.; De Giorgio, R.; Carelli, V.; Contin, M. 2014: HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 949-950: 58-62

Serna-Jiménez, C.E.; del Rio Sancho, S.; Calatayud-Pascual, M.A.; Balaguer-Fernández, C.; Femenía-Font, A.; López-Castellano, A.; Merino, V. 2012: HPLC-UV analytical method for determination of pizotifen after in vitro transdermal diffusion studies. Biomedical Chromatography: Bmc 26(6): 769-774

Zeng, L.; Nath, C.E.; Shaw, P.J.; Earl, J.W.; McLachlan, A.J. 2009: HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children. Biomedical Chromatography: Bmc 23(1): 92-100

Szkutnik-Fiedler, D.; Grześkowiak, E.; Gaca, M.ł; Borowicz, M. 2011: HPLC-UV determination of morphine in human plasma and its application to the clinical study. Acta Poloniae Pharmaceutica 68(4): 473-479

Kathiwala, M.; Affum, A.O.; Brajter-Toth, A. 2010: HPLC-UV measurements of metabolites in the supernatant of endothelial cells exposed to oxidative stress. Analytical and Bioanalytical Chemistry 396(5): 1763-1771

Almousa, A.A.; Ikeda, R.; Wada, M.; Kuroda, N.; Hanajiri, R.-K.; Nakashima, K. 2011: HPLC-UV method development for fentanyl determination in rat plasma and its application to elucidate pharmacokinetic behavior after I.p. administration to rats. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 879(27): 2941-2944

Patel, M.; Vasaya, M.M.; Asker, D.; Parsons, R.B. 2013: HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples: evidence for substrate inhibition kinetics. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 921-922: 87-95

Pigatto, M.C.ás.; Mossmann, D.L.; Dalla Costa, T. 2015: HPLC-UV method for quantifying etoposide in plasma and tumor interstitial fluid by microdialysis: application to pharmacokinetic studies. Biomedical Chromatography: Bmc 29(4): 529-536

Rojsitthisak, P.; Jongaroonngamsang, N.; Romero, R.M.; Haworth, I.S. 2011: HPLC-UV, MALDI-TOF-MS and ESI-MS/MS analysis of the mechlorethamine DNA crosslink at a cytosine-cytosine mismatch pair. Plos one 6(6): E20745

Dong, L.; Zhang, C.-y.; Chen, S.-l. 2011: HPLC-UV-ELSD characteristic figure and chemical pattern recognition of Panacis Quinquefolii Radix. Yao Xue Xue Bao 46(2): 198-202

Lech, K.; Witkoś, K.; Jarosz, M. 2014: HPLC-UV-ESI MS/MS identification of the color constituents of sawwort (Serratula tinctoria L.). Analytical and Bioanalytical Chemistry 406(15): 3703-3708

Rainha, N.; Koci, K.; Coelho, A.V.; Lima, E.; Baptista, J.é; Fernandes-Ferreira, M. 2013: HPLC-UV-ESI-MS analysis of phenolic compounds and antioxidant properties of Hypericum undulatum shoot cultures and wild-growing plants. Phytochemistry 86: 83-91

Brito, A.; Ramirez, J.E.; Areche, C.; Sepúlveda, B.; Simirgiotis, M.J. 2014: HPLC-UV-MS profiles of phenolic compounds and antioxidant activity of fruits from three citrus species consumed in Northern Chile. Molecules 19(11): 17400-17421

Ganesh, N.V.; Fujikawa, K.; Tan, Y.H.; Stine, K.J.; Demchenko, A.V. 2012: HPLC-assisted automated oligosaccharide synthesis. Organic Letters 14(12): 3036-3039

Li, Y.; Plitzko, I.; Zaugg, J.; Hering, S.; Hamburger, M. 2010: HPLC-based activity profiling for GABA(A) receptor modulators: a new dihydroisocoumarin from Haloxylon scoparium. Journal of Natural Products 73(4): 768-770

Yang, X.; Baburin, I.; Plitzko, I.; Hering, S.; Hamburger, M. 2011: HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root). Molecular Diversity 15(2): 361-372

Rueda, D.C.; De Mieri, M.; Hering, S.; Hamburger, M. 2014: HPLC-based activity profiling for GABAA receptor modulators in Adenocarpus cincinnatus. Journal of Natural Products 77(3): 640-649

Julianti, T.; De Mieri, M.; Zimmermann, S.; Ebrahimi, S.N.; Kaiser, M.; Neuburger, M.; Raith, M.; Brun, R.; Hamburger, M. 2014: HPLC-based activity profiling for antiplasmodial compounds in the traditional Indonesian medicinal plant Carica papaya L. Journal of Ethnopharmacology 155(1): 426-434

Zaugg, J.; Eickmeier, E.; Rueda, D.C.; Hering, S.; Hamburger, M. 2011: HPLC-based activity profiling of Angelica pubescens roots for new positive GABAA receptor modulators in Xenopus oocytes. Fitoterapia 82(3): 434-440

Zaugg, J.; Baburin, I.; Strommer, B.; Kim, H-Jung.; Hering, S.; Hamburger, M. 2010: HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site. Journal of Natural Products 73(2): 185-191

White, C.C.; Krejsa, C.J.; Eaton, D.L.; Kavanagh, T.J. 2001: HPLC-based assays for enzymes of glutathione biosynthesis. Current Protocols in Toxicology Chapter 6: Unit 6.5

Chrysanthakopoulos, M.; Nicolaou, I.; Demopoulos, V.J.; Tsantili-Kakoulidou, A. 2010: HPLC-based lipophilicity of pyrrolyl-acetic acid ARIs: Relationships with biological activity. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 878(1): 61-67

Yang, S.-O.; Lee, S.W.; Kim, Y.O.; Sohn, S.-H.; Kim, Y.C.; Hyun, D.Y.; Hong, Y.P.; Shin, Y.S. 2013: HPLC-based metabolic profiling and quality control of leaves of different Panax species. Journal of Ginseng Research 37(2): 248-253

Kalyanaraman, B.; Dranka, B.P.; Hardy, M.; Michalski, R.; Zielonka, J. 2014: HPLC-based monitoring of products formed from hydroethidine-based fluorogenic probes--the ultimate approach for intra- and extracellular superoxide detection. Biochimica et Biophysica Acta 1840(2): 739-744

Evjenth, R.H.; Van Damme, P.; Gevaert, K.; Arnesen, T. 2013: HPLC-based quantification of in vitro N-terminal acetylation. Methods in Molecular Biology 981: 95-102

Siluk, D.; Kim, H.Seung.; Cole, T.; Wainer, I.W. 2008: HPLC-electrospray mass spectrometric assay for the determination of (R,R)-fenoterol in rat plasma. Journal of Pharmaceutical and Biomedical Analysis 48(3): 960-964

Jiang, Z.; Liang, Q.; Luo, G.; Hu, P.; Li, P.; Wang, Y. 2009: HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy. Talanta 77(4): 1279-1284

Sun, X.-F.; Zhang, H.-Y.; Xia, Q.; Zhao, H.-J.; Wu, L.-F.; Zhang, L.-Z.; Shi, R.-B. 2014: HPLC-fingerprint-based quality evaluation on a Tibetan medicine Phyllanthus emblica and its tannin parts. Zhongguo Zhong Yao Za Zhi 39(7): 1173-1178

Lin, F.-J.; Yen, F.-L.; Chen, P.-C.; Wang, M.-C.; Lin, C.-N.; Lee, C.-W.; Ko, H.-H. 2014: HPLC-fingerprints and antioxidant constituents of Phyla nodiflora. Thescientificworldjournal 2014: 528653

Zeng, L.; Nath, C.E.; Shaw, P.J.; Earl, J.W.; McLachlan, A.J. 2008: HPLC-fluorescence assay for acyclovir in children. Biomedical Chromatography: Bmc 22(8): 879-887

Cheng, C.-L.; Chang, Y.-W.; Chou, C.-H. 2010: HPLC-fluorescence assay for measuring mosapride in small volumes of rat plasma. Biomedical Chromatography: Bmc 24(3): 281-288

Kameník, Z.; Kopecký, J.; Marecková, M.ét.; Ulanová, D.; Novotná, J.; Pospísil, S.; Olsovská, J. 2009: HPLC-fluorescence detection method for determination of key intermediates of the lincomycin biosynthesis in fermentation broth. Analytical and Bioanalytical Chemistry 393(6-7): 1779-1787

Kono, Y.; Iizuka, H.; Isokawa, M.; Tsunoda, M.; Ichiba, H.; Sadamoto, K.; Fukushima, T. 2014: HPLC-fluorescence determination of thiol compounds in the serum of human male and female subjects using HILIC-mode column. Biomedical Chromatography: Bmc 28(5): 589-593

Al Za'abi, M.; Ali, B.; Al Toubi, M. 2013: HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. Journal of Chromatographic Science 51(1): 40-43

Alanazi, A.M.; Hefnawy, M.M.; Al-Majed, A.A.; Al-Suwailem, A.K.; Kassem, M.G.; Mostafa, G.A.; Attia, S.M.; Khedr, M.A.; Khedr, M.M. 2014: HPLC-fluorescence method for the enantioselective analysis of propranolol in rat serum using immobilized polysaccharide-based chiral stationary phase. Chirality 26(4): 194-199

Karkabounas, A.; Kitsiouli, E.I.; Nakos, G.; Lekka, M.E. 2011: HPLC-fluorimetric assay of phospholipase A2. Application to biological samples with high protein content and various reaction conditions. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 879(19): 1557-1564

Jiwan, J.-L.H.; Wallemacq, P.; Hérent, M.-F. 2011: HPLC-high resolution mass spectrometry in clinical laboratory?. Clinical Biochemistry 44(1): 136-147

Komori, K.; Komae, R.; Yamazaki, Y.; Nakano, S.; Mitamura, S.; Miyazaki, T.; Kikuta, M.; Takada, M.; Shuto, M.; Hane, Y.; Yamamoto, T. 2013: HPLC-method for deliberation of drug mammary transfer-evaluation of over-the-counter drugs (Loxonin(®)-S, Bufferin(®) A) in mother mice. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 133(8): 905-911

Shishovska, M.; Trajkovska, V. 2010: HPLC-method for determination of permethrin enantiomers using chiral beta-cyclodextrin-based stationary phase. Chirality 22(5): 527-533

Seo, C.-S.; Ha, H.; Kim, Y.-J.; Jungb, J.-Y. 2014: HPLC-pDA simultaneous determination and protective effect of Anemarrhena asphodeloides against acute renal failure. Natural Product Communications 9(6): 829-832

Gao, J.; Owen, B.C.; Borton, D.J.; Jin, Z.; Kenttämaa, H.I. 2012: HPLC/APCi mass spectrometry of saturated and unsaturated hydrocarbons by using hydrocarbon solvents as the APCi reagent and HPLC mobile phase. Journal of the American Society for Mass Spectrometry 23(5): 816-822

Bataineh, M.; Lübcke-von Varel, U.; Hayen, H.; Brack, W. 2010: HPLC/APCI-FTICR-MS as a tool for identification of partial polar mutagenic compounds in effect-directed analysis. Journal of the American Society for Mass Spectrometry 21(6): 1016-1027

Arráez-Román, D.; Fu, S.; Sawalha, S.M.S.; Segura-Carretero, A.; Fernández-Gutiérrez, A. 2010: HPLC/CE-ESI-TOF-MS methods for the characterization of polyphenols in almond-skin extracts. Electrophoresis 31(13): 2289-2296

Xu, F.; Liu, Y.; Song, R.; Dong, H.; Zhang, Z. 2010: HPLC/DAD comparison of sixteen bioactive components between Da-Cheng-Qi decoction and its parent herbal medicines. Natural Product Communications 5(6): 893-896

Romani, A.; Vignolini, P.; Tanini, A.; Pampaloni, B.; Heimler, D. 2010: HPLC/DAD/MS and antioxidant activity of isoflavone-based food supplements. Natural Product Communications 5(11): 1775-1780

Sardella, R.; Gioiello, A.; Ianni, F.; Venturoni, F.; Natalini, B. 2012: HPLC/ELSD analysis of amidated bile acids: an effective and rapid way to assist continuous flow chemistry processes. Talanta 100: 364-371

Popot, M.A.; Garcia, P.; Hubert, C.; Bolopion, A.; Bailly-Chouriberry, L.; Bonnaire, Y.; Thibaud, D.; Guyonnet, J. 2014: HPLC/ESI-MS(n) method for non-amino bisphosphonates: application to the detection of tiludronate in equine plasma. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 958: 108-116

Liu, W.; Pi, Z.; Wang, X.; Song, F.; Liu, S. 2010: HPLC/ESI-MSn and ESI-MS studies on the Aconitum alkaloids in three Chinese medicinal herbs. Journal of Separation Science 33(17-18): 2898-2906

Li, W-Tao.; Xu, Z-Xiao.; Li, A-Min.; Wu, W.; Zhou, Q.; Wang, J-Nan. 2013: HPLC/HPSEC-FLD with multi-excitation/emission scan for EEM interpretation and dissolved organic matter analysis. Water Research 47(3): 1246-1256

Meermann, B.ör.; Hulstaert, A.; Laenen, A.; Van Looveren, C.; Vliegen, M.; Cuyckens, F.; Vanhaecke, F. 2012: HPLC/ICP-MS in combination with "reverse" online isotope dilution in drug metabolism studies. Analytical Chemistry 84(5): 2395-2401

Aguirre-Hernández, E.; González-Trujano, M.Eva.; Martínez, A.Laura.; Moreno, J.; Kite, G.; Terrazas, T.; Soto-Hernández, M. 2010: HPLC/MS analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from Tilia americana var. mexicana. Journal of Ethnopharmacology 127(1): 91-97

Evans, J.E.; McCaffery, P. 2010: HPLC/MS(N) analysis of retinoids. Methods in Molecular Biology 652: 149-162

Xia, B.; Wang, T.; Fox, L.M.; Wang, D. 2009: HPLC/MS/MS analysis of 3-carbamyl-4-methylpyrrole analog MNP001, a highly potent antihypertensive agent, in rat plasma. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 877(20-21): 1867-1872

Xu, N.; Qiu, C.; Wang, W.; Wang, Y.; Chai, C.; Yan, Y.; Zhu, D. 2011: HPLC/MS/MS for quantification of two types of neurotransmitters in rat brain and application: myocardial ischemia and protection of Sheng-Mai-San. Journal of Pharmaceutical and Biomedical Analysis 55(1): 101-108

Haidar, E.A.C.; Lee, T.D.; Barton, J.D.; Coates, A.R.M.; Mantle, P.G. 2011: HPLC/MS/MS methodology for sensitive quantitation of monic acid A, the metabolic product of the antibiotic mupirocin. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 16(5): 422-425

Lundström, S.L.; D'Alexandri, F.L.; Nithipatikom, K.; Haeggström, J.Z.; Wheelock, A.M.; Wheelock, C.E. 2009: HPLC/MS/MS-based approaches for detection and quantification of eicosanoids. Methods in Molecular Biology 579: 161-187

Sabatino, L.; Scordino, M.; Gargano, M.; Belligno, A.; Traulo, P.; Gagliano, G. 2011: HPLC/PDA/ESI-MS evaluation of saffron (Crocus sativus L.) adulteration. Natural Product Communications 6(12): 1873-1876

Zhang, X.; Lv, H.; Li, Z.; Jiang, K.; Lee, M.-R. 2015: HPLC/QTOF-MS/MS application to investigate phenolic constituents from Ficus pandurata H. aerial roots. Biomedical Chromatography: Bmc 29(6): 860-868

He, J.-Y.; Zhu, S.; Komatsu, K. 2014: HPLC/UV analysis of polyacetylenes, phenylpropanoid and pyrrolidine alkaloids in medicinally used Codonopsis species. Phytochemical Analysis: Pca 25(3): 213-219

Wang, D.-d.; Liang, J.; Yang, W.-z.; Hou, J.-j.; Yang, M.; Da, J.; Wang, Y.; Jiang, B.-h.; Liu, X.; Wu, W.-y.; Guo, D.-a. 2014: HPLC/qTOF-MS-oriented characteristic components data set and chemometric analysis for the holistic quality control of complex TCM preparations: Niuhuang Shangqing pill as an example. Journal of Pharmaceutical and Biomedical Analysis 89: 130-141

Robinson, A.L. 1979: HPLC: the new King of Analytical Chemistry?. Science 203(4387): 1329-1332

Mei, S.-L.; Zhu, D.-H. 2014: HPM-based dynamic sparse grid approach for Perona-Malik equation. Thescientificworldjournal 2014: 417486

Shouval, D. 2010: New insight into the mechanism of hepatic involvement in brucellosis. Journal of Hepatology 53(1): 1-2

Ruttekolk, I.R.; Duchardt, F.; Fischer, R.; Wiesmüller, K.-H.; Rademann, J.ör.; Brock, R. 2008: HPMA as a scaffold for the modular assembly of functional peptide polymers by native chemical ligation. Bioconjugate Chemistry 19(10): 2081-2087

Hemmelmann, M.; Knoth, C.; Schmitt, U.; Allmeroth, M.; Moderegger, D.; Barz, M.; Koynov, K.; Hiemke, C.; Rösch, F.; Zentel, R. 2011: HPMA based amphiphilic copolymers mediate central nervous effects of domperidone. Macromolecular Rapid Communications 32(9-10): 712-717

Kostková, H.; Etrych, T.áš; Ríhová, B.; Kostka, L.; Starovoytová, L.; Kovář, M.; Ulbrich, K. 2013: HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy. Macromolecular Bioscience 13(12): 1648-1660

Etrych, T.ás.; Sírová, M.; Starovoytova, L.; Ríhová, B.; Ulbrich, K. 2010: HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Molecular Pharmaceutics 7(4): 1015-1026

Etrych, T.ás.; Strohalm, J.í; Kovár, L.ír.; Kabesová, M.; Ríhová, B.; Ulbrich, K. 2009: HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Journal of Controlled Release: Official Journal of the Controlled Release Society 140(1): 18-26

Larson, N.; Ray, A.; Malugin, A.; Pike, D.B.; Ghandehari, H. 2010: HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer. Pharmaceutical Research 27(12): 2683-2693

Zhou, Y.; Yang, J.; Rhim, J.S.; Kopeček, J.ři. 2013: HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects. Journal of Controlled Release: Official Journal of the Controlled Release Society 172(3): 946-953

Sirova, M.; Kabesova, M.; Kovar, L.; Etrych, T.; Strohalm, J.; Ulbrich, K.; Rihova, B. 2013: HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death. Current Medicinal Chemistry 20(38): 4815-4826

Pike, D.B.; Ghandehari, H. 2010: HPMA copolymer-cyclic RGD conjugates for tumor targeting. Advanced Drug Delivery Reviews 62(2): 167-183

Etrych, T.áš; Subr, V.ír.; Strohalm, J.ří; Sírová, M.; Ríhová, B.; Ulbrich, K. 2012: HPMA copolymer-doxorubicin conjugates: the effects of molecular weight and architecture on biodistribution and in vivo activity. Journal of Controlled Release: Official Journal of the Controlled Release Society 164(3): 346-354

Zarabi, B.; Nan, A.; Zhuo, J.; Gullapalli, R.; Ghandehari, H. 2008: HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation. Macromolecular Bioscience 8(8): 741-748

Kelsch, A.; Tomcin, S.; Rausch, K.; Barz, M.; Mailänder, V.; Schmidt, M.; Landfester, K.; Zentel, R. 2012: HPMA copolymers as surfactants in the preparation of biocompatible nanoparticles for biomedical application. Biomacromolecules 13(12): 4179-4187

Fisher, K.D.; Seymour, L.W. 2010: HPMA copolymers for masking and retargeting of therapeutic viruses. Advanced Drug Delivery Reviews 62(2): 240-245

Minko, T. 2010: HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance. Advanced Drug Delivery Reviews 62(2): 192-202

Lammers, T.; Ulbrich, K. 2010: HPMA copolymers: 30 years of advances. Advanced drug delivery reviews 62(2): 119-121

Kopecek, J.; Kopecková, P. 2010: HPMA copolymers: origins, early developments, present, and future. Advanced Drug Delivery Reviews 62(2): 122-149

Allmeroth, M.; Moderegger, D.; Gündel, D.; Koynov, K.; Buchholz, H.-G.; Mohr, K.; Rösch, F.; Zentel, R.; Thews, O. 2013: HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution. Biomacromolecules 14(9): 3091-3101

Hejcl, A.; Sedý, J.í; Kapcalová, M.; Toro, D.A.; Amemori, T.; Lesný, P.; Likavcanová-Mašínová, K.; Krumbholcová, E.; Prádný, M.; Michálek, J.í; Burian, M.; Hájek, M.; Jendelová, P.; Syková, E. 2010: HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells and Development 19(10): 1535-1546

Krakovicová, H.; Etrych, T.ás.; Ulbrich, K. 2009: HPMA-based polymer conjugates with drug combination. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 37(3-4): 405-412

Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P.E.; Hennink, W.E.; Storm, G.; Kiessling, F. 2010: HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations. Nanomedicine 5(10): 1501-1523

Pola, R.; Studenovský, M.; Pechar, M.; Ulbrich, K.; Hovorka, O.; Vetvicka, D.; Ríhová, B. 2009: HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides. Journal of Drug Targeting 17(10): 763-776

Johnson, R.N.; Chu, D.S.H.; Shi, J.; Schellinger, J.G.; Carlson, P.M.; Pun, S.H. 2011: HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight. Journal of Controlled Release: Official Journal of the Controlled Release Society 155(2): 303-311

Riekes, M.K.üp.; Kuminek, G.; Rauber, G.S.; de Campos, C.E.M.; Bortoluzzi, A.J.ão.; Stulzer, H.K. 2014: HPMC as a potential enhancer of nimodipine biopharmaceutical properties via ball-milled solid dispersions. Carbohydrate Polymers 99: 474-482

Al-Tabakha, M.M. 2010: HPMC capsules: current status and future prospects. Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 13(3): 428-442

Horiuchi, T.; Matsunaga, K.; Banno, M.; Nakano, Y.; Nishimura, K.; Hanzawa, C.; Miyamoto, K.-i.; Nomura, S.; Ohta, Y. 2009: HPMCs induce greater intercellular delocalization of tight junction-associated proteins due to a higher susceptibility to H2O2 compared with HUVECs. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(2): 217-226

Shi, D.; Guo, S.; Jiang, B.; Guo, C.; Wang, T.; Zhang, L.; Li, J. 2013: HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice. Marine Drugs 11(2): 350-362

McCall, R.D. 2011: HPNS seizure risk: a role for the Golgi-associated retrograde protein complex?. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 38(1): 3-9

Baucum, M.; John, R. 2018: Causal evidence in risk and policy perceptions: Applying the covariation/mechanism framework. Acta Psychologica 186: 90-103

Sampath, S.; Keats, B.J.B.; Lacassie, Y. 2011: HPPD: a newly recognized autosomal dominant disorder involving hypertelorism, preauricular sinus, punctal pits, and deafness mapping to chromosome 14q31. American Journal of Medical Genetics. Part a 155a (5): 976-985

López-Ramos, M.; Perruccio, F. 2010: HPPD: ligand- and target-based virtual screening on a herbicide target. Journal of Chemical Information and Modeling 50(5): 801-814

Ricketts, T.C.; Thompson, K.; Neuwahl, S.; McGee, V. 2011: HPRI data tracks. Developing an index of surgical underservice. Bulletin of the American College of Surgeons 96(7): 45-7 57

Neuwahl, S.; Thompson, K.; Fraher, E.; Ricketts, T. 2012: HPRi data tracks. Urology workforce trends. Bulletin of the American College of Surgeons 97(1): 46-49

Kang, T.H.; Guibinga, G.-H.; Jinnah, H.A.; Friedmann, T. 2011: HPRT deficiency coordinately dysregulates canonical Wnt and presenilin-1 signaling: a neuro-developmental regulatory role for a housekeeping gene?. Plos one 6(1): E16572

Torres, R.J.; Prior, C.; Garcia, M.G.; Beltran, L.M.; Puig, J.G. 2014: HPRT deficiency in Spain: what have we learned in the past 30 years (1984-2013)?. Nucleosides Nucleotides and Nucleic Acids 33(4-6): 223-232

Zamora, A.; Escárcega, R.O.; Vazquez, R.; Zamora, A.; O'Neill, J.P. 2007: HPRT deficiency in a two-month-old child presenting acute renal failure and gout with a new deletion of two bases in exon 3 of the HPRT gene. Archives of Medical Research 38(4): 460-462

Corrigan, A.; Arenas, M.; Escuredo, E.; Fairbanks, L.; Marinaki, A. 2011: HPRT deficiency: identification of twenty-four novel variants including an unusual deep intronic mutation. Nucleosides Nucleotides and Nucleic Acids 30(12): 1260-1265

Guibinga, G.-H.; Murray, F.; Barron, N. 2013: HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: mechanistic insight and potential target for Lesch-Nyhan Disease?. Plos one 8(5): E63333

Dickson, H.; Walchuk, M.; Ryan, M.T.; Little, C.A.; Roessler, G.S.; Classic, K.; Edwards, J. 2013: HPS publications implement society's "SI Only" position. Health Physics 105(2 Suppl. 2): S109-S110

Masana, L.; Cabré, A.; Plana, N. 2013: HPS2-THRIVE results: bad for niacin/laropiprant, good for ezetimibe?. Atherosclerosis 229(2): 449-450

Yu, H.; Luo, N.; Sun, L.; Liu, D. 2012: HPS4/SABRE regulates plant responses to phosphate starvation through antagonistic interaction with ethylene signalling. Journal of Experimental Botany 63(12): 4527-4538

Li, K.; Yang, L.; Zhang, C.; Niu, Y.; Li, W.; Liu, J.-J. 2014: HPS6 interacts with dynactin p150Glued to mediate retrograde trafficking and maturation of lysosomes. Journal of Cell Science 127(Part 21): 4574-4588

Tonn, K. 2007: HPSA and the Anti-Kickback safe harbor: are we sending doctors to the right neighborhoods?. Annals of Health Law 16(2): 241-262 Table of Content

Jokinen, J.; Samuelsson, M.; Nordström, A.-L.; Nordström, P. 2008: HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters. Journal of Affective Disorders 111(1): 119-124

Nile, S.H.; Park, S.W. 2014: HPTLC Analysis, Antioxidant and Antigout Activity of Indian Plants. Iranian Journal of Pharmaceutical Research: Ijpr 13(2): 531-539

Joshi, M.; Nikalje, A.P.; Shahed, M.; Dehghan, M. 2009: HPTLC Method for the Simultaneous Estimation of Emtricitabine and Tenofovir in Tablet Dosage Form. Indian Journal of Pharmaceutical Sciences 71(1): 95-97

Shah, N.J.; Suhagia, B.N.; Shah, R.R.; Patel, N.M. 2009: HPTLC Method for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form. Indian Journal of Pharmaceutical Sciences 71(1): 72-74

Nile, S.H.; Park, S.W. 2014: HPTLC analysis, antioxidant, anti-inflammatory and antiproliferative activities of Arisaema tortuosum tuber extract. Pharmaceutical Biology 52(2): 221-227

Suganthi, G.; Sripathy, S.K.; Manian, K. 2008: HPTLC and antibacterial analysis of extracts of Cressa cretica Linn. Ancient Science of Life 27(3): 1-14

Priya Rani, M.; Padmakumari, K.P. 2012: HPTLC and reverse phase HPLC methods for the simultaneous quantification and in vitro screening of antioxidant potential of isolated sesquiterpenoids from the rhizomes of Cyperus rotundus. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 904: 22-28

Alam, P.; Alqasoumi, S.I.; Shakeel, F.; Abdel-Kader, M.S. 2011: HPTLC densitometric analysis of arbutin in bulk drug and methanolic extracts of Arctostaphylos uva-ursi. Natural Product Research 25(17): 1671-1675

Dey, A.; Pandey, D.K. 2014: HPTLC detection of altitudinal variation of the potential antivenin stigmasterol in different populations of the tropical ethnic antidote Rauvolfia serpentina. Asian Pacific Journal of Tropical Medicine 7s1: S540-S545

Ranjane, P.N.; Gandhi, S.V.; Kadukar, S.S.; Bothara, K.G. 2010: HPTLC determination of cefuroxime axetil and ornidazole in combined tablet dosage form. Journal of Chromatographic Science 48(1): 26-28

Toniolo, C.; Nicoletti, M.; Maggi, F.; Venditti, A. 2014: HPTLC determination of chemical composition variability in raw materials used in botanicals. Natural Product Research 28(2): 119-126

Shao, Y.-H.; Wang, J.-G.; Lai, X.-P.; Wu, X.-W.; Ding, P. 2014: HPTLC fingerprint analysis of andrographolides from Andrographis paniculata. Zhong Yao Cai 37(2): 219-223

El-Koussi, W.M.; Atia, N.N.; Mahmoud, A.M.; El-Shabouri, S.R. 2014: HPTLC method for direct determination of gemifloxacin mesylate in human plasma. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 967: 98-101

Verma, P.K.; Kamboj, V.K. 2013: HPTLC method for estimation of olmesartan medoxomil in tablet formulation with stability studies. Pakistan Journal of Pharmaceutical Sciences 26(1): 209-215

Londhe, S.V.; Nanaware, S.M. 2013: HPTLC method for simultaneous analysis of stevioside and rebaudioside-A in Stevia rebaudiana. Journal - Association of Official Analytical Chemists 96(1): 24-26

Jain, K.L.; Patel, R.K.; Patel, H.P. 2014: HPTLC method for simultaneous determination of piperine, embeline, and carvone in the ayurvedic formulation Catpusphadhya churna. Journal - Association of Official Analytical Chemists 97(3): 773-777

Gupta, S.; Shanker, K.; Srivastava, S.K. 2012: HPTLC method for the simultaneous determination of four indole alkaloids in Rauwolfia tetraphylla: a study of organic/green solvent and continuous/pulse sonication. Journal of Pharmaceutical and Biomedical Analysis 66: 33-39

Shewiyo, D.H.; Kaale, E.; Risha, P.G.; Dejaegher, B.; Smeyers-Verbeke, J.; Vander Heyden, Y. 2012: HPTLC methods to assay active ingredients in pharmaceutical formulations: a review of the method development and validation steps. Journal of Pharmaceutical and Biomedical Analysis 66: 11-23

Haghighi, S.; Shapouri, M.R.; Amoli-Diva, M.; Pourghazi, K.; Afruzi, H. 2013: HPTLC-Densitometric Determination of Cetirizine and Montelukast Analysis in Combined Tablet Dosage Forms. Iranian Journal of Pharmaceutical Research: Ijpr 12(2): 303-309

Kasaye, L.; Hymete, A.; Mohamed, A.-M.I. 2010: HPTLC-densitometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in dry powder inhalers. Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 18(3): 153-159

Nowak, R.; Wójciak-Kosior, M.; Sowa, I.; Sokołowska-Krzaczek, A.; Pietrzak, W.; Szczodra, A.; Kocjan, R. 2013: HPTLC-densitometry determination of triterpenic acids in Origanum vulgare, Rosmarinus officinalis and Syzygium aromaticum. Acta Poloniae Pharmaceutica 70(3): 413-418

Pasilis, S.P.; Kertesz, V.; Van Berkel, G.J.; Schulz, M.; Schorcht, S. 2008: HPTLC/DESI-MS imaging of tryptic protein digests separated in two dimensions. Journal of Mass Spectrometry: Jms 43(12): 1627-1635

Guffey, M.Bradford.; Richardson, B.; Husnik, M.; Makanani, B.; Chilongozi, D.; Yu, E.; Ramjee, G.; Mgodi, N.; Gomez, K.; Hillier, S.L.; Karim, S.Abdool.; Black, R.; Soto-Torres, L.; Estep, S.; Profy, A.; Moench, T.; Karim, S.; Taha, T.; Kumwenda, N.; Makanani, B.; Hurst, S.; Nkhoma, C.; Kachale, E.; Ramjee, G.; Govinden, R.; Coumi, N.; Dladla-Qwabe, N.; Ganesh, S.; Morar, N.; Chirenje, Z.; Padian, N.; van der Straten, A.; Magure, T.; Mlingo, M.; Mgodi, N.; Hoffman, I.; Martinson, F.; Tembo, T.; Chinula, L.; Mvalo, T.; Parham, G.; Kapina, M.; Reid, C.; Kasaro, M.; Brahmi, A.; Maslankowski, L.; Prince, J.; Tustin, N.; Whittington, S.; Yu, E.; Cates, W.; Coletti, A.; Gomez, K.; White, R.; Cian 2014: HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sexually Transmitted Infections 90(5): 363-369

Epstein, H.; Morris, M. 2011: HPTN 052 and the future of HIV treatment and prevention. Lancet 378(9787): 225

Seale, A.; Lazarus, J.V.; Grubb, I.; Fakoya, A.; Atun, R. 2011: HPTN 052 and the future of HIV treatment and prevention. Lancet 378(9787): 226

Corneli, A.; Pettifor, A.; Kamanga, G.; Golin, C.; McKenna, K.; Ou, S.-S.; Hamela, G.; Massa, C.; Martinson, F.; Tharaldson, J.; Hilgenberg, D.; Yu, X.; Chege, W.; Hoffman, I. 2014: HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi. Aids and Behavior 18(9): 1785-1800

Cori, A.; Ayles, H.; Beyers, N.; Schaap, A.; Floyd, S.; Sabapathy, K.; Eaton, J.W.; Hauck, K.; Smith, P.; Griffith, S.; Moore, A.; Donnell, D.; Vermund, S.H.; Fidler, S.; Hayes, R.; Fraser, C.; Agyei, Y.; Baldwin, M.; Barnes, M.; Bond, V.; Burns, D.; Chishinga, N.; Cummings, V.; Emel, L.; Eshleman, S.; Godfrey-Faussett, P.; Greene, E.; Hargreaves, J.; Headen, T.; Horn, L.; Kim, P.; Piwowar-Manning, E.; McCarthy, K.; Musheke, M.; Mwango, A.; Mwinga, A.; Muyoyeta, M.; Simwinga, M.; Shanaube, K.; Watson-Jones, D.; Wolf, S.; White, R. 2014: HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. Plos one 9(1): E84511

Hayes, R.; Ayles, H.; Beyers, N.; Sabapathy, K.; Floyd, S.; Shanaube, K.; Bock, P.; Griffith, S.; Moore, A.; Watson-Jones, D.; Fraser, C.; Vermund, S.H.; Fidler, S. 2014: HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials 15: 57

Bharadwaj, M.; Hussain, S.; Nasare, V.; Das, B.C. 2009: HPV and HPV vaccination: issues in developing countries. Indian Journal of Medical Research 130(3): 327-333

Kostas-Polston, E.A.; Johnson-Mallard, V.; Berman, N.R. 2012: HPV & age-appropriate cervical cancer prevention for adolescents. Nurse Practitioner 37(6): 30-38

Goon, P.K.C.; Stanley, M.A.; Ebmeyer, Jörg.; Steinsträsser, L.; Upile, T.; Jerjes, W.; Bernal-Sprekelsen, M.; Görner, M.; Sudhoff, H.H. 2009: HPV & head and neck cancer: a descriptive update. Head and Neck Oncology 1: 36

Konno, R. 2012: HPV (human papillomavirus) vaccine. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 175-183

Stanley, M. 2010: HPV - immune response to infection and vaccination. Infectious Agents and Cancer 5: 19

Steinberg, B.; Norrild, B. 2010: HPV - oral, pharyngeal and laryngeal infections. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 118(6-7): 421

Bermúdez-Morales, V.H.; Peralta-Zaragoza, O.; Guzmán-Olea, E.; García-Carrancá, A.; Bahena-Román, M.; Alcocer-González, J.M.; Madrid-Marina, V. 2009: HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 30(2): 61-72

Loffredo D'Ottaviano, M.G.; Discacciati, M.G.; Andreoli, M.A.; Costa, M.C.íl.; Termini, L.; Rabelo-Santos, S.H.; Villa, L.L.; Zeferino, L.C. 2013: HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: a Case Series. Obstetrics and Gynecology International 2013: 328909

Indrová, M.; Bieblová, J.; Rossowska, J.; Kuropka, P.; Pajtasz-Piasecka, E.; Bubeník, J.; Reinis, M. 2009: HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy. International Journal of Oncology 34(1): 173-179

Riedmann, E.M. 2014: HPV 16/18 prevalence reduced 3 years following vaccine introduction. Human Vaccines and Immunotherapeutics 10(2): 254

Tjalma, W.A.A.; De Ridder, M.R. 2009: HPV 18 antibody levels, clinical efficacy and induced immune memory: a trio?. Vaccine 27(43): 5921-5922

Wallace, N.A.; Robinson, K.; Howie, H.L.; Galloway, D.A. 2012: HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. Plos Pathogens 8(7): E1002807

Anonymous 2012: HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment. Prescrire International 21(130): 208

Dunne, E.F.; Nielson, C.M.; Hagensee, M.E.; Papenfuss, M.R.; Harris, R.B.; Herrel, N.; Gourlie, J.; Abrahamsen, M.; Markowitz, L.E.; Giuliano, A.R. 2009: HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sexually Transmitted Diseases 36(11): 671-674

An, H.; Song, K.-S.; Nimse, S.B.; Kim, J.; Nguyen, V.-T.; Ta, V.-T.; Sayyed, D.R.; Kim, T. 2012: HPV 9G DNA chip: 100% clinical sensitivity and specificity. Journal of Clinical Microbiology 50(3): 562-568

Song, K.-S.; Nimse, S.B.; An, H.; Kim, J.; Nguyen, V.-T.; Ta, V.-T.; Kim, T. 2012: HPV 9G DNAChip: Based on the 9G DNAChip technology. Journal of Virological Methods 183(2): 132-138

Colón-López, V.; Quiñones, V.; Del Toro-Mejías, L.M.; Conde-Toro, A.; Serra-Rivera, M.J.; Martínez, T.M.; Rodríguez, Vónica.; Berdiel, L.; Villanueva, Héctor. 2015: HPV Awareness and Vaccine Willingness Among Dominican Immigrant Parents Attending a Federal Qualified Health Clinic in Puerto Rico. Journal of immigrant and minority health 17(4): 1086-1090

Ozalp, S.S.; Us, T.; Arslan, E.; Oge, T.; Kaşifoğlu, N.ün. 2012: HPV DNA and Pap smear test results in cases with and without cervical pathology. Journal of the Turkish German Gynecological Association 13(1): 8-14

Shah, A.A.; Evans, M.F.; Adamson, C.S.-C.; Peng, Z.; Rajendran, V.; Cooper, K. 2010: HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16(INK4a) immunoreactivity. Head and Neck Pathology 4(2): 106-112

Lee, S.Hang. 2010: HPV DNA test utilization. American Journal of Clinical Pathology 133(2): 339; Author Reply 240

Egawa, N.; Kiyono, T. 2010: HPV DNA testing and application for cervical cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 535-540

Tarkkanen, J.; Auvinen, E.; Nieminen, P.; Malmi, R.; Vartiainen, J.; Timonen, T.; Laurila, P.; Räisänen, I.; Unnerus, H-Anders.; Sakki, A.; Mattila, P.; Van Den Brule, A.Van.Den.; Tapper, A-Maija. 2007: HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland. Acta Obstetricia et Gynecologica Scandinavica 86(3): 367-372

Budal, E.B.; Haugland, H.K.; Skar, R.; Maehle, B.ør.O.; Bjørge, T.; Vintermyr, O.K. 2014: HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. a population-based follow-up study from Western Norway. Cancer Medicine 3(1): 182-189

Bandyopadhyay, S.; Cao, M.; Liu, Y.; Hermonat, P.L. 2010: HPV E1 up-regulates replication-related biochemistries of AAV Rep78. Virology 402(1): 94-101

Li, G-Ling.; Jiang, W.; Xia, Q.; Chen, S-Hua.; Ge, X-Rui.; Gui, S-Qi.; Xu, C-Jian. 2010: HPV E6 down-regulation and apoptosis induction of human cervical cancer cells by a novel lipid-soluble extract (PE) from Pinellia pedatisecta Schott in vitro. Journal of Ethnopharmacology 132(1): 56-64

Manzo-Merino, J.; Thomas, M.; Fuentes-Gonzalez, A.M.; Lizano, M.; Banks, L. 2013: HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers. Expert Opinion on Therapeutic Targets 17(11): 1357-1368

Day, T.; Vaziri, C. 2009: HPV E6 oncoprotein prevents recovery of stalled replication forks independently of p53 degradation. Cell Cycle 8(14): 2138

Liu, X.; Dakic, A.; Zhang, Y.; Dai, Y.; Chen, R.; Schlegel, R. 2009: HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proceedings of the National Academy of Sciences of the United States of America 106(44): 18780-18785

Heaton, P.R.; Deyrieux, A.F.; Bian, X.-L.; Wilson, V.G. 2011: HPV E6 proteins target Ubc9, the SUMO conjugating enzyme. Virus Research 158(1-2): 199-208

Beaudenon, S.; Huibregtse, J.M. 2008: HPV E6, E6AP and cervical cancer. Bmc Biochemistry 9(Suppl 1): S4

Evans, M.F.; Peng, Z.; Clark, K.M.; Adamson, C.S.-C.; Ma, X.-J.; Wu, X.; Wang, H.; Luo, Y.; Cooper, K. 2014: HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade. Plos one 9(3): E91142

Sørbye, S.W.; Arbyn, M.; Fismen, S.; Gutteberg, T.J.; Mortensen, E.S.øv. 2011: HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. Plos one 6(10): E26022

Montoya-Durango, D.E.; Ramos, K.S. 2012: HPV E7 viral oncoprotein disrupts transcriptional regulation of L1Md retrotransposon. Febs Letters 586(1): 102-106

Alsbeih, G. 2014: HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination. Frontiers in Oncology 4: 65

Trimble, C.L. 2014: HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment. Cancer Immunology Research 2(10): 937-942

Acosta, A.M.; Bonney, L.E.; Fost, M.; Green, V.L.; del Rio, C. 2013: HPV Knowledge Among a Marginalized Population [Letter. Preventing Chronic Disease 10: E44

Hernandez, J.; Elahi, A.; Siegel, E.; Coppola, D.; Riggs, B.; Shibata, D. 2011: HPV L1 capsid protein detection and progression of anal squamous neoplasia. American Journal of Clinical Pathology 135(3): 436-441

de Sanjosé, S. 2012: HPV Prevention series. Infectious Agents and Cancer 7(1): 37

Ko, E.M.; Tambouret, R.; Wilbur, D.; Goodman, A. 2011: HPV Reflex Testing in Menopausal Women. Pathology Research International 2011: 181870

Wakisaka, N.; Yoshida, S.; Kondo, S.; Kita, M.; Endo, K.; Tsuji, A.; Murono, S.; Muramatsu, M.; Yoshizaki, T. 2015: HPV Status Determines the Efficacy of Adjuvant Chemotherapy with S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer. Annals of Otology Rhinology and Laryngology 124(5): 400-406

Wilson, R.M.; Brown, D.R.; Carmody, D.P.; Fogarty, S. 2015: HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center. Journal of Community Health 40(3): 395-403

Kent, A. 2010: HPV Vaccination and Testing. Reviews in Obstetrics and Gynecology 3(1): 33-34

Nigam, A.; Saxena, P.; Acharya, A.S.; Mishra, A.; Batra, S. 2014: HPV Vaccination in India: Critical Appraisal. Isrn Obstetrics and Gynecology 2014: 394595

Dalvi, S. 2014: HPV Vaccine: how Far have we Achieved?. Journal of Obstetrics and Gynaecology of India 64(5): 317-320

Moscicki, A.-B. 2008: HPV Vaccines: today and in the Future. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 43(4 Suppl): S26-S40

Bishop, J.A.; Ogawa, T.; Chang, X.; Illei, P.B.; Gabrielson, E.; Pai, S.I.; Westra, W.H. 2012: HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. American Journal of Surgical Pathology 36(1): 142-148

Bellaminutti, S.; Seraceni, S.; De Seta, F.; Gheit, T.; Tommasino, M.; Comar, M. 2014: HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. Journal of Medical Virology 86(11): 1920-1925

Bambury, I. 2013: HPV and HPV Vaccine Awareness: Where Are We?. West Indian Medical Journal 62(8): 683-684

Coşar, E.; Gencer, M.; Hacivelioğlu, S.O.; Güngör, A.C.; Uysal, A. 2014: HPV and HPV vaccination: knowledge and consciousness of young women. European Journal of Gynaecological Oncology 35(5): 554-556

Samaritan, G.; Pearlman, R.A. 2007: Underdiagnosed and undertreated colorectal cancer tops liability list. Journal of the Medical Association of Georgia 96(1): 48

Reiter, P.L.; Stubbs, B.; Panozzo, C.A.; Whitesell, D.; Brewer, N.T. 2011: HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(11): 2354-2361

Grabiel, M.; Reutzel, T.J.; Wang, S.; Rubin, R.; Leung, V.; Ordonez, A.; Wong, M.; Jordan, E. 2013: HPV and HPV vaccines: the knowledge levels, opinions, and behavior of parents. Journal of Community Health 38(6): 1015-1021

Dunne, E.F.; Park, I.U. 2013: HPV and HPV-associated diseases. Infectious Disease Clinics of North America 27(4): 765-778

Baker, E. 2013: HPV and Pap: shifting roles in cervical cancer screening. Mlo: Medical Laboratory Observer 45(11): 24; 26

Schim van der Loeff, M.F.; Mooij, S.H.; Richel, O.; de Vries, H.J.C.; Prins, J.M. 2014: HPV and anal cancer in HIV-infected individuals: a review. Current Hiv/Aids Reports 11(3): 250-262

Carcopino, X.; Bretelle, F.; Boubli, L. 2008: HPV and cancer. Medecine et Maladies Infectieuses 38(Suppl 2): S47-S48

Qun, Z.; Xinkai, Y.; Jing, W. 2014: Effects of eccentric exercise on branched-chain amino acid profiles in rat serum and skeletal muscle. Journal of Animal Physiology and Animal Nutrition 98(2): 215-222

Petry, K.U. 2014: HPV and cervical cancer. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 244: 59-62; Discussion 62

Ishi, K.; Shiraishi, T. 2009: HPV and cervical cancer examination--prospects in cervical cancer examination. Rinsho Byori. Japanese Journal of Clinical Pathology 57(9): 903-904

Exner, D.V.; Kavanagh, K.M.; Slawnych, M.P.; Mitchell, L.B.; Ramadan, D.; Aggarwal, S.G.; Noullett, C.; Van Schaik, A.; Mitchell, R.T.; Shibata, M.A.; Gulamhussein, S.; McMeekin, J.; Tymchak, W.; Schnell, G.; Gillis, A.M.; Sheldon, R.S.; Fick, G.H.; Duff, H.J. 2007: Noninvasive risk assessment early after a myocardial infarction the REFINE study. Journal of the American College of Cardiology 50(24): 2275-2284

Sussman, A.L.; Helitzer, D.; Sanders, M.; Urquieta, B.; Salvador, M.; Ndiaye, K. 2007: HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Annals of Family Medicine 5(4): 298-304

Hong, Y.; Zhang, C.; Li, X.; Lin, D.; Liu, Y. 2013: HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. Bmc Public Health 13: 696

Vanslyke, J.Gaylord.; Baum, J.; Plaza, V.; Otero, M.; Wheeler, C.; Helitzer, D.L. 2008: HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qualitative Health Research 18(5): 584-596

Berraho, M.; Fakir, S.E.; Abda, N.; Mathoulin-Pelissier, S.; Nejjari, C. 2013: HPV and cervical cancer: knowledge and practices of physicians in Fez. Sante Publique 25(3): 351-357

Subramanya, D.; Grivas, P.D. 2008: HPV and cervical cancer: updates on an established relationship. Postgraduate Medicine 120(4): 7-13

Corneanu, L.M.; Stănculescu, D.; Corneanu, C. 2011: HPV and cervical squamous intraepithelial lesions: clinicopathological study. Romanian Journal of Morphology and Embryology 52(1): 89-94

Castellsagué, X.; Albero, G.; Clèries, R.ón.; Bosch, F.X. 2007: HPV and circumcision: a biased, inaccurate and misleading meta-analysis. Journal of Infection 55(1): 91

Lehtinen, M.; Eriksson, T.; Apter, D. 2009: HPV and effectiveness of chlamydia control. Duodecim; Laaketieteellinen Aikakauskirja 125(13): 1377-1384

Nureña, C.és.R.; Brown, B.; Galea, J.T.; Sánchez, H.; Blas, M.M. 2013: HPV and genital warts among Peruvian men who have sex with men and transgender people: knowledge, attitudes and treatment experiences. Plos one 8(3): E58684

Wiwanitkit, V. 2012: HPV and glottic cancer. Journal of voice: official journal of the Voice Foundation 26(5): 676.e21; author reply 676.e23

Cummings, C.W. 2012: HPV and head and neck cancer. Otolaryngologic Clinics of North America 45(4): Ix

Loope, T.; Aburto, T.; Logan, H.L. 2011: HPV and head and neck cancer: a content analysis of information in dental journals. Today's Fda: Official Monthly Journal of the Florida Dental Association 23(1): 62

Fakhry, C.; Psyrri, A.; Chaturvedhi, A. 2014: HPV and head and neck cancers: state-of-the-science. Oral Oncology 50(5): 353-355

De Jong, M.C.; Pramana, J.; Knegjens, J.L.; Balm, A.J.M.; van den Brekel, M.W.M.; Hauptmann, M.; Begg, A.C.; Rasch, C.R.N. 2010: HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 95(3): 365-370

Gillison, M. 2010: HPV and its effect on head and neck cancer prognosis. Clinical Advances in Hematology and Oncology: H&o 8(10): 680-682

Zhai, K.; Ding, J.; Shi, H.-Z. 2015: HPV and lung cancer risk: a meta-analysis. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 63: 84-90

Fleisher, R.M. 2012: HPV and oral health. Journal of the American Dental Association 143(5): 440

Gillison, M.L. 2009: HPV and prognosis for patients with oropharynx cancer. European Journal of Cancer 45(Suppl 1): 383-385

Nikolopoulos, T.P. 2013: HPV and recurrent respiratory papillomatosis: a modern virus and a serious disease with controversial management. International Journal of Pediatric Otorhinolaryngology 77(12): 1917-1918

Pfister, H. 2008: HPV and skin neoplasia. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 59(1): 26-30

Kŭlvachev, Z.; Draganov, P.; Minkov, L.; Ivanov, I.; Dimova, D.; Shishkova, S. 2007: HPV and spontaneous abortion: results from a virological study. Akusherstvo i Ginekologiia 46(6): 8-12

Stone, S.C.; Rossetti, R.A.M.; Lima, A.M.; Lepique, A.P. 2014: HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immunity Inflammation and Disease 2(2): 63-75

Tartaglia, E.; Iafusco, D.; Cocca, A.; Palomba, S.; Rotondi, M.; Mastrantonio, P. 2012: HPV at the time of vaccine: has screening reached its goal?. European Journal of Gynaecological Oncology 33(6): 591-597

Colón-López, V.; Del Toro-Mejías, L.M.; Ortiz, A.P.; Tortolero-Luna, G.; Palefsky, J.M. 2012: HPV awareness and willingness to HPV vaccination among high-risk men attending an STi clinic in Puerto Rico. Puerto Rico Health Sciences Journal 31(4): 227-231

Brendle, S.A.; Christensen, N.D. 2015: HPV binding assay to Laminin-332/integrin α6β4 on human keratinocytes. Methods in Molecular Biology 1249: 53-66

Couto, E.; Sæterdal, I.; Juvet, L.K.; Klemp, M. 2014: HPV catch-up vaccination of young women: a systematic review and meta-analysis. Bmc Public Health 14: 867

Pan, W.-w.; Cao, L.-x.; Yi, F.-p.; Xu, Y.; Bu, Y.-q.; Lai, G.-q.; Ma, Y.-p.; Song, F.-z. 2009: HPV caused pathological changes in genital system of mice. Bing du Xue Bao 25(1): 35-40

Jalil, E.M.; Bastos, F.I.; Melli, P.P.D.S.; Duarte, G.; Simoes, R.T.; Yamamoto, A.Y.; Morais, R.A.A.d.; Quintana, S.M. 2013: HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. Bmc Infectious Diseases 13: 564

Heard, I.; Favre, M. 2015: HPV contamination of endocavity vaginal ultrasound probes. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 44(2): 102-106

Pantanowitz, L.; Hornish, M.; Cao, Q.J.; Goulart, R.A. 2010: HPV data can be used as a cytopathology laboratory quality indicator. Diagnostic Cytopathology 38(2): 159-160

Krambeck, W.M.; Cadidé, R.M.; Dalmarco, E.M.; de Cordova, C.M.M. 2008: HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clinical and Experimental Obstetrics and Gynecology 35(3): 175-178

Venezuela, F.; Kremer, L.E.; Kiguen, X.; Cuffini, C. 2010: HPV detection and genotyping in males from the city of Córdoba, Argentina. Revista Argentina de Microbiologia 42(3): 184-188

Siriaunkgul, S.; Settakorn, J.; Sukpan, K.; Srisomboon, J.; Utaipat, U.; Lekawanvijit, S.; Khunamornpong, S. 2014: HPV detection and genotyping in vulvar squamous cell carcinoma in northern Thailand. Asian Pacific Journal of Cancer Prevention: Apjcp 15(8): 3773-3778

Hantz, S.; Goudard, M.; Marczuk, V.; Renaudie, J.; Dussartre, C.; Bakeland, D.; Denis, F.; Alain, S. 2010: HPV detection and typing by INNO-LiPA assay on liquid cytology media Easyfix Labonord after extraction QIAamp DNA Blood Mini Kit Qiagen and Nuclisens easyMAG Biomérieux. Pathologie-Biologie 58(2): 179-183

Lora, V.; Kanitakis, J. 2009: HPV detection in 'large-cell acanthomas': a word of caution. Journal of the European Academy of Dermatology and Venereology: Jeadv 23(12): 1468-1469

Kamal, E.M.; El Sayed, G.A.; El Behery, M.M.; El Shennawy, G.A. 2014: HPV detection in a self-collected vaginal swab combined with VIA for cervical cancer screening with correlation to histologically confirmed CIN. Archives of Gynecology and Obstetrics 290(6): 1207-1213

De Guglielmo, Z.; Avila, M.; Veitía, D.; Fernández, A.; Venegas, C.; Correnti de Plata, M. 2012: HPV detection in the mouth and cervix of patients with histological diagnosis suggestive of genital infection. Anales del Sistema Sanitario de Navarra 35(3): 445-454

Chhieng, D.C.; Bakdounes, K.; Connolly, M.; Gallaspy, S.; Roberson, J.; Eltoum, I. 2009: HPV detection rate in discordant Pap tests between cytotechnologists and pathologists. Diagnostic Cytopathology 37(5): 320-323

Adamopoulou, M.; Vairaktaris, E.; Panis, V.; Nkenke, E.; Neukam, F.W.; Yapijakis, C. 2008: HPV detection rate in saliva may depend on the immune system efficiency. In Vivo 22(5): 599-602

Fuste, P.; Bellosillo, B.; Santamaria, X.; Mancebo, G.; Mariñoso, L.; Alameda, F.; Espinet, B.; Sole, F.; Serrano, S.; Carreras, R. 2009: HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 28(2): 120-126

Vargens, O.M.d.C.; Silva, C.M.; Azevedo E Silva, G.; Girianelli, V.ân.R. 2013: HPV diagnosis: woman's process of interaction with her partner. Revista Brasileira de Enfermagem 66(3): 327-332

López-Romero, R.; Iglesias-Chiesa, C.; Alatorre, B.; Vázquez, K.; Piña-Sánchez, P.; Alvarado, I.; Lazos, M.; Peralta, R.úl.; González-Yebra, B.; Romero, A.; Salcedo, M. 2013: HPV frequency in penile carcinoma of Mexican patients: important contribution of HPV16 European variant. International Journal of Clinical and Experimental Pathology 6(7): 1409-1415

Lowe, B.; Kobayashi, L.; Lorincz, A.; Mallonee, R.; O'Neil, D.; Thai, H.; Nazarenko, I. 2010: HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP. Journal of Molecular Diagnostics: Jmd 12(6): 847-853

Sjoeborg, K.D.; Tropé, A.; Lie, A.K.; Jonassen, C.M.; Steinbakk, M.; Hansen, M.; Jacobsen, M.B.; Cuschieri, K.; Eskild, A. 2010: HPV genotype distribution according to severity of cervical neoplasia. Gynecologic Oncology 118(1): 29-34

Mane, A.; Nirmalkar, A.; Risbud, A.R.; Vermund, S.H.; Mehendale, S.M.; Sahasrabuddhe, V.V. 2012: HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. Plos one 7(6): E38731

Kingma, D.W.; Allen, R.A.; Moore, W.; Caughron, S.K.; Melby, M.; Gillies, E.M.; Marlar, R.A.; Dunn, S.T. 2010: HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Anticancer Research 30(12): 5099-5104

Tabrizi, S.N.; Brotherton, J.M.L.; Stevens, M.P.; Condon, J.R.; McIntyre, P.; Smith, D.; Garland, S.M. 2014: HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 60(3): 250-256

Stevens, M.P.; Garland, S.M.; Tan, J.H.; Quinn, M.A.; Petersen, R.W.; Tabrizi, S.N. 2009: HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. Journal of Medical Virology 81(7): 1283-1291

Pons-Salort, M.; Thiébaut, A.C.M.; Guillemot, D.; Favre, M.; Delarocque-Astagneau, E. 2013: HPV genotype replacement: too early to tell. LANCET. Infectious Diseases 13(12): 1012

Jing, L.; Zhong, X.; Huang, W.; Liu, Y.; Wang, M.; Miao, Z.; Zhang, X.; Zou, J.; Zheng, B.; Chen, C.; Liang, X.; Yang, G.; Jing, C.; Wei, X. 2014: HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study. Bmc Infectious Diseases 14: 388

Vidal, A.C.; Smith, J.S.; Valea, F.; Bentley, R.; Gradison, M.; Yarnall, K.S.H.; Ford, A.; Overcash, F.; Grant, K.; Murphy, S.K.; Hoyo, C. 2014: HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. Cancer Causes and Control: Ccc 25(8): 1055-1062

Benevolo, M.; Mottolese, M.; Marandino, F.; Carosi, M.; Diodoro, M.G.; Sentinelli, S.; Visca, P.; Rollo, F.; Mariani, L.; Vocaturo, G.; Sindico, R.; Di Giannuario, D.; Perrone Donnorso, R.; Pellicciotta, M.; Vocaturo, A. 2007: HPV genotypes concordance between sex partners. Journal of Experimental and Clinical Cancer Research: Cr 26(4): 609-612

Kelly, J.J.; Unger, E.R.; Dunne, E.F.; Murphy, N.J.; Tiesinga, J.; Koller, K.R.; Swango-Wilson, A.; Philemonof, D.; Lounmala, X.; Markowitz, L.E.; Steinau, M.; Hennessy, T. 2013: HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007. International journal of circumpolar health 72

Hariri, S.; Steinau, M.; Rinas, A.; Gargano, J.W.; Ludema, C.; Unger, E.R.; Carter, A.L.; Grant, K.L.; Bamberg, M.; McDermott, J.E.; Markowitz, L.E.; Brewer, N.T.; Smith, J.S. 2012: HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. PloS one 7(3): e34044

DI Gao, Z.; Pan, Q.; Lv, H.; Sun, Y.; Ma, X.; Qin, Z.; Sun, Y.Ping. 2013: HPV genotypes in paraffin sections of non-cervical squamous cell carcinoma in Qingdao of China. Oncology Letters 5(4): 1219-1222

Durzyńska, J.; Pacholska-Bogalska, J.; Kaczmarek, M.; Hanć, T.; Durda, M.; Skrzypczak, M.; Goździcka-Józefiak, A. 2011: HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland. European Journal of Pediatrics 170(6): 757-761

Wheeler, C.M. 2010: HPV genotypes: implications for worldwide cervical cancer screening and vaccination. LANCET. Oncology 11(11): 1013-1014

Sayyed, D.R.; Song, K.-S.; Nimse, S.B.; An, H.; Kim, J.; Kim, T. 2013: HPV genotyping 9G membrane test. Viruses 5(11): 2840-2855

Song, K.; Nimse, S.B.; An, H.; Kim, T. 2014: HPV genotyping 9G membrane test: a point-of-care diagnostic platform. Sensors 14(10): 19162-19175

Quint, K.D.; de Koning, M.N.C.; van Doorn, L.-J.; Quint, W.G.V.; Pirog, E.C. 2010: HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecologic Oncology 117(2): 297-301

Das, P.; Thomas, A.; Mahantshetty, U.; Shrivastava, S.K.; Deodhar, K.; Mulherkar, R. 2012: HPV genotyping and site of viral integration in cervical cancers in Indian women. Plos one 7(7): E41012

Roa, J.C.; Garcia, P.; Gomez, J.; Fernández, W.; Gaete, F.; Espinoza, A.; Lepetic, A.; Suarez, E. 2009: HPV genotyping from invasive cervical cancer in Chile. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(2): 150-153

Siriaunkgul, S.; Utaipat, U.; Suthipintawong, C.; Tungsinmunkong, K.; Triratanachat, S.; Khunamornpong, S. 2013: HPV genotyping in adenocarcinoma of the uterine cervix in Thailand. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 123(3): 226-230

González-Andrade, F.; Sánchez, D. 2009: HPV genotyping in anogenital abnormal samples of Ecuadorian women. Cancer Biomarkers: Section a of Disease Markers 5(4): 225-232

Siriaunkgul, S.; Utaipat, U.; Settakorn, J.; Sukpan, K.; Srisomboon, J.; Khunamornpong, S. 2011: HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 115(2): 175-179

Aggarwal, R.; Sachdeva, R.K.; Naru, J.; Suri, V.; Sharma, A.; Nijhawan, R. 2012: HPV genotyping in north Indian women infected with HIV. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 31(5): 475-481

Panigoro, R.; Susanto, H.; Novel, S.S.; Hartini, S.; Sahiratmadja, E. 2013: HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia. Asian Pacific Journal of Cancer Prevention: Apjcp 14(10): 5843-5847

Kim, J.-K. 2009: HPV genotyping prior to vaccination promise. Mlo: Medical Laboratory Observer 41(3): 36-37

Wigfall, L.; Rawls, A.; Sebastian, N.; Messersmith, A.; Pirisi-Creek, L.; Spiryda, L.; Williams, E.M.; Creek, K.; Glover, S.H. 2012: HPV high risk and protective behaviors: the effects of religious affiliation. Journal of Religion and Health 51(4): 1325-1336

Mougin, C.; Bourgault-Villada, I.; Coursaget, P. 2009: HPV immunization for the prevention of cervical cancer. Presse Medicale 38(12): 1750-1768

McKenzie, N.Dauphin.; Kobetz, E.N.; Ganjei-Azar, P.; Rosa-Cunha, I.; Potter, J.E.; Morishita, A.; Lucci, J.A.; Guettouche, T.; Hnatyszyn, J.H.; Koru-Sengul, T. 2014: HPV in HIV-Infected Women: Implications for Primary Prevention. Frontiers in Oncology 4: 179

Fontenot, H.B.; Fantasia, H.C.; Allen, J.D. 2007: HPV in adolescents. Making the wake-up call. Advance for Nurse Practitioners 15(10): 73

Morales, R.; Parada, R.; Giuliano, A.R.; Cruz, A.; Castellsagué, X.; Salmerón, J.; Lazcano-Ponce, E. 2012: HPV in female partners increases risk of incident HPV infection acquisition in heterosexual men in rural central Mexico. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 21(11): 1956-1965

Wallace, M.R.; Logan, H.; Orlando, C.; Mendenhall, W.; Herbstman, D.M.; Sack, B.; Wang, D.; Smith, E.M. 2010: HPV in head and neck cancers among 5-year survivors. American Journal of Clinical Oncology 33(4): 425-426

Fontenot, H.B.; Morelock, N. 2012: HPV in men is a women's health issue. Nursing for Women's Health 16(1): 57-65

Petersen, I.; Klein, F. 2008: HPV in non-gynecological tumors. Der Pathologe 29(Suppl 2): 118-122

Termine, N.; Panzarella, V.; Falaschini, S.; Russo, A.; Matranga, D.; Lo Muzio, L.; Campisi, G. 2008: HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Annals of oncology: official journal of the European Society for Medical Oncology 19(10): 1681-1690

De Marchi Triglia, R.; Metze, K.; Zeferino, L.C.; Lucci De Angelo Andrade, L.A. 2009: HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecologic Oncology 112(1): 114-118

Schneede, P.; Waidelich, R. 2013: HPV in urology. Basic principles and controversies. Der Urologe. Ausg. a 52(9): 1329-36: Quiz: 1337-1338

Visconti, V.; Antonilli, M.; Bellati, F.; Napoletano, C.; French, D.; Benedetti Panici, P.; Nuti, M. 2009: HPV induced triple neoplasms: a case report. American Journal of Obstetrics and Gynecology 201(2): E9

Husaiyin, S.; Niyazi, M.; Wang, L.h.; Wang, J.J.; Wang, J.B.; Simayi, A.; Wang, L.; Ainiwaer, Z.; Ma, C.H.; Smith, J.S. 2013: HPV infection among Uygur women in a rural area of Hetian Prefecture, Xinjiang Uygur Autonomous Region, China. Biomedical and Environmental Sciences: Bes 26(11): 934-936

Schmidt-Grimminger, D.C.; Bell, M.C.; Muller, C.J.; Maher, D.M.; Chauhan, S.C.; Buchwald, D.S. 2011: HPV infection among rural American Indian women and urban white women in South Dakota: an HPV prevalence study. BMC infectious diseases 11: 252

Lee, S.H.; Vigliotti, V.S.; Pappu, S. 2009: HPV infection among women in a representative rural and suburban population of the USA. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(3): 210-214

Yu, J.J.; Fu, P.; Pink, J.J.; Dawson, D.; Wasman, J.; Orem, J.; Mwanda, W.O.; Zhu, H.; Liang, X.; Guo, Y.; Petros, W.P.; Mitsuyasu, R.T.; Wabinga, H.; Remick, S.C. 2010: HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma. Plos one 5(5): E10477

Damin, A.P.; Damin, D.C.; Alexandre, C.O.P. 2007: HPV infection and breast cancer. Breast 16(3): 222

Carter, J.R.; Ding, Z.; Rose, B.R. 2011: HPV infection and cervical disease: a review. Australian and New Zealand Journal of Obstetrics and Gynaecology 51(2): 103-108

Carvalho, N.S.ér.d.; Ferreira, A.M.; Bueno, C.C.T. 2011: HPV infection and intraepithelial lesions from the anal region: how to diagnose?. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 15(5): 473-477

Roccio, M.; Dal Bello, B.; Gardella, B.; Carrara, M.; Gulminetti, R.; Mariani, B.; Spinillo, A. 2012: HPV infection and intraepithelial lesions: comparison between HIV positive and negative women. Current HIV Research 10(7): 614-619

Acha-Sagredo, A.; Ruesga, M.-T.; Aguirregaviria, J.-I.; Aguirre-Urizar, J.-M. 2010: HPV infection and oral carcinogenesis. Medicina Oral Patologia Oral y Cirugia Bucal 15(1): E1-E2

Tsai, Y.-Y.; Chang, C.-C.; Chiang, C.-C.; Yeh, K.-T.; Chen, P.-L.; Chang, C.-H.; Chou, M.-C.; Lee, H.; Cheng, Y.-W. 2009: HPV infection and p53 inactivation in pterygium. Molecular Vision 15: 1092-1097

Piana, A.F.; Sotgiu, G.; Muroni, M.R.; Cossu-Rocca, P.; Castiglia, P.; De Miglio, M.R. 2014: HPV infection and triple-negative breast cancers: an Italian case-control study. Virology Journal 11: 190

Méndez Toro, L.; Rodríguez Meza, A.; López de Sánchez, M.; Toro de Méndez, M. 2011: HPV infection associated with nonclassic cytological signs in patients from Mérida, Venezuela. Investigacion Clinica 52(2): 162-169

Oliveira, L.R.; Ribeiro-Silva, A.; Ramalho, L.N.Z.; Simões, A.L.; Zucoloto, S. 2008: HPV infection in Brazilian oral squamous cell carcinomapatients and its correlation with clinicopathological outcomes. Molecular Medicine Reports 1(1): 123-129

De Vuyst, H.; Clifford, G.; Li, N.; Franceschi, S. 2009: HPV infection in Europe. European Journal of Cancer 45(15): 2632-2639

Madeddu, G.; Mameli, G.; Capobianco, G.; Babudieri, S.; Maida, I.; Bagella, P.; Rocca, G.; Cherchi, P.L.; Sechi, L.A.; Zanetti, S.; Nunnari, G.; Dessole, S.; Mura, M.S. 2014: HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. European Review for Medical and Pharmacological Sciences 18(8): 1277-1285

Matsuda, A.; Takahashi, K.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Kawakami, M.; Kawachi, H.; Suzuki, H.; Furukawa, K.; Tajiri, T.; Mori, T. 2009: HPV infection in an HIV-positive patient with primary squamous cell carcinoma of rectum. International Journal of Clinical Oncology 14(6): 551-554

Cao, F.; Han, H.; Zhang, F.; Wang, B.; Ma, W.; Wang, Y.; Sun, G.; Shi, M.; Ren, Y.; Cheng, Y. 2014: HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in northern China. Thescientificworldjournal 2014: 804738

Olejek, A. 2008: HPV infection in etiology of uterine cervix cancer. Ginekologia Polska 79(2): 126-132

Ihloff, A.S.; Knecht, R.; Tribius, S. 2010: HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010. HNO 58(12): 1163-1167

Graziottin, A.; Serafini, A. 2009: HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. Journal of Sexual Medicine 6(3): 633-645

Birch-Johansen, F.; Norrild, B.; Olesen, A.B.; Jensen, A.; Kjær, S.K.üg. 2012: HPV infection might play a role in the development of non-melanoma skin cancer in immunocompetent individuals. Ugeskrift for Laeger 174(7): 413-417

Pankova, T.; Stoikov, S.; Nikolova, M. 2010: Pregnancy and malignant melanoma. Akusherstvo i Ginekologiia 49(3): 43-47

Anonymous 2009: HPV infection screening is important for HIV MSM. HIV & HPV connection studied. AIDS alert 24(10): 113-114

Stanley, M.A.; Winder, D.M.; Sterling, J.C.; Goon, P.K.C. 2012: HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. Bmc Cancer 12: 398

Isaakidis, P.; Pimple, S.; Varghese, B.; Khan, S.; Mansoor, H.; Ladomirska, J.; Sharma, N.; Silva, E.D.; Metcalf, C.; Caluwaerts, S.; Alders, P.; Ntzani, E.E.; Reid, T. 2013: HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mumbai, India: 12-month follow-up. International Journal of Women's Health 5: 487-494

Vera-Uehara, C.; Sánchez-Alemán, M.Angel.; Uribe-Salas, F.Javier.; Ramos-Castañeda, Jé.; Olamendi-Portugal, M.Leónidez.; Conde-Glez, C.Jesús. 2014: HPV infection, risk factors and viral load among Mexican male college students. Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 18(1): 71-76

Nirchio, V.; Lipsi, R.; Fusilli, S.; Ciccone, E.; Murino, L.; Santangelo, A.; Romano, F.; Di Taranto, A.M.; Pedà, D.; Castriota, M.; Antonetti, R.; Bondi, A. 2008: HPV infection: comparison between morphological studies and molecular biology. Pathologica 100(3): 149-155

Deligeoroglou, E.; Giannouli, A.; Athanasopoulos, N.; Karountzos, V.; Vatopoulou, A.; Dimopoulos, K.; Creatsas, G. 2013: HPV infection: immunological aspects and their utility in future therapy. Infectious Diseases in Obstetrics and Gynecology 2013: 540850

Zhang, D.-Y.; Yin, Y.-P.; Feng, T.-J.; Hong, F.-C.; Jiang, N.; Wang, B.-X.; Chen, X.-S. 2014: HPV infections among MSM in Shenzhen, China. Plos one 9(5): E96364

Kirnbauer, R.; Schellenbacher, C.; Shafti-Keramat, S.; Handisurya, A. 2009: HPV infections of the oral and genital mucosa. Possibilities for primary prevention. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 60(11): 878-880

Foldvari, M. 2012: HPV infections: can they be eradicated using nanotechnology?. Nanomedicine: Nanotechnology Biology and Medicine 8(2): 131-135

Raybould, R.; Fiander, A.; Wilkinson, G.W.G.; Hibbitts, S. 2014: HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR. Journal of Virological Methods 206: 51-54

Khangura, R.K.; Sengupta, S.; Sircar, K.; Sharma, B.; Singh, S.; Rastogi, V. 2013: HPV involvement in OSCC: Correlation of PCR results with light microscopic features. Journal of Oral and Maxillofacial Pathology: Jomfp 17(2): 195-200

Rotnáglová, E.šk.; Tachezy, R.; Saláková, M.; Procházka, B.ír.; Košl'abová, E.; Veselá, E.; Ludvíková, V.; Hamšíková, E.; Klozar, J. 2011: HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. International Journal of Cancer 129(1): 101-110

Evans, M.F.; Adamson, C.S.-C.; Schned, L.M.; St John, T.L.; Leiman, G.; Ashikaga, T.; Cooper, K. 2010: HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 19(3): 144-150

Daley, E.M.; Perrin, K.M.; Vamos, C.; Webb, C.; Mueller, T.; Packing-Ebuen, J.L.; Rayko, H.L.; McFarlane, M.; McDermott, R.J. 2008: HPV knowledge among HPV+ women. American Journal of Health Behavior 32(5): 477-487

D'Urso, J.; Thompson-Robinson, M.; Chandler, S. 2007: HPV knowledge and behaviors of black college students at a historically black university. Journal of American college health: J of ACH 56(2): 159-163

Piñeros, M.; Hernández-Suárez, G.; Orjuela, L.; Vargas, J.C.; Pérez, G. 2013: HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients. Bmc Public Health 13: 272

Tiggelaar, S.M.; Rafalski, M.; Davidson, M.A.; Hu, Y.; Burnett, L. 2014: HPV knowledge and vaccine acceptability in Appalachian Tennessee and Kentucky, USA. Journal of Family Planning and Reproductive Health Care 40(1): 75-76

Chau, J.; Kibria, F.; Landi, M.; Reilly, M.; Medeiros, T.; Johnson, H.; Yekta, S.; De Groot, A.S. 2014: HPV knowledge and vaccine acceptance in an uninsured Hispanic population in Providence, Ri. Rhode Island Medical Journal 97(5): 35-39

Vogtmann, E.; Harlow, Sán.D.; Valdez, A.Cruz.; Valdez, J.Carlos.Cruz.; Ponce, E.Lazcano. 2011: HPV knowledge in Mexican college students: implications for intervention programmes. Health and Social Care in the Community 19(2): 148-157

Fernandez, M.E.; McCurdy, S.A.; Arvey, S.R.; Tyson, S.K.; Morales-Campos, D.; Flores, B.; Useche, B.; Mitchell-Bennett, L.; Sanderson, M. 2009: HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethnicity and Health 14(6): 607-624

Sørbye, S.W.; Fismen, S.; Gutteberg, T.J.; Mortensen, E.S.øv.; Skjeldestad, F.E. 2014: HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions. Plos one 9(11): E112934

Sorbye, S.W.; Fismen, S.; Gutteberg, T.J.; Mortensen, E.S. 2010: HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway. Journal of Virological Methods 169(1): 219-222

Burger, E.A.; Kornør, H.; Klemp, M.; Lauvrak, V.; Kristiansen, I.S. 2011: HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecologic Oncology 120(3): 430-438

Feller, L.; Wood, N.H.; Khammissa, R.A.G.; Chikte, U.M.E.; Meyerov, R.; Lemmer, J. 2010: HPV modulation of host immune responses. Sadj: Journal of the South African Dental Association 65(6): 266-268

Martini, S.; Colella, G.; Masiello, A.; Lanza, A.; Pisapia, R.; Cascone, A.; Di Martino, F.; Filippini, A.; Filippini, P. 2007: HPV oral infection. Case report of an HIV-positive Nigerian sex worker. Le Infezioni in Medicina 15(2): 115-118

Jones, J.-A. 2013: HPV oropharyngeal cancer: a killer among us. Dentistry Today 32(4): 10; 12

Rioux, M.; Garland, A.; Webster, D.; Reardon, E. 2013: HPV positive tonsillar cancer in two laser surgeons: case reports. JournalofOtolaryngology-HeadandNeckSurgery 42: 54

Benevolo, M.; Mottolese, M.; Marandino, F.; Carosi, M.; Diodoro, M.G.; Sentinelli, S.; Visca, P.; Rollo, F.; Mariani, L.; Vocaturo, G.; Sindico, R.; Terrenato, I.; Donnorso, R.P.; Vocaturo, A. 2008: HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection. Journal of Medical Virology 80(7): 1275-1281

Reiter, P.L.; Katz, M.L.; Ruffin, M.T.; Hade, E.M.; DeGraffenreid, C.R.; Patel, D.A.; Paskett, E.D.; Unger, E.R. 2013: HPV prevalence among women from Appalachia: results from the CARE project. Plos one 8(8): E74276

Giorgi-Rossi, P.; Franceschi, S.; Ronco, G. 2012: HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. International Journal of Cancer 130(6): 1387-1394

Zhang, H.-Y.; Tiggelaar, S.M.; Sahasrabuddhe, V.V.; Smith, J.S.; Jiang, C.-Q.; Mei, R.-B.; Wang, X.-G.; Li, Z.-A.; Qiao, Y.-L. 2012: HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pacific Journal of Cancer Prevention: Apjcp 13(1): 91-96

Bonde, J.; Rebolj, M.; Ejegod, D.M.øl.; Preisler, S.; Lynge, E.; Rygaard, C. 2014: HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system. Bmc Infectious Diseases 14: 413

Wang, S.-M.; Li, J.; Qiao, Y.-L. 2010: HPV prevalence and genotyping in the cervix of Chinese women. Frontiers of Medicine in China 4(3): 259-263

Cymet, T. 2007: HPV prevalence and transmission. JAMA 298(1): 38; Author Reply 38

Grozdanov, P.; Zlatkov, V.; Ganchev, G.; Karagiosov, I.; Toncheva, D.; Galabov, A.S. 2014: HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria. Journal of Medical Virology 86(11): 1905-1910

Ursu, R.G.; Onofriescu, M.; Nemescu, D.ş; Iancu, L.ţa.-S. 2011: HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virology Journal 8: 558

Banister, C.E.; Messersmith, A.R.; Chakraborty, H.; Wang, Y.; Spiryda, L.B.; Glover, S.H.; Pirisi, L.; Creek, K.E. 2013: HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. International journal of women's health 5: 379-388

Murillo, R.úl.; Molano, M.ón.; Martínez, G.; Mejía, J.-C.; Gamboa, O. 2009: HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infectious Diseases in Obstetrics and Gynecology 2009: 653598

Allred, S.; Cox, J.Thomas.; Mahoney, M. 2006: HPV prevention and the promise of the new vaccines. Journal of the American Academy of Nurse Practitioners 18 Suppl. 2: 1-11

Klisz, C.; Kaplan, C. 2009: HPV prevention update. New vaccine offers additional options. Advance for Nurse Practitioners 17(11): 28-9 54

Finn, A. 2010: HPV prevention: waiting for screening services. Lancet 375(9727): 1694

Villa, L.L. 2011: HPV prophylactic vaccination: the first years and what to expect from now. Cancer Letters 305(2): 106-112

Baudoin, A.; Sabiani, L.; Oundjian, F.; Tabouret, E.; Agostini, A.; Courbière, B.; Boubli, L.; Carcopino, X. 2015: HPV prophylactic vaccine coverage and factors impacting its practice among students and high school students in Marseilles' area. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 44(2): 126-135

Sabiani, L.; Bremond, A.; Mortier, I.; Lecuyer, M.; Boubli, L.; Carcopino, X. 2012: HPV prophylactic vaccine coverage in France: Results of a survey among high school and university students in Marseilles' area. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 41(2): 136-144

Gillison, M.L.; Chaturvedi, A.K.; Lowy, D.R. 2008: HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113(10 Suppl): 3036-3046

Ma, B.; Roden, R.B.S.; Hung, C.-F.; Wu, T.C. 2011: HPV pseudovirions as DNA delivery vehicles. Therapeutic Delivery 2(4): 427-430

Canepa, P.; Orsi, A.; Martini, M.; Icardi, G. 2013: HPV related diseases in males: a heavy vaccine-preventable burden. Journal of Preventive Medicine and Hygiene 54(2): 61-70

Brotherton, J.; Kaldor, J.M.; McIntyre, P. 2010: HPV related surveillance activities in Australia. Vaccine 28(47): 7453-7454

Ankit, J.; Prakriti, J.; Lakshmaiah, K.C. 2009: HPV screening for cervical cancer in rural India. New England Journal of Medicine 361(3): 304-305; Author Reply 306

Bhatla, N.; Maheswari N, D. 2009: HPV screening for cervical cancer in rural India: do we have an answer?. National Medical Journal of India 22(4): 183-184

Kmietowicz, Z. 2013: HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis. Bmj 347: F6624

Untiet, S.; Vassilakos, P.; McCarey, C.; Tebeu, P.-M.; Kengne-Fosso, G.èl.; Menoud, P.-A.; Boulvain, M.; Navarria, I.; Petignat, P. 2014: HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. International Journal of Cancer 135(8): 1911-1917

Gravitt, P.E.; Rositch, A.F. 2014: HPV self-testing and cervical cancer screening coverage. Lancet. Oncology 15(2): 128-129

Didelot-Rousseau, M.-N.; Diafouka, F.ço.; Yayo, E.; Kouadio, L.-P.; Monnet, D.; Segondy, M. 2007: HPV seminal shedding among men seeking fertility evaluation in Abidjan, Ivory Coast. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 39(2): 153-155

Mooij, S.H.; Landén, O.; van der Klis, F.R.M.; van der Sande, M.A.B.; de Melker, H.E.; Xiridou, M.; van Eeden, A.; Heijman, T.; Speksnijder, A.G.C.L.; Snijders, P.J.F.; Schim van der Loeff, M.F. 2014: HPV seroconversion following anal and penile HPV infection in HIV-negative and HIV-infected MSM. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(11): 2455-2461

Yang, J.; Wu, H.; Wei, S.; Xiong, H.; Fu, X.; Qi, Z.; Jiang, Q.; Li, W.; Hu, G.; Yuan, X.; Liao, Z. 2014: HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC). BMC cancer 14: 501

Dimitrov, G.; Talevska, B.; Nikolovski, S.; Micevska, M.; Panov, S.; Dimitrov, G. 2013: HPV status after cold knife conization. Akusherstvo i Ginekologiia 52(2): 65-68

Tahtali, A.; Hey, C.; Geissler, C.; Filman, N.; Diensthuber, M.; Leinung, M.; Stöver, T.; Wagenblast, J. 2013: HPV status and overall survival of patients with oropharyngeal squamous cell carcinoma--a retrospective study of a German head and neck cancer center. Anticancer Research 33(8): 3481-3485

Xu, C.C.; Biron, V.L.; Puttagunta, L.; Seikaly, H. 2013: HPV status and second primary tumours in oropharyngeal squamous cell carcinoma. Journal of Otolaryngology-Head and Neck Surgery 42: 36

Glombitza, F.; Guntinas-Lichius, O.; Petersen, I. 2010: HPV status in head and neck tumors. Pathology Research and Practice 206(4): 229-234

Hong, A.; Jones, D.; Chatfield, M.; Lee, C.S.; Zhang, M.; Clark, J.; Elliott, M.; Harnett, G.; Milross, C.; Rose, B. 2013: HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results. Annals of Surgical Oncology 20(Suppl 3): S450-S458

Bennett, K.L.; Lee, W.; Lamarre, E.; Zhang, X.; Seth, R.; Scharpf, J.; Hunt, J.; Eng, C. 2010: HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes and Cancer 49(4): 319-326

Pagliusi, S.R. 2007: HPV technologies advancing public health: discussion of recent evidence. Collegium Antropologicum 31 Suppl. 2: 55-60

Wilander, E.; Wikström, I. 2008: HPV test for quality control of gynecologic cytological tests. Lakartidningen 105(48-49): 35603564

Sørbye, S.Wergeland.; Fismen, S.; Gutteberg, T.Jarl.; Mortensen, E. 2012: HPV test in the prevention of cervix cancer. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(4): 396-397

Andersson, S.; Hjerpe, A.; Johansson, B.C.; Hagmar, Börn. 2007: HPV test makes cytological examination more accurate. Cervical cancer can be discovered more efficiently. Lakartidningen 104(39): 2797-2799

Olovsson, M.; Aarnio, R.; Rezapour, M.; Segeblad, B.; Sjöö, E.-L.; Wilander, E. 2013: HPV test replaces Pap test in Uppsala. Lakartidningen 110(13-14): 695-696

Heider, A.; Austin, R.M.; Zhao, C. 2011: HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results. Acta Cytologica 55(1): 48-53

Gyllensten, U.; Lindell, M.; Gustafsson, I.; Wilander, E. 2010: HPV test shows low sensitivity of Pap screen in older women. LANCET. Oncology 11(6): 509

Wan, W.H. 2013: HPV testing and cancer: will E6/E7 change the paradigm?. Mlo: Medical Laboratory Observer 45(4): 13-14

Monsonego, J. 2012: HPV testing and cervical cancer screening. Evidences, resistances and current practices. Gynecologie Obstetrique and Fertilite 40(5): 269-272

Sørbye, S.; Fismen, S.; Gutteberg, T.J.; Mortensen, E. 2011: HPV testing and cervix cancer. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 131(4): 333

Leeson, S.C.; Alibegashvili, T.; Arbyn, M.; Bergeron, C.; Carriero, C.; Mergui, J.-L.; Nieminen, P.; Prendiville, W.; Redman, C.W.E.; Rieck, G.C.; Quaas, J.; Petry, K.U. 2014: HPV testing and vaccination in Europe. Journal of Lower Genital Tract Disease 18(1): 61-69

Kitchener, H.C.; Walker, P.G.; Nelson, L.; Hadwin, R.; Patnick, J.; Anthony, G.B.; Sargent, A.; Wood, J.; Moore, C.; Cruickshank, M.E. 2008: HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. Bjog: An International Journal of Obstetrics and Gynaecology 115(8): 1001-1007

Lloveras, B.én.; Gomez, S.; Alameda, F.; Bellosillo, B.; Mojal, S.; Muset, M.è; Parra, M.; Palomares, J.é C.; Serrano, S. 2013: HPV testing by cobas HPV test in a population from Catalonia. Plos one 8(3): E58153

Flores, Y.N.; Bishai, D.M.; Lorincz, A.; Shah, K.V.; Lazcano-Ponce, E.; Hernández, M.; Granados-García, V.íc.; Pérez, R.; Salmerón, J. 2011: HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes and Control: Ccc 22(2): 261-272

Grce, M.; Grahovac, B.; Rukavina, T.; Vrdoljak-Mozetic, D.; Glavas-Obrovac, L.; Kaliterna, V.; Zele-Starcević, L. 2007: HPV testing for cervical cancer screening in Croatia. Collegium Antropologicum 31(Suppl 2): 67-71

Ronco, G.; Segnan, N. 2007: HPV testing for primary cervical cancer screening. Lancet 370(9601): 1740-1742

Kitchener, H.C.; Almonte, M.; Thomson, C.; Wheeler, P.; Sargent, A.; Stoykova, B.; Gilham, C.; Baysson, H.; Roberts, C.; Dowie, R.; Desai, M.; Mather, J.; Bailey, A.; Turner, A.; Moss, S.; Peto, J. 2009: HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. LANCET. Oncology 10(7): 672-682

Monsonego, J. 2013: HPV testing in prevention of cervical cancer: practices and current trends. Annales de Biologie Clinique 71: 27-32

Murphy, J.; Kennedy, E.B.; Dunn, S.; McLachlin, C.M.; Kee Fung, M.F.; Gzik, D.; Shier, M.; Paszat, L. 2012: HPV testing in primary cervical screening: a systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Canada: Jogc 34(5): 443-452

Heley, S. 2013: HPV testing in the National Cervical Screening Program--when is it recommended?. Australian Family Physician 42(7): 463-466

Giorgi Rossi, P.; Carozzi, F.; Collina, G.; Confortini, M.; Dalla Palma, P.; De Lillo, M.; Del Mistro, A.; Ghiringhello, B.; Gillio-Tos, A.; Maioli, P.; Pellegrini, A.; Schiboni, M.L.; Segnan, N.; Zaffina, L.M.T.; Zorzi, M.; Ronco, G.; Mari, D.; Giubilato, P.; De Marco, L.; Ghiringhello, B.; Parisio, F.; Berardengo, E.; As, G.; Andrion, A.; Coverlizza, S.; Taraglio, S.; Accinellli, M. G.; Polla, E.; Pojer, A.; Girlando, S.; Aldovini, D.; Vettorazzi, M.; Matteucci, M.; Onnis, L.; Insacco, E.; Minucci, D.; Lestani, M.; Vignato, A.; Manfredi, M.; Pierotti, P.; Casadei, G. P.; Collina, G.; Schincaglia, P.; Serafini, M.; Vitali, B.; Sintoni, C.; Aldi, M.; Folicaldi, S.; Nannini, R.; Galanti, G.; Naldoni, C.; Iossa, A.; Ciatto, S.; Cariaggi, M. P 2012: HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening. American Journal of Clinical Pathology 138(1): 65-71

Anonymous 2014: HPV testing more reassuring than Pap. Cancer discovery 4(10): 1111

Gök, M.; Heideman, D.ël.A.M.; van Kemenade, F.J.; Berkhof, J.; Rozendaal, L.; Spruyt, J.W.M.; Voorhorst, F.; Beliën, J.A.M.; Babovic, M.; Snijders, P.J.F.; Meijer, C.J.L.M. 2010: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. Bmj 340: C1040

McCaffery, K.J.; Irwig, L.; Chan, S.F.; Macaskill, P.; Barratt, A.; Lewicka, M.; Clarke, J.; Weisberg, E. 2008: HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice. Patient Education and Counseling 73(3): 473-479; 481

Louvanto, K.; Chevarie-Davis, M.; Ramanakumar, A.V.; Franco, E.L.; Ferenczy, A. 2014: HPV testing with cytology triage for cervical cancer screening in routine practice. American Journal of Obstetrics and Gynecology 210(5): 474.E1-7

Sønbø Kristiansen, I. 2012: HPV testing--weak justification for controversial decision. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(12-13): 1476-1478

Øvestad, I.T.; Janssen, E.; Kjellevold, K.; Baak, J. 2010: HPV tests at Stavanger University Hospital. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 130(22): 2219

Howard, K.; Salkeld, G.; McCaffery, K.; Irwig, L. 2008: HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?. Health Economics 17(5): 593-605

Wahl, R.U.; Blazek, C.; Megahed, M. 2009: HPV type 16-associated anal intraepithelial neoplasia (AIN). Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 60(5): 371-372

Berlin Grace, V.M. 2009: HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India. Indian Journal of Cancer 46(3): 203-207

Wahl, R.U.; Knückel, R.; Megahed, M. 2009: HPV type 33-associated penile intraepithelial neoplasia (PIN). Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 60(12): 952-954

Nicollas, R.; Henry, M.; Triglia, J.M.; Tamalet, C. 2007: HPV type 6 and 16 co-infection in a 11-year-old girl presenting laryngeal papillomatosis. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 40(3): 252-254

Hariri, S.; Unger, E.R.; Schafer, S.; Niccolai, L.M.; Park, I.U.; Bloch, K.C.; Bennett, N.M.; Steinau, M.; Johnson, M.L.; Markowitz, L.E.; Bauer, H.; Whitney, E.; Williamson, A.; Hadler, J.; Julian, P.; Meek, J.; Sosa, L.; Scahill, M.; Patel, D.; Abdullah, N.; Laing, R.; Levine, D.; Pemmaraju, M.; Sharma, J.; Miller, D. 2015: HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 24(2): 393-399

Bruggink, S.C.; Gussekloo, J.; de Koning, M.N.C.; Feltkamp, M.C.W.; Bavinck, J.N.B.; Quint, W.G.V.; Assendelft, W.J.J.; Eekhof, J.A.H. 2013: HPV type in plantar warts influences natural course and treatment response: secondary analysis of a randomised controlled trial. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 57(3): 227-232

Gonçalves, M.A.G.; Randi, G.; Arslan, A.; Villa, L.L.; Burattini, M.N.; Franceschi, S.; Donadi, E.A.; Massad, E. 2008: HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infectious Agents and Cancer 3: 5

Bierkens, M.; Wilting, S.M.; van Wieringen, W.N.; van de Wiel, M.A.; Ylstra, B.; Meijer, C.J.L.M.; Snijders, P.J.F.; Steenbergen, R.D.M. 2012: HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia. Bmc Cancer 12: 36

KrennHrubec, K.; Mrad, K.; Sriha, B.; Ben Ayed, F.; Bottalico, D.M.; Ostolaza, J.; Smith, B.; Tchaikovska, T.; Soliman, A.S.; Burk, R.D. 2011: HPV types and variants among cervical cancer tumors in three regions of Tunisia. Journal of Medical Virology 83(4): 651-657

Seedat, R.Y.; Thukane, M.; Jansen, A.C.; Rossouw, I.; Goedhals, D.; Burt, F.J. 2010: HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa. International Journal of Pediatric Otorhinolaryngology 74(3): 255-259

Dursun, P.; Ayhan, A.; Mutlu, L.; Çağlar, M.; Haberal, A.; Güngör, T.; Özat, M.; Özgü, E.; Onan, A.ıl.; Taşkiran, C.ğa.; Güner, H.; Yetımalar, H.; Kasap, B.; Yüce, K.; Salman, M.C.şk.; Sayal, B.; Doğan, S.; Harma, M.üg.; Harma, M.; Basaran, M.; Aydoğmuş, H.üs.; Ergün, Y.; Şehıralı, S.; Gültekın, E.; Köse, S.ük.; Yildirim, Y.; Yenen, M.üf.; Dede, M.; Alanbay, I.; Karaca, R.ız.; Metındır, J.; Keskın, L.; Üstüner, I.şık.; Avşar, F.; Yüksel, H.; Kirdar, S. 2013: HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Dergisi 29(3): 210-216

Giorgi Rossi, P.; Ronco, G. 2011: HPV types in early-onset cervical cancer. Lancet. Oncology 12(2): 117; Author Reply 117-8

Esmaeili, M.; Bonyadi, M.; Dastranj, A.; Alizadeh, M.; Melli, M.S.; Shobeiri, M.J. 2008: HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecologic and Obstetric Investigation 66(1): 68-72

Ondič, O.; Kašpírková, J.; Májek, O.ře.; Kinkorová, I. 2014: HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women. Virchows Archiv: An International Journal of Pathology 464(1): 79-83

Leiner, S. 2009: HPV vaccination. New England Journal of Medicine 361(16): 1610; Author Reply 1610-1611

Tisi, G.; Salinaro, F.; Apostoli, P.; Bassani, R.; Bellicini, A.; Groppi, L.; Donarini, P.; Pecorelli, S. 2013: HPV vaccination acceptability in young boys. Annali Dell'istituto Superiore di Sanita 49(3): 286-291

Castellsagué, X.; Schneider, A.; Kaufmann, A.M.; Bosch, F.Xavier. 2009: HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecologic oncology 115(3 Suppl): S15-S23

Lutringer-Magnin, D.; Cropet, C.; Barone, G.; Canat, G.; Kalecinski, J.; Leocmach, Y.; Vanhems, P.; Chauvin, F.; Lasset, C. 2013: HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers' uptake of Pap smear screening: a study in general practice. Vaccine 31(45): 5243-5249

Reiter, P.L.; Katz, M.L.; Paskett, E.D. 2012: HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 21(12): 2220-2230

McRee, A-Laurie.; Katz, M.L.; Paskett, E.D.; Reiter, P.L. 2014: HPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults. Vaccine 32(37): 4736-4742

Mills, L.A.; Head, K.J.; Vanderpool, R.C. 2013: HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Preventing Chronic Disease 10: E17

Lally, M.Ann.; Lemei, K.; Bonney, L.E.; Zimet, G. 2007: HPV vaccination an opportune time for HIV testing. Journal of adolescent health: official publication of the Society for Adolescent Medicine 40(4): 384; author reply 384-5

Sigurdsson, K.án. 2007: HPV vaccination and cervical cancer screening. Laeknabladid 93(12): 819; 821

Jeyakumar, A.; Mitchell, R. 2011: HPV vaccination and recurrent respiratory papillomatosis. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 144(1): 133

Milliez, J. 2008: HPV vaccination and screening to eliminate cervical cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 101(2): 216-217

Marchand, E.; Glenn, B.A.; Bastani, R. 2013: HPV vaccination and sexual behavior in a community college sample. Journal of community health 38(6): 1010-1014

Bistoletti, P.; Andersson, S.; Johansson, B.C. 2008: HPV vaccination and testing can improve cervix cancer screening. Lakartidningen 105(1-2): 56-57

Markman, M. 2007: HPV vaccination and the prevention of cervical cancer: the long road ahead. Journal of Women's Health 16(9): 1366-1367

Anonymous 2014: HPV vaccination beneficial to those with low CD4 counts. Aids Policy and Law 29(7): 4

Weisberg, E.; Bateson, D.; McCaffery, K.; Skinner, S.Rachel. 2009: HPV vaccination catch up program - utilisation by young Australian women. Australian Family Physician 38(1-2): 72-76

Berry-Cabán, Cóbal.S.; Buenaventura, J.B. 2009: HPV vaccination coverage among adolescents aged 9 to 17 years in a United States military treatment facility. International Journal of Adolescent Medicine and Health 21(4): 567-570

Deleré, Y.; Böhmer, M.M.; Walter, D.; Wichmann, O. 2013: HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey. Human Vaccines and Immunotherapeutics 9(8): 1706-1711

Bertaut, Aélie.; Chavanet, P.; Aho, S.; Astruc, K.; Douvier, S.; Fournel, I. 2013: HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of Côte d'Or. European Journal of Obstetrics Gynecology and Reproductive Biology 170(2): 526-532

Poethko-Müller, C.; Buttmann-Schweiger, N. 2014: HPV vaccination coverage in German girls: results of the KiGGS study: first follow-up (KiGGS Wave 1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(7): 869-877

Jeannot, E.; Sudre, P.; Chastonay, P. 2012: HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland. International journal of public health 57(3): 629-632

Ceballos, S.G. 2009: HPV vaccination for adolescents. An ethics case study. Advance for Nurse Practitioners 17(11): 31-32

Garattini, L.; van de Vooren, K. 2012: HPV vaccination for boys? Talking economic sense. Journal of Sexual Medicine 9(8): 2195-2196

Isshiki, T. 2014: HPV vaccination for cervical cancer prevention is not cost-effective in Japan. Asian Pacific Journal of Cancer Prevention: Apjcp 15(15): 6177-6180

Anonymous 2010: HPV vaccination for the prevention of cervical cancer. Nursing for Women's Health 14(1): 81-82

Kahn, J.A. 2009: HPV vaccination for the prevention of cervical intraepithelial neoplasia. New England Journal of Medicine 361(3): 271-278

Fagot, J-Paul.; Boutrelle, Aélie.; Ricordeau, P.; Weill, A.; Allemand, H. 2011: HPV vaccination in France: uptake, costs and issues for the National Health Insurance. Vaccine 29(19): 3610-3616

Holzgreve, H. 2009: Biomarkers and hypertension. MMW Fortschritte der Medizin 151(51-52): 46-47

Chan, Z.C.Y.; Chan, T.S.; Lam, Y.M.; Lau, L.M.; Li, K.K.; Tam, W.H. 2011: HPV vaccination in Hong Kong: implications for medical education. Asian Pacific Journal of Cancer Prevention: Apjcp 12(4): 1095-1099

Li, S.L.; Lau, Y.L.; Lam, T.H.; Yip, P.S.F.; Fan, S.Y.S.; Ip, P. 2013: HPV vaccination in Hong Kong: uptake and reasons for non-vaccination amongst Chinese adolescent girls. Vaccine 31(49): 5785-5788

Palefsky, J. 2014: HPV vaccination in India. South Asian Journal of Cancer 3(1): 93-94

O'Connor, M.B.; O'Connor, C. 2009: HPV vaccination in Ireland. Irish Journal of Medical Science 178(4): 513-514

Cristina, M.L.; Sartini, M.; Spagnolo, A.M. 2009: Health care-acquired aspergillosis and air conditioning systems. Journal of Preventive Medicine and Hygiene 50(1): 3-8

Icardi, G. 2008: HPV vaccination in Italy: perspectives after 1-year experience. Journal of Preventive Medicine and Hygiene 49(4): 125-128

Stanley, M. 2014: HPV vaccination in boys and men. Human Vaccines and Immunotherapeutics 10(7): 2109-2111

Wierzbicka, M.łg.; Józefiak, A.; Jackowska, J.; Szydłowski, J.ła.; Goździcka-Józefiak, A. 2014: HPV vaccination in head and neck HPV-related pathologies. Otolaryngologia Polska 68(4): 157-173

Waller, J.; Wardle, J. 2008: HPV vaccination in the UK. Bmj 336(7652): 1028-1029

Solomon, D.; Castle, P.; Hildesheim, A.; Katki, H.A.; Schiffman, M.; Wacholder, S. 2009: HPV vaccination in women aged 24-45 years. Lancet 374(9697): 1239; Author Reply 1239-40

Mazza, D.; Petrovic, K.; Grech, C.; Harris, N. 2014: HPV vaccination in women aged 27 to 45 years: what do general practitioners think?. Bmc Women's Health 14: 91

Basu, P.; Ngan, H.Yuen.Sheung.; Hseon, T.Eng.; Tan, J.; Huat, L.Lean.; Manuel-Limson, G.; Nuranna, L.; Liu, J.; Karunaratne, K.; Kung-Liahng, W.; Wah, L.Bee.; Pancharoen, C.; Chi-Jen, C.; Chow, S-Nan.; Domingo, E.; Alesna-Llanto, E.; Pak, J-Sup.; Ruey, S.; Nhung, V.Thi.; Srisomboon, J.; Yin, A.Cheung.Nga.; Putra, A.Darma.; Kim, Y-Tak.; Yahya, A.Aziz.; Termrungruanglert, W.; Phuong, N.Thi.Ngoc.; Tang-Yuan, C.; Bhatla, N.; Lin, Q.You.; Sheung, P.Chan.Kay. 2009: HPV vaccination in women over 25 years of age: Asian Cervical Cancer Prevention Advisory Board recommendations. journal of obstetrics and gynaecology research 35(4): 712-716

Huh, W.K. 2013: HPV vaccination in women treated for CIN2/3: it's still all about prevention. Gynecologic Oncology 130(2): 255-256

Gross, G. 2008: HPV vaccination is important for dermatologists. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 59(11): 929-932

Gaudelus, J.; Cohen, R.; Martinot, A.; Stahl, J.-P.; Lery, T.; Le Danvic, M.; Denis, F. 2014: HPV vaccination is still difficult to implement. Medecine et Maladies Infectieuses 44(7): 289-291

Colgrove, J.; Abiola, S.; Mello, M.M. 2010: HPV vaccination mandates--lawmaking amid political and scientific controversy. New England Journal of Medicine 363(8): 785-791

Allison, M.A.; Dunne, E.F.; Markowitz, L.E.; O'Leary, S.T.; Crane, L.A.; Hurley, L.P.; Stokley, S.; Babbel, C.I.; Brtnikova, M.; Beaty, B.L.; Kempe, A. 2013: HPV vaccination of boys in primary care practices. Academic Pediatrics 13(5): 466-474

Hairon, N. 2007: HPV vaccination of girls to help prevent cervical cancer. Nursing Times 103(45): 23-24

Henderson, C.E.; Rich, J.D.; Lally, M.A. 2010: HPV vaccination practices among juvenile justice facilities in the United States. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 46(5): 495-498

Gilmour, S.; Kanda, M.; Kusumi, E.; Tanimoto, T.; Kami, M.; Shibuya, K. 2013: HPV vaccination programme in Japan. Lancet 382(9894): 768

Wilyman, J. 2013: HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery. Infectious Agents and Cancer 8(1): 21

Anonymous 2010: HPV vaccination recommended for 9- to 26-year-old male patients. AIDS patient care and STDs 24(8): 531

van der Loeff, M.F.Schim.; Nyitray, A.G.; Giuliano, A.R. 2011: HPV vaccination to prevent HIV infection: time for randomized controlled trials. Sexually Transmitted Diseases 38(7): 640-643

Lawton, M.D.; Nathan, M.; Asboe, D. 2013: HPV vaccination to prevent anal cancer in men who have sex with men. Sexually Transmitted Infections 89(5): 342-343

Ma, R. 2014: HPV vaccination uptake lowest in young women at greatest risk. Practitioner 258(1770): 5

Schwartz, J.L. 2010: HPV vaccination's second act: promotion, competition, and compulsion. American Journal of Public Health 100(10): 1841-1844

Sawaya, G.F.; Smith-McCune, K. 2007: HPV vaccination--more answers, more questions. New England Journal of Medicine 356(19): 1991-1993

Sturgis, E.M.; Dahlstrom, K.R. 2009: HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. Bmj 339: B4525

Kiely, M.; Dubé, E.; Turmel, B. 2014: HPV vaccination. Nurses' perceptions in the school setting. Better understanding the causes of vaccine coverage reduction and addressing it. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(1): 47-50

Foresta, C.; Ferlin, A.; Garolla, A. 2009: HPV vaccination. what about male specific HPV related diseases?. Bmj 339: B4514

Walker, P. 2007: HPV vaccination: an opportunity for good and the potential for harm. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 27(7): 645-647

Hofstetter, A.M.; Stockwell, M.S.; Al-Husayni, N.; Ompad, D.; Natarajan, K.; Rosenthal, S.L.; Soren, K. 2014: HPV vaccination: are we initiating too late?. Vaccine 32(17): 1939-1945

Kothari, A. 2014: HPV vaccination: effects on cervical screening. Nursing Times 110(24): 19-21

Castle, P.E.; Schmeler, K.M. 2014: HPV vaccination: for women of all ages?. Lancet 384(9961): 2178-2180

Singla, S.; Bhatla, N. 2012: HPV vaccination: more evidence of benefit. National Medical Journal of India 25(3): 159-160

Gray, J.R. 2007: HPV vaccination: should it be mandatory for entry into public school?. Nursing for Women's Health 11(2): 133-138

Donaldson, C.; Gehring, A. 2008: HPV vaccination: taking the knowledge to the streets. Journal of the Royal Society for the Promotion of Health 128(5): 218-219

Lepique, A.P.; Rabachini, T.; Villa, L.L. 2009: HPV vaccination: the beginning of the end of cervical cancer? - a Review. Memorias do Instituto Oswaldo Cruz 104(1): 1-10

Montanari, G.R.; Confortini, M.; Ghiringhello, B. 2007: HPV vaccination: the bewilderment of the staff engaged in traditional cervical cancer screening. Epidemiologia e Prevenzione 31(4): 189-191

Sankaranarayanan, R. 2009: HPV vaccination: the promise and problems. Indian Journal of Medical Research 130(3): 322-326

Yudin, M.H. 2010: HPV vaccination: time to end the debate. Journal of Pediatric and Adolescent Gynecology 23(1): 55-56

Kahn, J.A.; Bernstein, D.I. 2013: HPV vaccination: too soon for 2 doses?. JAMA 309(17): 1832-1834

Linhares, I.M.; Witkin, S.S. 2015: HPV vaccination: unanswered questions remain. Bjog: An International Journal of Obstetrics and Gynaecology 122(1): 118

Paul-Ebhohimhen, V.; Huc, S.; Tissington, H.; Oates, K.; Stark, C. 2010: HPV vaccination: vaccine acceptance, side effects and screening intentions. Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 83(6): 30-33

Suba, E.J.; Raab, S.S. 2010: HPV vaccination: waiting for evidence of effectiveness. Lancet 375(9715): 639-640

Hausdorf, K.; Newman, B.; Whiteman, D.; Aitken, J.; Frazer, I. 2007: HPV vaccination: what do Queensland parents think?. Australian and New Zealand Journal of Public Health 31(3): 288-289

Tanday, S. 2014: HPV vaccinations do not encourage risky sexual behaviour. LANCET. Oncology 15(3): E109

Ginsberg, G.M. 2014: HPV vaccinations--possibly necessary but not sufficient. Lancet. Global Health 2(7): E367-E368

Becker-Dreps, S.; Otieno, W.A.; Brewer, N.T.; Agot, K.; Smith, J.S. 2010: HPV vaccine acceptability among Kenyan women. Vaccine 28(31): 4864-4867

Young, A.M.; Crosby, R.A.; Jagger, K.S.; Richardson, M.B.; Kloha, R.A.; Safarian, V. 2010: HPV vaccine acceptability among women in the Philippines. Asian Pacific Journal of Cancer Prevention: Apjcp 11(6): 1781-1787

Mazzadi, A.; Paolino, M.; Arrossi, S. 2012: HPV vaccine acceptability and knowledge among gynecologists in Argentina. Salud Publica de Mexico 54(5): 515-522

Podolsky, R.; Cremer, M.; Atrio, J.; Hochman, T.; Arslan, A.A. 2009: HPV vaccine acceptability by Latino parents: a comparison of U.S. and Salvadoran populations. Journal of Pediatric and Adolescent Gynecology 22(4): 205-215

Coleman, M.A.; Levison, J.; Sangi-Haghpeykar, H. 2011: HPV vaccine acceptability in Ghana, West Africa. Vaccine 29(23): 3945-3950

Fazekas, K.I.; Brewer, N.T.; Smith, J.S. 2008: HPV vaccine acceptability in a rural Southern area. Journal of Women's Health 17(4): 539-548

Gilbert, P.; Brewer, N.T.; Reiter, P.L.; Ng, T.W.; Smith, J.S. 2011: HPV vaccine acceptability in heterosexual, gay, and bisexual men. American Journal of Men's Health 5(4): 297-305

Sanderson, M.; Coker, A.L.; Eggleston, K.S.; Fernandez, M.E.; Arrastia, C.D.; Fadden, M.K. 2009: HPV vaccine acceptance among Latina mothers by HPV status. Journal of Women's Health 18(11): 1793-1799

Bakogianni, G.D.; Nikolakopoulos, K.M.; Nikolakopoulou, N.M. 2010: HPV vaccine acceptance among female Greek students. International Journal of Adolescent Medicine and Health 22(2): 271-273

Ferris, D.G.; Waller, J.L.; Owen, A.; Smith, J. 2008: HPV vaccine acceptance among mid-adult women. Journal of the American Board of Family Medicine: Jabfm 21(1): 31-37

Young, A. 2010: HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pacific Journal of Cancer Prevention: Apjcp 11(3): 641-649

Dempsey, A.F.; Patel, D.A. 2010: HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now?. Human Vaccines 6(9)

Bansal, V.; Goyal, K.; Singh, M.P. 2011: HPV vaccine against HPV infection and disease in males. New England Journal of Medicine 364(22): 2163-2164

Wieland, U.; Kreuter, A. 2011: HPV vaccine against HPV infection and disease in males. New England Journal of Medicine 364(22): 2163; Author Reply 2164-2165

Palefsky, J.M.; Giuliano, A.R.; Goldstone, S.; Moreira, E.D.; Aranda, C.; Jessen, H.; Hillman, R.; Ferris, D.; Coutlee, F.; Stoler, M.H.; Marshall, J.Brooke.; Radley, D.; Vuocolo, S.; Haupt, R.M.; Guris, D.; Garner, E.I.O. 2011: HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. New England Journal of Medicine 365(17): 1576-1585

Wieland, U.; Stuecker, M.; Kreuter, A. 2012: HPV vaccine against anal intraepithelial neoplasia. New England Journal of Medicine 366(4): 378; Author Reply 378-379

Pélissier, Géraldine.; Bastides, Fédéric. 2008: HPV vaccine and cervical cancer prevention in general practice. Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher. La Revue du Praticien 58(19 Suppl): 25-31

Zimet, G.D.; Rosenthal, S.L. 2010: HPV vaccine and males: issues and challenges. Gynecologic Oncology 117(2 Suppl): S26-S31

Okonofua, F. 2007: HPV vaccine and prevention of cervical cancer in Africa. African Journal of Reproductive Health 11(2): 7-12

Huey, N.L.; Clark, A.D.; Kluhsman, B.C.; Lengerich, E.J. 2009: HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Preventing Chronic Disease 6(2): A49

Durusoy, R.; Yamazhan, M.; Taşbakan, M.Işikgöz.; Ergin, Işil.; Aysin, M.; Pullukçu, Hüsnü.; Yamazhan, T. 2010: HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. Asian Pacific Journal of Cancer Prevention: Apjcp 11(6): 1695-1701

Anonymous 2014: HPV vaccine backed to prevent cancer. Nursing Times 110(28): 4

Grotowski, M.; May, J. 2008: HPV vaccine catch up schedule - an opportunity for chlamydia screening. Australian Family Physician 37(7): 529-530

Haupt, R.M.; Sattler, C. 2010: HPV vaccine continues to be safe and effective, and its benefits continue to outweigh its risks. Expert Review of Vaccines 9(7): 697-701

Anonymous 2013: HPV vaccine could also prevent oropharyngeal cancer, says IARC. Central European Journal of Public Health 21(3): 149 154

Meites, E.; Markowitz, L.E.; Paz-Bailey, G.; Oster, A.M.; White, J.; Todd, J.; Bautista, G.; Flynn, C.; German, D.; Miminos, M.; Doherty, R.; Wittke, C.; Prachand, N.; Benbow, N.; Melville, S.; Sheu, S.; Novoa, A.; Thrun, M.; Al-Tayyib, A.; Wilmoth, R.; Griffin, V.; Higgins, E.; MacMaster, K.; Wolverton, M.; Rehman, H.; Padgett, P.; Bingham, T.; Sey, E.Kwa.; LaLota, M.; Metsch, L.; Forrest, D.; Anderson, B.J.; Watson, C-Ann.; Smith, L.; Gruber, D.; Robinson, W.T.; Barak, N.; Neai-gus, A.; Reilly, K.H.; Wendel, T.; Bolden, B.; Wogayehu, A.; Godette 2014: HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011. Vaccine 32(48): 6356-6359

De Vincenzo, R.; Ricci, C.; Conte, C.; Scambia, G. 2013: HPV vaccine cross-protection: Highlights on additional clinical benefit. Gynecologic oncology 130(3): 642-651

Hughes, C.C.; Jones, A.L.; Feemster, K.A.; Fiks, A.G. 2011: HPV vaccine decision making in pediatric primary care: a semi-structured interview study. Bmc Pediatrics 11: 74

Shelton, R.C.; Snavely, A.C.; De Jesus, M.; Othus, M.D.; Allen, J.D. 2013: HPV vaccine decision-making and acceptance: does religion play a role?. Journal of Religion and Health 52(4): 1120-1130

Grimes, J.L. 2006: HPV vaccine development: A case study of prevention and politics. Biochemistry and Molecular Biology Education: a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology 34(2): 148-154

Füessl, H.S. 2013: HPV vaccine does not promote recklessness. MMW Fortschritte der Medizin 155(8): 38

Rosberger, Z.; Krawczyk, A.; Stephenson, E.; Lau, S. 2014: HPV vaccine education: enhancing knowledge and attitudes of community counselors and educators. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 29(3): 473-477

Saraiya, M.; Hariri, S. 2011: HPV vaccine effect: is the glass half full or half empty?. Lancet 377(9783): 2057-2058

Bryan, J. 2007: HPV vaccine facts: can't see the forest through the trees. Human Vaccines 3(6): 295-296

Bush, M. 2008: HPV vaccine for MSM. Australian Nursing Journal 16(3): 33

Reiter, P.L.; McRee, A.-L.; Gottlieb, S.L.; Brewer, N.T. 2010: HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine 28(38): 6292-6297

Michels, K.B.; zur Hausen, H. 2009: HPV vaccine for all. Lancet 374(9686): 268-270

Kawana, K. 2010: HPV vaccine for cervical cancer prevention. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(6): 1163-1168

Judlin, P. 2010: HPV vaccine for men too?. Gynecologie Obstetrique and Fertilite 38(12): 721-722

Jha, A.K.; Jha, J.; Bista, R.; Basnet, B.; Kandel, P.; Lama, G.; Banthia, P.; Thakali, K. 2009: A scenario of cervical carcinoma in a cancer hospital. Jnma; Journal of the Nepal Medical Association 48(175): 199-202

Sarin, R. 2008: HPV vaccine for primary prevention of cervical cancer in developing countries: the missing links. Journal of Cancer Research and Therapeutics 4(3): 105-106

Burns, J. 2012: HPV vaccine goes underused. Managed Care 21(9): 26-28; 30-32

McRee, A.-L.; Gilkey, M.B.; Dempsey, A.F. 2014: HPV vaccine hesitancy: findings from a statewide survey of health care providers. Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates and Practitioners 28(6): 541-549

Meites, E.; Llata, E.; Hariri, S.; Zenilman, J.; Longfellow, L.; Schwebke, J.; Tabidze, I.; Mettenbrink, C.; Jenkins, H.; Guerry, S.; Pathela, P.; Asbel, L.; Stover, J.A.; Bernstein, K.; Kerani, R.P.; Dunne, E.F.; Markowitz, L.E. 2012: HPV vaccine implementation in STD clinics--STD Surveillance Network. Sexually Transmitted Diseases 39(1): 32-34

Binagwaho, A.; Wagner, C.M.; Nutt, C.T. 2011: HPV vaccine in Rwanda: different disease, same double standard. Lancet 378(9807): 1916

Mathew, J.L. 2009: HPV vaccine in the Indian context. Indian Pediatrics 46(7): 645-646

Bynum, S.A.; Malo, T.L.; Lee, J.-H.; Guiliano, A.R.; Vadaparampil, S.T. 2011: HPV vaccine information-seeking behaviors among US physicians: government, media, or colleagues?. Vaccine 29(32): 5090-5093

Piñeros, M.; Wiesner, C.; Cortés, C.; Trujillo, L.M.ía. 2010: HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors. Cadernos de Saude Publica 26(5): 900-908

Farley, H. 2012: HPV vaccine is needed. Minnesota Medicine 95(1): 6

Campos-Outcalt, D. 2012: HPV vaccine is now routinely indicated for males. Journal of Family Practice 61(1): 38-40

Thompson, F. 2012: The role of information technology in alliance action. Michigan Medicine 111(2): 21

Do, H.; Seng, P.; Talbot, J.; Acorda, E.; Coronado, G.D.; Taylor, V.M. 2009: HPV vaccine knowledge and beliefs among Cambodian American parents and community leaders. Asian Pacific journal of cancer prevention: APJCP 10(3): 339-344

Wang, H-Ho.; Wu, S-Ying. 2013: HPV vaccine knowledge and perceived risk of cervical cancer among female college students in Taiwan. Asian Pacific journal of cancer prevention: APJCP 14(12): 7371-7374

Anonymous 2014: HPV vaccine less effective in "older" women. Cancer Discovery 4(4): OF6

Onder, R.F. 2008: HPV vaccine mandates: just say 'no' to the "great big public health experiment". Missouri Medicine 105(1): 8-11

Martin, W.A. 2011: HPV vaccine may have role in wart treatment. Bmj 343: D4351

Garattini, L.; van de Vooren, K.; Casadei, G. 2011: HPV vaccine prices in Italy. Bmj 343: D6668

Juraskova, I.; Bari, R.A.; O'Brien, M.T.; McCaffery, K.J. 2011: HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?. Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 21(1): 71-79

Kmietowicz, Z. 2014: HPV vaccine protects against cervical abnormalities in young women, study finds. Bmj 348: G1873

Nettersheim, D.; Biermann, K.; Gillis, A.J.M.; Steger, K.; Looijenga, L.H.J.; Schorle, H. 2011: NANOG promoter methylation and expression correlation during normal and malignant human germ cell development. Epigenetics 6(1): 114-122

Griesser, H.; Sander, H.; Walczak, C.; Hilfrich, R.A. 2009: HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions. American Journal of Clinical Pathology 132(6): 840-845

Hodge, F.S.; Itty, T.; Cardoza, B.; Samuel-Nakamura, C. 2011: HPV vaccine readiness among American Indian college students. Ethnicity and Disease 21(4): 415-420

Potera, C. 2011: HPV vaccine reduces cervical abnormalities in teens. American Journal of Nursing 111(9): 16

Van den Bergh, J.M.J.; Guerti, K.; Willemen, Y.; Lion, E.; Cools, N.; Goossens, H.; Vorsters, A.; Van Tendeloo, V.F.I.; Anguille, S.éb.; Van Damme, P.; Smits, E.L.J.M. 2014: HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells. Journal of Cellular and Molecular Medicine 18(7): 1372-1380

Hawkes, S.; Lewis, D.A. 2014: HPV vaccine strategies: equitable and effective?. Sexually Transmitted Infections 90(7): 510-511

Morris, S.R. 2009: HPV vaccine strategies: the cost of HPV and the choice of vaccine. Sexually Transmitted Infections 85(5): 315-316

Feinberg, M. 2010: HPV vaccine suspension in India. Lancet 376(9753): 1644-1645

Srinivasan, S. 2011: HPV vaccine trials and sleeping watchdogs. Indian Journal of Medical Ethics 8(2): 73-74

Mendoza, N.; Hernandez, P.O.; Tyring, S.K. 2011: HPV vaccine update: new indications and controversies. Skin Therapy Letter 16(8): 1-3

Hense, S.; Hillebrand, K.; Horn, J.; Mikolajczyk, R.; Schulze-Rath, R.; Garbe, E. 2014: HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data. Human Vaccines and Immunotherapeutics 10(6): 1729-1733

Nomura, K.; Rahman, M. 2014: HPV vaccine uptake among Asian American girls aged 9-17 years during 2008-2010. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 126(1): 91-92

Printz, C. 2013: HPV vaccine uptake remains low. Why some adolescents are not receiving the vaccine, and what can be done about it. Cancer 119(16): 2947-2948

Hull, P.C.; Williams, E.A.; Khabele, D.; Dean, C.; Bond, B.; Sanderson, M. 2014: HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach. Gynecologic Oncology 132 Suppl. 1: S13-S20

Kouros, N. 2013: HPV vaccine working in Australia. Monash Bioethics Review 31(2): 8-9

Anonymous 2014: HPV vaccine works against nine viral types. Cancer Discovery 4(1): OF2

Kim, S. 2014: HPV vaccine, is it really harmful?. Journal of Korean Medical Science 29(6): 749-750

Watts, L.A.; Joseph, N.; Wallace, M.; Rauh-Hain, J.A.; Muzikansky, A.; Growdon, W.B.; del Carmen, M.G. 2009: HPV vaccine: a comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecologic Oncology 112(3): 577-582

Szarewski, A. 2010: HPV vaccine: Cervarix. Expert Opinion on Biological Therapy 10(3): 477-487

Schäffer, V.; Wimmer, S.; Rotaru, I.; Topakian, R.; Haring, H.-P.; Aichner, F.T. 2008: HPV vaccine: a cornerstone of female health a possible cause of ADEM?. Journal of Neurology 255(11): 1818-1820

Mariani, L.; Venuti, A. 2010: HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. Journal of Translational Medicine 8: 105

Anonymous 2007: HPV vaccine: beyond the hype. Consumer Reports 72(10): 47

Somasundaram, K. 2008: HPV vaccine: end to women's major health problem?. Indian Journal of Medical Research 127(6): 511-513

Ohri, L.K. 2007: HPV vaccine: immersed in controversy. Annals of PharmacoTherapy 41(11): 1899-1902

Schmidt, J.V. 2007: HPV vaccine: implications for nurses and patients. Nursing for Women's Health 11(1): 83-87

Ciofi degli Atti, M.L.; Donati, S.; Salmaso, S. 2007: HPV vaccine: making decisions in public health. Epidemiologia e Prevenzione 31(4): 181-182

Snow, M. 2007: HPV vaccine: new treatment for an old disease. Nursing 37(3): 67

Hammoud, M. 2008: HPV vaccine: not immune to controversy. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 101(2): 123-124

Cameron, J.C.; Wallace, L.A.; Ahmed, S.; Duff, R.; Donaghy, M.; Goldberg, D.J. 2007: HPV vaccine: positive insights from universal adolescent HepB vaccination. Journal of Epidemiology and Community Health 61(12): 1018-1019

D'Argenio, P. 2007: HPV vaccine: using it in the best way, now. Epidemiologia e Prevenzione 31(4): 185-188

Shoenfeld, Y. 2012: HPV vaccines and autoimmune diseases. Journal of Internal Medicine 272(1): 98; Author Reply 99

Bosch, F.X. 2008: HPV vaccines and cervical cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 19(Suppl 5): V48-V51

Anonymous 2012: HPV vaccines and pregnancy: the situation in early 2012. Prescrire International 21(128): 154-157

Markowitz, L.E. 2007: HPV vaccines prophylactic, not therapeutic. JAMA 298(7): 805-806

Dochez, C.; Bogers, J.J.; Verhelst, R.; Rees, H. 2014: HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine 32(14): 1595-1601

Gjertsen, M.Klemp.; Neilson, A.Rae.; de Blasio, B.Freiesleben. 2007: HPV vaccines--effect, safety and cost-effectiveness. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(12): 1674; Author Reply 1674

Kirnbauer, R. 2007: HPV vaccines. Prophylactic vaccines from virus-like particles. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 58(6): 489-492

Stanley, M. 2008: HPV vaccines: are they the answer?. British Medical Bulletin 88(1): 59-74

Saca-Hazboun, H. 2008: HPV vaccines: are we ready to protect our children?. Ons Connect 23(10): 27

Thomas, C. 2008: HPV vaccines: bring me your daughters!. South African Medical Journal 98(4): 259-261

Szarewski, A. 2008: HPV vaccines: peering through the fog. Journal of Family Planning and Reproductive Health Care 34(4): 207-209

Gissmann, L. 2009: HPV vaccines: preclinical development. Archives of Medical Research 40(6): 466-470

Kang, G. 2010: HPV vaccines: separating real hope from drug company hype. Indian Journal of Medical Ethics 7(1): 56-57

D'Andrilli, G.; Bovicelli, A.; Giordano, A. 2010: HPV vaccines: state of the art. Journal of Cellular Physiology 224(3): 601-604

Riethmuller, D. 2011: HPV vaccines: the current disorder and the absolute necessity of returning to basics. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 40(5): 385-386

Stanley, M. 2007: HPV vaccines: where are we now?. Journal of Family Planning and Reproductive Health Care 33(4): 227-229

Léniz, J.; Barriga, M.ía.I.; Lagos, M.; Ibáñez, C.; Puschel, K.; Ferreccio, C. 2013: HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud Publica de Mexico 55(2): 162-169

De Araujo Souza, P.íc.S.; Sichero, L.; Maciag, P.C. 2009: HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncology 5(3): 359-370

Gisvold, C. 2013: HPV's new targets. the head, neck and oral cavity. Advance for Nps and Pas 4(3): 31-33

Aréchaga-Ocampo, E.; Pereira-Suárez, A.L.; del Moral-Hernández, O.; Cedillo-Barrón, L.; Rodríguez-Sastre, M.A.; Castillo-Alvarez, A.íd.; López-Bayghen, E.; Villegas-Sepúlveda, N.ás. 2008: HPV+ cervical carcinomas and cell lines display altered expression of caspases. Gynecologic Oncology 108(1): 10-18

Radojicic, J.; Zaravinos, A.; Spandidos, D.A. 2012: HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. International Journal of Biological Markers 27(1): 1-12

Apolikhin, O.I.; Kakorina, E.P.; Sivkov, A.V.; Beshliev, D.A.; Solntseva, T.V.; Komarova, V.A. 2008: Official statistics on urological morbidity in the Russian Federation. Urologiia 24(3): 3-9

Brondani, M. 2008: HPV, oral sex, and the risk of oral cancer: food for thought. Special Care in Dentistry: Official Publication of the American Association of Hospital Dentists the Academy of Dentistry for the Handicapped and the American Society for Geriatric Dentistry 28(5): 183-184

Northridge, M.E.; Manji, N.; Piamonte, R.T.; More, F.G.; Katz, R.V. 2012: HPV, oropharyngeal cancer, and the role of the dentist: a professional ethical approach. Journal of Health Care for the Poor and Underserved 23(4 Suppl): 47-57

Khristamian, A. 2008: HPV--detection, therapy, follow-up. Akusherstvo i Ginekologiia 47(Suppl 1): 22-27

De Oliveira, C.M.; Aguiar, L.S.; Genta, M.L.D.N.; Alves, V.ân.A.F.; Levi, J.é E. 2011: HPV-11 associated metastatic cervical cancer. Gynecologic Oncology Case Reports 2(1): 18-19

Kahla, S.; Kochbati, L.; Chanoufi, M.B.; Maalej, M.; Oueslati, R. 2014: HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas. International Journal of Biological Markers 29(1): E78-E85

Campo, M.S.; Graham, S.V.; Cortese, M.S.; Ashrafi, G.H.; Araibi, E.H.; Dornan, E.S.; Miners, K.; Nunes, C.; Man, S. 2010: HPV-16 E5 down-regulates expression of surface HLA class i and reduces recognition by CD8 T cells. Virology 407(1): 137-142

Boscolo-Rizzo, P.; Da Mosto, M.C.; Fuson, R.; Frayle-Salamanca, H.; Trevisan, R.; Del Mistro, A. 2009: HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. Journal of Cancer Research and Clinical Oncology 135(4): 559-566

Diaz, D.; Santander, M.A.S.; Chavez, J.ús.A.M. 2012: HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. International Journal of Oncology 41(1): 141-146

Au Yeung, C.L.; Tsang, W.P.; Tsang, T.Y.; Co, N.N.; Yau, P.L.; Kwok, T.T. 2010: HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncology Reports 24(6): 1599-1604

Spardy, N.; Duensing, A.; Hoskins, E.E.; Wells, S.I.; Duensing, S. 2008: HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies. Cancer Research 68(23): 9954-9963

Alaez-Verson, C.; Berumen-Campos, J.; Munguía-Saldaña, A.; Flores-Aguilar, H.; Guardado-Estrada, M.; Rodríguez-Gomez, A.; Gorodezky-Lauferman, C. 2011: HPV-16 and HLA-DRB1 alleles are associated with cervical carcinoma in Mexican Mestizo women. Archives of Medical Research 42(5): 421-425

Baussano, I.; Ronco, G.; Segnan, N.; French, K.; Vineis, P.; Garnett, G.P. 2010: HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions. Epidemics 2(1): 21-28

Nichols, A.C.; Faquin, W.C.; Westra, W.H.; Mroz, E.A.; Begum, S.; Clark, J.R.; Rocco, J.W. 2009: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 140(2): 228-234

Marques-Silva, L.; Farias, L.C.ção.; Fraga, C.A.d.C.; de Oliveira, M.V.íc.M.; Cardos, C.áu.M.; Fonseca-Silva, T.; Gomes, C.C.; De-Paula, A.M.íc.B.; Gomez, R.S.; Guimarães, A.é L.S. 2012: HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients. Oncology Letters 3(4): 945-949

Zhang, G.; Sun, L.; Li, Z.; Si, L.; Song, T.; Huang, C.; Zhang, W. 2009: HPV-16E6 can induce multiple site phosphorylation of p53. Oncology Reports 21(2): 371-377

Tan, C.L.; Gunaratne, J.; Lai, D.; Carthagena, L.; Wang, Q.; Xue, Y.Z.; Quek, L.S.; Doorbar, J.; Bachelerie, F.ço.; Thierry, F.ço.; Bellanger, S. 2012: HPV-18 E2^E4 chimera: 2 new spliced transcripts and proteins induced by keratinocyte differentiation. Virology 429(1): 47-56

Kho, E.-Y.; Wang, H.-K.; Banerjee, N.S.; Broker, T.R.; Chow, L.T. 2013: HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proceedings of the National Academy of Sciences of the United States of America 110(19): 7542-7549

Kang, W.D.; Kim, C.H.; Cho, M.K.; Kim, J.W.; Cho, H.Y.; Kim, Y.H.; Choi, H.S.; Kim, S.M. 2011: HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy. Gynecologic Oncology 121(3): 546-550

Raiol, T.á; de Amorim, R.M.S.; Galante, P.; Martins, C.áu.R.F.; Villa, L.L.; Sichero, L. 2011: HPV-58 molecular variants exhibit different transcriptional activity. Intervirology 54(3): 146-150

Kreuter, A.; Potthoff, A.; Brockmeyer, N.; Stücker, M.; Wieland, U. 2011: HPV-73- and HPV-82 positive anal margin carcinoma with secondary ulcerating Herpes simplex-virus 2 infection. Journal der Deutschen Dermatologischen Gesellschaft 9(8): 628-630

Eleutério, J.é; Barros, I.C.; Cavalcante, D.I.M.; Eleutério, R.M.N.; Giraldo, P.C.és. 2010: HPV-DNA hybrid capture test: influence of cellularity in penile samples. Acta Cytologica 54(4): 546-550

Williams, V.M.; Filippova, M.; Soto, U.; Duerksen-Hughes, P.J. 2011: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virology 6(1): 45-57

Foresta, C.; Noventa, M.; De Toni, L.; Gizzo, S.; Garolla, A. 2015: HPV-DNA sperm infection and infertility: from a systematic literature review to a possible clinical management proposal. Andrology 3(2): 163-173

Origoni, M.; Cristoforoni, P.; Costa, S.; Mariani, L.; Scirpa, P.; Lorincz, A.; Sideri, M. 2012: HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice. Ecancermedicalscience 6: 258

Piana, L.; Leandri, Fçois-Xavier.; Le Retraite, L.; Heid, P.; Tamalet, C.; Sancho-Garnier, Hélène. 2011: HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône. Bulletin du Cancer 98(7): 723-731

Yin, L.; Yao, J.; Gardner, B.P.; Chang, K.; Yu, F.; Goodenow, M.M. 2012: HPV-QUEST: a highly customized system for automated HPV sequence analysis capable of processing Next Generation sequencing data set. Bioinformation 8(8): 388-390

Horn, L.-C.; Klostermann, K.; Hautmann, S.; Höhn, A.K.; Beckmann, M.W.; Mehlhorn, G. 2011: HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology. Der Pathologe 32(6): 467-475

Hollwitz, B.; Rinnau, F.; Holm, S.; Petry, K.U.; Hillemanns, P. 2008: HPV-associated anogenital neoplasia in HIV. MMW Fortschritte der Medizin 150(Special Issue 1): 30

Moscicki, A.-B. 2011: HPV-associated cancers: it's not all about the cervix. Preventive Medicine 53(Suppl 1): S3-S4

Blazek, C.; Ghassemi, A.; Megahed, M. 2007: HPV-associated carcinoma of the buccal mucosa in a female patient with cicatricial mucosal pemphigoid. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 58(5): 388-390

Reuschenbach, M.; Vinokurova, S.; von Knebel Doeberitz, M. 2011: HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development. Der Pathologe 32(6): 451-460

Kiyofumi, E. 2008: HPV-associated cutaneous lesions. Uirusu 58(2): 173-182

Ljubojevic, S.; Skerlev, M. 2014: HPV-associated diseases. Clinics in Dermatology 32(2): 227-234

Wittekindt, C.; Wagner, S.; Klussmann, J.P. 2011: HPV-associated head and neck cancer. The basics of molecular and translational research. Hno 59(9): 885-892

Marur, S.; D'Souza, G.; Westra, W.H.; Forastiere, A.A. 2010: HPV-associated head and neck cancer: a virus-related cancer epidemic. LANCET. Oncology 11(8): 781-789

Kimple, A.J.; Torres, A.D.; Yang, R.Z.; Kimple, R.J. 2012: HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratification. Sensors 12(4): 5159-5169

Pai, S.I. 2012: HPV-associated head and neck cancers. Otolaryngologic Clinics of North America 45(4): Xi-Xii

Ragin, C.; Obikoya-Malomo, M.; Kim, S.; Chen, Z.; Flores-Obando, R.; Gibbs, D.; Koriyama, C.; Aguayo, F.; Koshiol, J.; Caporaso, N.E.; Carpagnano, G.E.; Ciotti, M.; Dosaka-Akita, H.; Fukayama, M.; Goto, A.; Spandidos, D.A.; Gorgoulis, V.; Heideman, Dëlle.A.M.; van Boerdonk, R.A.A.; Hiroshima, K.; Iwakawa, R.; Kastrinakis, N.G.; Kinoshita, I.; Akiba, S.; Landi, M.T.; Eugene Liu, H.; Wang, J-Li.; Mehra, R.; Khuri, F.R.; Lim, W-Teck.; Owonikoko, T.K.; Ramalingam, S.; Sarchianaki, E.; Syrjanen, K.; Tsao, M-Sound.; Sykes, J.; Hee, S.Wan.; Yokota, J.; Zaravinos 2014: HPV-associated lung cancers: an international pooled analysis. Carcinogenesis 35(6): 1267-1275

Kraft, S.; Faquin, W.C.; Krane, J.F. 2012: HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior. American Journal of Surgical Pathology 36(3): 321-330

Feller, L.; Khammissa, R.A.G.; Wood, N.H.; Marnewick, J.C.; Meyerov, R.; Lemmer, J. 2011: HPV-associated oral warts. Sadj: Journal of the South African Dental Association 66(2): 82-85

Mollenhauer, M.; Assmann, G.; Zengel, P.; Guntinas-Lichius, O.; Ihrler, S. 2014: HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary. Der Pathologe 35(2): 127-140; Quiz: 141-142

Lassen, P.; Eriksen, J.G.; Hamilton-Dutoit, S.; Tramm, T.; Alsner, J.; Overgaard, J. 2010: HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 94(1): 30-35

Assmann, G.; Sotlar, K. 2011: HPV-associated squamous cell carcinogenesis. Der Pathologe 32(5): 391-398

Ananiev, J.; Tchernev, G. 2012: HPV-associated verrucous carcinoma of the perianal region--complete remission after surgical excision and postoperative monochemotherapy with methotrexat. Akusherstvo i Ginekologiia 51(1): 54-57

Patra, J.; Dikshit, R.; Bhatia, M.; Ramasundarahettige, C.; Jha, P. 2015: HPV-avertable cancer risks in India: a pooled analysis of 9 observational studies. International Journal of Cancer 136(2): 491-492

Arbyn, M.; Walker, A.; Meijer, C.J.L.M. 2010: HPV-based cervical-cancer screening in China. LANCET. Oncology 11(12): 1112-1113

Schneider, A.; Petry, U.; Erdemoglu, E.; Paavonen, J. 2014: HPV-based screening for prevention of invasive cervical cancer. Lancet 383(9925): 1294-1295

Rübben, A. 2011: HPV-induced diseases. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 62(1): 5

Schmidt, D. 2011: HPV-induced diseases of the female genital tract. Der Pathologe 32(6): 449-450

Davis, E.; Marcus, G. 2017: Causal generative models are just a start. Behavioral and Brain Sciences 40: E262

Louw, L.; Walsh, C. 2008: HPV-induced recurrent laryngeal papillomatosis: dietary fatty acid and micronutrient intakes. Asia Pacific Journal of Clinical Nutrition 17(2): 352-357

Louw, L.; Seedat, R.; Claassen, A. 2008: HPV-induced recurrent laryngeal papillomatosis: fatty acid role-players. Asia Pacific Journal of Clinical Nutrition 17(Suppl 1): 208-211

Louw, L.; Claassen, A.é 2008: HPV-induced recurrent laryngeal papillomatosis: rationale for adjuvant fatty acid therapy. Asia Pacific Journal of Clinical Nutrition 17(2): 187-193

Schmidt-Petruschkat, S. 2007: HPV-infection. MMW Fortschritte der Medizin 149(12): 29-31

Laurence, J. 2008: HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls. Aids Reader 18(7): 345-346

Boccardo, E. 2010: HPV-mediated genome instability: at the roots of cervical carcinogenesis. Cytogenetic and Genome Research 128(1-3): 57-65

Rodríguez-Carunchio, L.; Soveral, I.; Steenbergen, R.D.M.; Torné, A.; Martinez, S.; Fusté, P.; Pahisa, J.; Marimon, L.; Ordi, J.; del Pino, M. 2015: HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. Bjog: An International Journal of Obstetrics and Gynaecology 122(1): 119-127

Ordi, J.; Alejo, M.; Fusté, V.òr.; Lloveras, B.; Del Pino, M.; Alonso, I.; Torné, A. 2009: HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN. American Journal of Surgical Pathology 33(11): 1659-1665

Busch, C.-J.; Kriegs, M.; Laban, S.; Tribius, S.; Knecht, R.; Petersen, C.; Dikomey, E.; Rieckmann, T. 2013: HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 108(3): 495-499

Minassian, M. 2014: HPV-positive head and neck cancers: a review of the literature. Journal of Dental Hygiene: Jdh 88(4): 194-201

Peres, J. 2010: HPV-positive oropharyngeal cancer: data may justify new approach. Journal of the National Cancer Institute 102(19): 1456-1459

Van Kempen, P.M.W.; van Bockel, L.; Braunius, W.W.; Moelans, C.B.; van Olst, M.; de Jong, R.; Stegeman, I.; van Diest, P.J.; Grolman, W.; Willems, S.M. 2014: HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. Cancer Medicine 3(5): 1185-1196

Maxwell, J.H.; Kumar, B.; Feng, F.Y.; McHugh, J.B.; Cordell, K.G.; Eisbruch, A.; Worden, F.P.; Wolf, G.T.; Prince, M.E.; Moyer, J.S.; Teknos, T.N.; Chepeha, D.B.; Stoerker, J.; Walline, H.; Carey, T.E.; Bradford, C.R. 2010: HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head and Neck 32(5): 562-567

Schiech, L. 2010: HPV-related cancer: An equal opportunity danger. Nursing 40(10): 22-28; Quiz: 28-29

Ben Aissa, A.; Mach, N. 2012: HPV-related cancer: should young men be vaccinated?. Revue Medicale Suisse 8(342): 1087-1090

Madeleine, M.M.; Finch, J.L.; Lynch, C.F.; Goodman, M.T.; Engels, E.A. 2013: HPV-related cancers after solid organ transplantation in the United States. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13(12): 3202-3209

Lizano, M.; Berumen, J.; García-Carrancá, A. 2009: HPV-related carcinogenesis: basic concepts, viral types and variants. Archives of Medical Research 40(6): 428-434

Lozza, V.; Pieralli, A.; Corioni, S.; Longinotti, M.; Bianchi, C.; Moncini, D.; Fallani, M.G. 2014: HPV-related cervical disease and oropharyngeal cancer. Archives of Gynecology and Obstetrics 290(2): 375-379

Scaglione, G.; Li Destri, N.; Scibetta, N.; Alio, W.; Prestileo, T. 2011: HPV-related diseases and screening program in male partners. Le Infezioni in Medicina 19(3): 176-181

Marhefka, S.L.; Daley, E.M.; Anstey, E.H.; Vamos, C.A.; Buhi, E.R.; Kolar, S.; Giuliano, A.R. 2012: HPV-related information sharing and factors associated with U.S. men's disclosure of an HPV test result to their female sexual partners. Sexually Transmitted Infections 88(3): 171-176

Kostareli, E.; Holzinger, D.; Bogatyrova, O.; Hielscher, T.; Wichmann, G.; Keck, M.; Lahrmann, B.; Grabe, N.; Flechtenmacher, C.; Schmidt, C.R.; Seiwert, T.; Dyckhoff, G.; Dietz, A.; Höfler, D.; Pawlita, M.; Benner, A.; Bosch, F.X.; Plinkert, P.; Plass, C.; Weichenhan, D.; Hess, J. 2013: HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. Journal of Clinical Investigation 123(6): 2488-2501

Chernock, R.D.; El-Mofty, S.K.; Thorstad, W.L.; Parvin, C.A.; Lewis, J.S. 2009: HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head and Neck Pathology 3(3): 186-194

Kaczmar, J.M.; Tan, K.S.; Heitjan, D.F.; Lin, A.; Ahn, P.H.; Newman, J.G.; Rassekh, C.H.; Chalian, A.A.; O'Malley, B.W.; Cohen, R.B.; Weinstein, G.S. 2016: HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head and Neck 38(1): 59-65

Van Limbergen, E.J.; Dok, R.; Laenen, A.; Hauben, E.; Van den Weyngaert, D.; Voordeckers, M.; De Neve, W.; Duprez, F.; Nuyts, S. 2014: HPV-related oropharyngeal cancers in Flanders (Belgium): a multicenter study. B-Ent 10(1): 7-14

Tornesello, M.L.; Perri, F.; Buonaguro, L.; Ionna, F.; Buonaguro, F.M.; Caponigro, F. 2014: HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches. Cancer Letters 351(2): 198-205

Sanguineti, G.; Pai, S.; Agbahiwe, H.; Ricchetti, F.; Westra, W.; Sormani, M.Pia.; Clemente, S.; Califano, J. 2014: HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V. Acta Oncologica 53(5): 662-668

Melkane, A.E.; Mirghani, H.ït.; Aupérin, A.; Saulnier, P.; Lacroix, L.; Vielh, P.; Casiraghi, O.; Griscelli, F.; Temam, S.ép. 2014: HPV-related oropharyngeal squamous cell carcinomas: a comparison between three diagnostic approaches. American Journal of Otolaryngology 35(1): 25-32

Ozçelik, D.; Unveren, T.; Comunoğlu, N.U.ün.ğ; Yildirim, U.; Gürol, Y.şi.; Senyuva, C. 2009: HPV-related scrotal verrucous carcinoma and anal condyloma acuminatum. European Journal of Dermatology: Ejd 19(6): 649-650

Maniar, K.P.; Nayar, R. 2014: HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines. Advances in Anatomic Pathology 21(5): 341-358

Iavazzo, C.; Fotiou, S.; Salakos, N.; Bakalianou, K.; Kondi-Pafiti, A. 2011: HPV-related verrucous carcinoma of the vulva. A case report and literature review. European Journal of Gynaecological Oncology 32(6): 680-681

Bruchim, I.; Gotlieb, W.H.; Mahmud, S.; Tunitsky, E.; Grzywacz, K.; Ferenczy, A. 2007: HPV-related vulvar intraepithelial neoplasia: outcome of different management modalities. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 99(1): 23-27

Van de Wall, S.; Nijman, H.W.; Daemen, T. 2014: HPV-specific immunotherapy: key role for immunomodulators. Anti-Cancer Agents in Medicinal Chemistry 14(2): 265-279

Mariani, L. 2009: HPV-vaccine and screening programs: the new era of global prevention. Journal of Preventive Medicine and Hygiene 50(2): 90-95

Rose, S.B.; Lawton, B.A.; Lanumata, T.; Hibma, M.; Baker, M.G. 2010: HPV/cervical cancer vaccination: parental preferences on age, place and information needs. Journal of Primary Health Care 2(3): 190-198

Pusiol, T. 2014: HPV11 Positive Endometrioid Carcinoma of the Endometrium with Signet-Ring Cells: Diagnostic Criteria and Review of the Literature. Case Reports in Pathology 2014: 380571

Hu, Y.-X.; Li, M.; Jia, X.-H.; Du, Q.-X.; Miao, F.-T.; Yao, L.; Shen, J.-D. 2013: HPV16 CTL epitope peptide-activated dendritic cell and natural killer co-culture for therapy of cervical cancer in an animal model. Asian Pacific Journal of Cancer Prevention: Apjcp 14(12): 7335-7338

Xue, Y.; Bellanger, S.; Zhang, W.; Lim, D.; Low, J.; Lunny, D.; Thierry, F.ço. 2010: HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Research 70(13): 5316-5325

Sunthamala, N.; Pientong, C.; Ohno, T.; Zhang, C.; Bhingare, A.; Kondo, Y.; Azuma, M.; Ekalaksananan, T. 2014: HPV16 E2 protein promotes innate immunity by modulating immunosuppressive status. Biochemical and Biophysical Research Communications 446(4): 977-982

Prabhavathy, D.; Prabhakar, B.N.; Karunagaran, D. 2014: HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis. Molecular and Cellular Biochemistry 394(1-2): 77-90

Purpura, V.; Belleudi, F.; Caputo, S.; Torrisi, M.R. 2013: HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells. Oncotarget 4(2): 192-205

Liao, S.-J.; Deng, D.-R.; Zeng, D.; Zhang, L.; Hu, X.-J.; Zhang, W.-N.; Li, L.; Jiang, X.-F.; Wang, C.-Y.; Zhou, J.-F.; Wang, S.-X.; Zhang, H.-W.; Ma, D. 2013: HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo. Journal of Huazhong University of Science and Technology. Medical Sciences 33(5): 735-742

Thomas, K.J.; Smith, K.L.; Youde, S.J.; Evans, M.; Fiander, A.N.; Borysiewicz, L.K.; Man, S. 2008: HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function. International Journal of Cancer 122(12): 2791-2799

Sominsky, S.; Kuslansky, Y.; Shapiro, B.; Jackman, A.; Haupt, Y.; Rosin-Arbesfeld, R.; Sherman, L. 2014: HPV16 E6 and E6AP differentially cooperate to stimulate or augment Wnt signaling. Virology 468-470: 510-523

Lichtig, H.; Gilboa, D.A.; Jackman, A.; Gonen, P.; Levav-Cohen, Y.; Haupt, Y.; Sherman, L. 2010: HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology 396(1): 47-58

Epshtein, A.; Jackman, A.; Gonen, P.; Sherman, L. 2009: HPV16 E6 oncoprotein increases cell adhesion in human keratinocytes. Archives of Virology 154(1): 55-63

Gokhale, P.S.; Sonawani, A.; Idicula-Thomas, S.; Kerkar, S.; Tongaonkar, H.; Mania-Pramanik, J. 2014: HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants. Journal of Medical Virology 86(6): 968-974

Pastuszak-Lewandoska, D.; Bartosińska-Dyc, A.; Migdalska-Sęk, M.; Czarnecka, K.H.; Nawrot, E.; Domańska, D.; Szyłło, K.; Brzeziańska, E. 2014: HPV16 E6*Ii gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study. Medical Oncology 31(3): 842

Hu, Y.; Ye, F.; Lu, W.; Hong, D.; Wan, X.; Xie, X. 2009: HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells. Cancer Investigation 27(3): 298-306

Hellner, K.; Mar, J.; Fang, F.; Quackenbush, J.; Münger, K. 2009: HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology 391(1): 57-63

Miller, J.; Dakic, A.; Chen, R.; Palechor-Ceron, N.; Dai, Y.; Kallakury, B.; Schlegel, R.; Liu, X. 2013: HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. Plos Pathogens 9(4): E1003284

Cardone, R.A.; Busco, G.; Greco, M.R.; Bellizzi, A.; Accardi, R.; Cafarelli, A.; Monterisi, S.; Carratù, P.; Casavola, V.; Paradiso, A.; Tommasino, M.; Reshkin, S.J. 2008: HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha. Plos one 3(10): E3529

Lorincz, A.T.; Brentnall, A.R.; Vasiljević, N.ša.; Scibior-Bentkowska, D.; Castanon, A.; Fiander, A.; Powell, N.; Tristram, A.; Cuzick, J.; Sasieni, P. 2013: HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology. International Journal of Cancer 133(3): 637-644

Abban, C.Y.; Bradbury, N.A.; Meneses, P.I. 2008: HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. American Journal of Therapeutics 15(4): 304-311

Ronco, G.; Franceschi, S.; Segnan, N. 2011: HPV16 and HPV18 genotyping in cervical cancer screening. LANCET. Oncology 12(9): 831-832

Kafali, H. 2008: HPV16 and increased risk of recurrence after treatment for CIN. Gynecologic Oncology 109(2): 309

Vrdoljak-Mozetič, D.; Krašević, M.; Verša Ostojić, D.; Štemberger-Papić, S.; Rubeša-Mihaljević, R.; Bubonja-Šonje, M. 2015: HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions. Cytopathology: Official Journal of the British Society for Clinical Cytology 26(1): 10-18

Collina, G.; Morandi, L.; Bianchi, T. 2008: HPV16 identification in pigmented lesions of genital skin. Pathologica 100(3): 206

Aksoy, P.ın.; Abban, C.Y.; Kiyashka, E.; Qiang, W.; Meneses, P.I. 2014: HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing. Virology 449: 45-52

Lei, Y.; Hu, C.; Xu, H.; Tian, Y. 2013: HPV16 infection regulates RASSF1A transcription mediated by p53. Molecular Medicine Reports 8(2): 413-418

Mirabello, L.; Frimer, M.; Harari, A.; McAndrew, T.; Smith, B.; Chen, Z.; Wentzensen, N.; Wacholder, S.; Castle, P.E.; Raine-Bennett, T.; Schiffman, M.; Burk, R.D. 2015: HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. International Journal of Cancer 136(4): E146-E153

Cardeal, L.B.d.S.; Boccardo, E.; Termini, L.; Rabachini, T.; Andreoli, M.A.; di Loreto, C.; Longatto Filho, A.; Villa, L.L.; Maria-Engler, S.S. 2012: HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis. Plos one 7(3): E33585

Kaewprag, J.; Umnajvijit, W.; Ngamkham, J.; Ponglikitmongkol, M. 2013: HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases. Plos one 8(8): E71611

Lin, S.-W.; Ghosh, A.; Porras, C.; Markt, S.C.; Rodriguez, A.C.; Schiffman, M.; Wacholder, S.; Kemp, T.J.; Pinto, L.A.; Gonzalez, P.; Wentzensen, N.; Esser, M.T.; Matys, K.; Meuree, A.; Quint, W.; van Doorn, L.-J.; Herrero, R.; Hildesheim, A.; Safaeian, M.; Alfaro, M.; Barrantes, M.; Bratti, M. C.; Cárdenas, F.; Cortés, B.; Espinoza, A.; Estrada, Y.; Gonzalez, P.; Guillén, D.; Herrero, R.; Jimenez, S.E.; Morales, J.; Morera, L.A.; Pérez, E.; Porras, C.; Rodriguez, A.C.; Villegas, M.; Freer, E.; Bonilla, J.; Silva, S.; Atmella, I.; Ramírez, M.; Macklin, N.; Hildesheim, A.; Lowy, D.R.; Schiffman, M.; Schiller, J.T.; Sherman, M.; Solomon, D.; Wacholder, S.; Pinto, L.; Garcia-Pineres, A.; Eklund, C.; Hutchinson, M.; Quint, W.; van Doorn, L 2013: HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. Plos one 8(1): E53067

Van Poelgeest, M.I.E.; Welters, M.J.P.; van Esch, E.M.G.; Stynenbosch, L.F.M.; Kerpershoek, G.; van Persijn van Meerten, E.L.; van den Hende, M.; Löwik, M.J.G.; Berends-van der Meer, D.M.A.; Fathers, L.M.; Valentijn, A.R.P.M.; Oostendorp, J.; Fleuren, G.J.; Melief, C.J.M.; Kenter, G.G.; van der Burg, S.H. 2013: HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase Ii trial. Journal of Translational Medicine 11: 88

Haddad, R.; Crum, C.; Chen, Z.; Krane, J.; Posner, M.; Li, Y.; Burk, R. 2008: HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncology 44(8): 812-815

Lepique, A.P.; Daghastanli, K.R.P.; Cuccovia, I.M.; Villa, L.L. 2009: HPV16 tumor associated macrophages suppress antitumor T cell responses. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(13): 4391-4400

Zuna, R.E.; Tuller, E.; Wentzensen, N.; Mathews, C.; Allen, R.A.; Shanesmith, R.; Dunn, S.T.; Gold, M.A.; Wang, S.S.; Walker, J.; Schiffman, M. 2011: HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infectious Agents and Cancer 6: 19

Bergot, A.-S.; Ford, N.; Leggatt, G.R.; Wells, J.W.; Frazer, I.H.; Grimbaldeston, M.A. 2014: HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells. Plos Pathogens 10(10): E1004466

Mehlhorn, G.; Hautmann, S.K.; Koch, M.C.; Strehl, J.D.; Hartmann, A.; Hilfrich, R.; Beckmann, M.W.; Griesser, H. 2014: HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. Anticancer Research 34(9): 5127-5132

Stone, S.C.; Rossetti, R.A.M.; Bolpetti, A.; Boccardo, E.; Souza, P.S.d.A.; Lepique, A.P. 2014: HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells. Journal of Leukocyte Biology 96(4): 619-631

Nakayama, C.; Hata, H.; Imafuku, K.; Toyonaga, E.; Shimizu, H. 2016: HPV16-related pigmented Bowen's disease on the palm. Journal of the European Academy of Dermatology and Venereology: Jeadv 30(1): 138-140

Liao, S.; Deng, D.; Hu, X.; Wang, W.; Li, L.; Li, W.; Zhou, J.; Xu, G.; Meng, L.; Wang, S.; Ma, D. 2013: HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7. International Journal of Molecular Medicine 31(1): 120-128

Kemp, T.J.; Hildesheim, A.; Safaeian, M.; Dauner, J.G.; Pan, Y.; Porras, C.; Schiller, J.T.; Lowy, D.R.; Herrero, R.; Pinto, L.A. 2011: HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine 29(11): 2011-2014

Coupé, V.M.H.; van Ginkel, J.; de Melker, H.E.; Snijders, P.J.F.; Meijer, C.J.L.M.; Berkhof, J. 2009: HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness. International Journal of Cancer 124(4): 970-978

Liang, F.; Kina, S.; Takemoto, H.; Matayoshi, A.; Phonaphonh, T.; Sunagawa, N.; Arakaki, K.; Arasaki, A.; Kuang, H.; Sunakawa, H. 2011: HPV16E6-dependent c-fos expression contributes to AP-1 complex formation in SiHa cells. Mediators of Inflammation 2011: 263216

Guo, H.; Hu, R.; Guan, X.; Guo, F.; Zhao, S.; Zhang, X. 2014: HPV16E7 silencing enhances susceptibility of CaSki cells to natural killer cells. Molecular Medicine Reports 9(4): 1351-1354

Yin, R.; Zheng, W.; Hao, F.; Yang, X.-C.; Zhong, B.-Y.; Li, Q.-J. 2009: HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity. Journal of Dermatological Science 55(2): 116-122

Kajitani, N.; Satsuka, A.; Yoshida, S.; Sakai, H. 2013: HPV18 E1^E4 is assembled into aggresome-like compartment and involved in sequestration of viral oncoproteins. Frontiers in Microbiology 4: 251

Baldez da Silva, M.F.P.T.; Chagas, B.S.; Guimarães, V.; Katz, L.M.C.; Felix, P.M.; Miranda, P.M.; Lima, A.A.; Arraes, L.C.; Martins, D.B.G.; Lima Filho, J.L.; Stocco, R.C.; Crovella, S.; Freitas, A.C.; Beçak, W. 2009: HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genetics and Molecular Research: Gmr 8(4): 1437-1443

Akgül, B.; Ghali, L.; Davies, D.; Pfister, H.; Leigh, I.M.; Storey, A. 2007: HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Experimental Dermatology 16(7): 590-599

Avitzur, O. 2012: HPV: a danger at any age. Consumer Reports 77(2): 12

Shaughnessy, J.N.; Farghaly, H.; Wilson, L.; Redman, R.; Potts, K.; Bumpous, J.; Silverman, C.; Dunlap, N.E. 2014: HPV: a factor in organ preservation for locally advanced larynx and hypopharynx cancer?. American Journal of Otolaryngology 35(1): 19-24

Reynolds, J.P. 2011: HPV: a look into new methods for high-risk testing. Mlo: Medical Laboratory Observer 43(7): 10; 12 14; Quiz 16, 18

Hathaway, J.K. 2012: HPV: diagnosis, prevention, and treatment. Clinical Obstetrics and Gynecology 55(3): 671-680

Tildon-Burton, J.E. 2007: HPV: government mandates vs. individual rights. Delaware Medical Journal 79(4): 143-144

Zhang, G.Lan.; Riemer, A.B.; Keskin, D.B.; Chitkushev, L.; Reinherz, E.L.; Brusic, V. 2014: HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology. Database: the Journal of Biological Databases and Curation 2014: Bau031

Lu, S.; Wang, D.; Jiang, S.P.; Xiang, Y.; Lu, J.; Zeng, J. 2010: HPW/MCM-41 phosphotungstic acid/mesoporous silica composites as novel proton-exchange membranes for elevated-temperature fuel cells. Advanced Materials 22(9): 971-976

Barišić-Jäger, E.; Kręcioch, I.; Hosiner, S.; Antic, S.; Dorner, S. 2013: HPat a decapping activator interacting with the miRNA effector complex. Plos one 8(8): E71860

Haas, G.; Braun, J.E.; Igreja, C.át.; Tritschler, F.; Nishihara, T.; Izaurralde, E. 2010: HPat provides a link between deadenylation and decapping in metazoa. Journal of Cell Biology 189(2): 289-302

Qin, Z.S.; Yu, J.; Shen, J.; Maher, C.A.; Hu, M.; Kalyana-Sundaram, S.; Yu, J.; Chinnaiyan, A.M. 2010: HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. Bmc Bioinformatics 11: 369

Park, Y.-H.; Lee, C.-R.; Choe, M.; Seok, Y.-J. 2013: HPr antagonizes the anti-σ70 activity of Rsd in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 110(52): 21142-21147

Pinedo, C.A.; Gage, D.J. 2009: HPrK regulates succinate-mediated catabolite repression in the gram-negative symbiont Sinorhizobium meliloti. Journal of Bacteriology 191(1): 298-309

Prince, B.; Lundevall, J. 2013: A growing codependency: compounding pharmacy and safety. International Journal of Pharmaceutical Compounding 17(6): 485-489

Kroken, P. 2009: HR 6331: Medicare mandated imaging accreditation. Radiology Management 31(2): 27-28

Wicks, J.R.; Oldridge, N.B.; Nielsen, L.K.; Vickers, C.E. 2011: HR index--a simple method for the prediction of oxygen uptake. Medicine and Science in Sports and Exercise 43(10): 2005-2012

Jones-Rikkers, C.G. 2010: HR policies can protect you from harassment cases. Mgma Connexion 10(8): 44-47

Sammons, R. 2010: HR policy. Positive change. Health Service Journal 120(6225): 24

Tye, G.Ah. 2009: HR rocks (and Whitney too!). Radiology Management 31(4): 60

Herber, A.P. 2013: HR space: the evolution of human rights protection gender identity and gender expression. Health Law in Canada 33(3): 77-78

Gander, P. 2008: HR workforce. Ever present. Health Service Journal 2008: 32-33

Ray, N.; Blackburn, L.A.; Doms, R.W. 2009: HR-2 mutations in human immunodeficiency virus type 1 gp41 restore fusion kinetics delayed by HR-1 mutations that cause clinical resistance to enfuvirtide. Journal of Virology 83(7): 2989-2995

Görling, B.; Bräse, S.; Luy, B. 2012: HR-HSBC: Measuring heteronuclear one-bond couplings with enhanced resolution. Magnetic Resonance in Chemistry: Mrc 50(Suppl 1): S58-S62

Jaeger, R.J.R.; Lamshöft, M.; Gottfried, S.; Spiteller, M.; Spiteller, P. 2013: HR-MALDI-MS imaging assisted screening of β-carboline alkaloids discovered from Mycena metata. Journal of Natural Products 76(2): 127-134

Choi, J.S.; Baek, H.-M.; Kim, S.; Kim, M.J.; Youk, J.H.; Moon, H.J.; Kim, E.-K.; Han, K.H.; Kim, D.-H.; Kim, S.I.; Koo, J.S. 2012: HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. Plos one 7(12): E51712

Wang, A.S.; Lodi, A.; Rivera, L.B.; Izquierdo-Garcia, J.L.; Firpo, M.A.; Mulvihill, S.J.; Tempero, M.A.; Bergers, G.; Ronen, S.M. 2014: HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. Nmr in Biomedicine 27(11): 1361-1370

De Oliveira, C.S.; Carlos, E.F.; Vieira, L.G.E.; Lião, L.M.; Alcantara, G.B. 2014: HR-MAS NMR metabolomics of 'Swingle' citrumelo rootstock genetically modified to overproduce proline. Magnetic Resonance in Chemistry: Mrc 52(8): 422-429

Ilg, K.; Zandomeneghi, G.; Rugarabamu, G.; Meier, B.H.; Aebi, M. 2013: HR-MAS NMR reveals a pH-dependent LPS alteration by de-O-acetylation at abequose in the O-antigen of Salmonella enterica serovar Typhimurium. Carbohydrate Research 382: 58-64

Elbayed, K.; Berl, V.ér.; Debeuckelaere, C.; Moussallieh, F.ço.-M.; Piotto, M.; Namer, I.-J.; Lepoittevin, J.-P. 2013: HR-MAS NMR spectroscopy of reconstructed human epidermis: potential for the in situ investigation of the chemical interactions between skin allergens and nucleophilic amino acids. Chemical Research in Toxicology 26(1): 136-145

Tripathi, P.; Somashekar, B.S.; Ponnusamy, M.; Gursky, A.; Dailey, S.; Kunju, P.; Lee, C.T.; Chinnaiyan, A.M.; Rajendiran, T.M.; Ramamoorthy, A. 2013: HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease. Journal of Proteome Research 12(7): 3519-3528

Varga, P.; Pahr, D.H.; Baumbach, S.; Zysset, P.K. 2010: HR-pQCT based FE analysis of the most distal radius section provides an improved prediction of Colles' fracture load in vitro. Bone 47(5): 982-988

Pahr, D.H.; Dall'Ara, E.; Varga, P.; Zysset, P.K. 2012: HR-pQCT-based homogenised finite element models provide quantitative predictions of experimental vertebral body stiffness and strength with the same accuracy as μFE models. Computer Methods in Biomechanics and Biomedical Engineering 15(7): 711-720

Krieger, J.ür.; Gondesen, I.; Forstner, M.; Gohl, T.; Dewer, Y.; Breer, H. 2009: HR11 and HR13 receptor-expressing neurons are housed together in pheromone-responsive sensilla trichodea of male Heliothis virescens. Chemical Senses 34(6): 469-477

Khan, O.; Fotheringham, S.; Wood, V.; Stimson, L.; Zhang, C.; Pezzella, F.; Duvic, M.; Kerr, D.J.; La Thangue, N.B. 2010: HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proceedings of the National Academy of Sciences of the United States of America 107(14): 6532-6537

Beigel, D. 2012: HR3630 and CMS: the small print and small labs. Mlo: Medical Laboratory Observer 44(6): 46

Sáenz-Mata, J.; Jiménez-Bremont, J.F. 2012: HR4 gene is induced in the Arabidopsis-Trichoderma atroviride beneficial interaction. International Journal of Molecular Sciences 13(7): 9110-9128

Roebuck, C. 2009: HR: the workforce drives efficiency. Health Service Journal 119(6177): 24

Cogoi, S.; Shchekotikhin, A.E.; Xodo, L.E. 2014: HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property. Nucleic Acids Research 42(13): 8379-8388